<SEC-DOCUMENT>0001104659-21-071417.txt : 20210525
<SEC-HEADER>0001104659-21-071417.hdr.sgml : 20210525
<ACCEPTANCE-DATETIME>20210524200010
ACCESSION NUMBER:		0001104659-21-071417
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210629
FILED AS OF DATE:		20210525
DATE AS OF CHANGE:		20210524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FENNEC PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001211583
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32295
		FILM NUMBER:		21956962

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 13628
		STREET 2:		68 TW ALEXANDER DRIVE
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709
		BUSINESS PHONE:		(919) 636-4530

	MAIL ADDRESS:	
		STREET 1:		PO BOX 13628
		STREET 2:		68 TW ALEXANDER DRIVE
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FENNEC PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20140903

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADHEREX TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20021223
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm212691d1_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>SECURITIES AND
EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Washington, D.C.
20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Proxy Statement
Pursuant to Section 14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>of the Securities
and Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>(Amendment No.
 &nbsp;&nbsp;&nbsp;&nbsp;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">Filed by
the Registrant&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">Filed by
a Party other than the Registrant&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">Check the
appropriate box</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">x</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FENNEC PHARMACEUTICALS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Registrant as Specified In Its
Charter)&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.55pt; text-align: justify; text-indent: -6.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate
box)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">x</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title of each class of securities to which the transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Aggregate number of securities to which the transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Proposed Maximum aggregate value of the transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0"></TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of the filing.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amount Previously Paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Form, Schedule or Registrant Statement No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Filing Party:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="margin: 0pt"></P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FENNEC PHARMACEUTICALS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE HELD ON JUNE 29, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOTICE IS HEREBY GIVEN
</B>that the annual meeting (the &#8220;<B>Meeting</B>&#8221;) of the holders of common shares (&#8220;<B>Common Shares</B>&#8221;) in
the capital of Fennec Pharmaceuticals Inc., 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, 27709 (&#8220;<B>Fennec</B>&#8221;
or the &#8220;<B>Corporation</B>&#8221;) will be held on June 29, 2021 at 1:00 p.m. EDT (10:00 a.m. PDT) at the law offices of Rutan
&amp; Tucker, LLP at 18575 Jamboree Road, 9<SUP>th</SUP> Floor, Irvine, CA 92612-2559 and online by visiting <U>www.virtualshareholdermeeting.com</U>/FENC2021,
where you will be able to listen to the meeting live, submit questions, and vote, for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">to receive the consolidated financial statements of the Corporation for the year ended December 31, 2020,
together with the report of the auditors thereon;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">to elect the six directors named in the Management Proxy Circular;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">to appoint auditors and to authorize the directors of the Corporation to fix the auditors&#8217; remuneration;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">to vote, on an advisory (non-binding) basis, on the compensation of our named executive officers; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">to transact such further or other business as may properly come before the Meeting or any adjournment
thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders attending the Meeting online may
register and log into the live audio webcast platform beginning at 12:45 p.m. EDT. We would appreciate your early registration so that
the Meeting may start promptly at 1:00 p.m. EDT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors of Fennec has fixed 5:00
p.m. EDT on May 17, 2020 (the &#8220;<B>Record Date</B>&#8221;), as the record date for determining the holders of record of Common Shares
who are entitled to receive notice of the Meeting and to attend and vote at the Meeting and any adjournment or postponement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec acknowledges and continues to follow the
restrictions regarding travel and gatherings that are currently in place due to the Coronavirus (COVID-19) pandemic and is holding a
&#8220;hybrid&#8221; meeting that includes both an in-person and virtual online component. Only registered shareholders or proxyholders
for registered shareholders will be permitted to attend the Meeting. In particular, Shareholders may attend the Meeting in person, online
by visiting <U>www.virtualshareholdermeeting.com</U>/FENC2021, or may be represented at the Meeting by proxy. To reduce the spread of
Coronavirus (COVID-19), many provincial and state governments, including British Columbia and California, have issued emergency orders
restricting travel outside the home, organized public events and social gatherings. If laws or orders limiting travel to, or the number
of attendees permitted at, the Meeting are in place on the date of the Meeting, Fennec intends to proceed with the Meeting to the extent
it is lawfully permitted to do so and quorum is satisfied. Regardless of whether any such orders have been lifted at the time of the
Meeting, there may be continuing public health recommendations in place to reduce the spread of Coronavirus (COVID-19). Further, in the
interest of protecting the health and safety of Fennec&#8217;s shareholders and employees and the communities in which they live, Fennec
intends to adopt screening or other measures for identifying Coronavirus (COVID-19) symptoms or risk factors as may be recommended or
required by applicable health authorities at the Meeting and reserves the right to refuse admission to a shareholder or proxyholder seeking
to attend the Meeting in person but who Fennec believes may pose a health risk to attendees at the Meeting. <B>Accordingly, we strongly
encourage shareholders to vote by attending the meeting online <U>www.virtualshareholdermeeting.com</U>/FENC2021 or by completing and
submitting the enclosed form of proxy, rather than attending in person. By doing so, a shareholder&#8217;s shares will be represented
at the Meeting and its wishes on matters for decision at the Meeting will be made known to the board and management of Fennec. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The Corporation reserves
the right to change the format of the Meeting if it determines that doing so is necessary to protect the health and safety of its shareholders,
employees, and community and comply with applicable requirements. Should the determination to hold a virtual-only Meeting be made, the
Corporation will inform shareholders by way of a news release. The Corporation may notify shareholders of such change without sending
additional proxy materials.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Proxies to be used at the
Meeting must be received no later than 1:00 p.m. (EDT) on June 25, 2021 and, if the Meeting is postponed or adjourned, no later than 48
hours (excluding weekends and statutory holidays) preceding the reconvened Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Important Notice Regarding the Availability
of Proxy Materials for the Shareholder Meeting to be held on June 29, 2021:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>This Notice, Management Proxy Circular and
the Corporation&#8217;s Annual Report on Form 10-K are available to you on the Internet at <U>www.proxyvote.com</U>. We encourage you
to access and review all of the important information contained in these materials before voting. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DATED at Research Triangle Park, North Carolina
this 14<SUP>th</SUP> day of May, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors of Fennec Pharmaceuticals Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <B>Khalid Islam</B></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Khalid Islam</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FENNEC PHARMACEUTICALS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MANAGEMENT PROXY CIRCULAR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Unless otherwise stated, information contained
in this management proxy circular (the &#8220;<B>Circular</B>&#8221;) is given as of May 10, 2021</I>. <I>Except as otherwise indicated,
all amounts are expressed in United States dollars. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Meeting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Circular is furnished in connection with
the solicitation of proxies by management of Fennec Pharmaceuticals Inc., 68 TW Alexander Drive, PO Box 13628, Research Triangle Park,
NC, 27709 (&#8220;<B>Fennec</B>&#8221; or the &#8220;<B>Corporation</B>&#8221;) for use at the annual meeting (the &#8220;<B>Meeting</B>&#8221;)
of the shareholders of Fennec to be held at 1:00 p.m. EDT (10:00 a.m. PDT) on June 29, 2021 at the law offices of Rutan &amp; Tucker,
LLP at 18575 Jamboree Road, 9<SUP>th</SUP> Floor, Irvine, CA 92612-2559 and online by visiting www.virtualshareholdermeeting.com/FENC2021,
and at any adjournment thereof, for the purposes set forth in the accompanying notice of annual general meeting (the &#8220;<B>Notice
of Meeting</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This year, as a precautionary measure to proactively
address the public health impact of coronavirus disease (COVID-19), to mitigate health and safety risks to our shareholders, employees
and other stakeholders, and to abide by applicable laws and emergency orders, the Meeting will be held in a &#8220;hybrid format&#8221;
with both in-person and virtual online component, which will be conducted via live audio webcast. Shareholders will have an equal opportunity
to participate in the Meeting online, regardless of geographic location. Registered shareholders and duly appointed proxyholders will
be able to participate in the Meeting, ask questions and vote, all in real time, provided they are connected to the Internet and comply
with all of the requirements set out in the Circular. Non-registered shareholders who have not duly appointed themselves as proxyholder
will be able to participate in the Meeting and also ask questions, but will not be able to vote at the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Solicitation of Proxies </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The persons named in the form of proxy accompanying
this Circular are officers and/or directors of Fennec. A holder (a &#8220;<B>Shareholder</B>&#8221;) of Fennec common shares (the &#8220;<B>Common
Shares</B>&#8221;) has the right to appoint a person, other than the persons named in the form of proxy accompanying this Circular, as
nominee to attend and act for and on behalf of such Shareholder at the Meeting, and may exercise such right by inserting the name of such
person in the blank space provided on the form of proxy, or by executing a proxy in a form similar to the form of proxy accompanying this
Circular. <FONT STYLE="color: windowtext">Your proxy may be revoked by written notice given to our Secretary at our headquarters at any
time before being voted. You may also revoke your proxy by submitting a proxy with a later date or by voting during your virtual attendance
at the Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The solicitation of proxies for the Meeting will
be primarily by mail, but proxies may also be solicited personally or by telephone by employees or agents of Fennec. Employees of Fennec
will not receive any extra compensation for such activities. Fennec will pay brokers or other persons holding Common Shares in their own
names, or in the names of nominees, for their reasonable expenses for sending proxies and proxy material to beneficial owners of Common
Shares and requesting authority to execute proxies in respect of such Common Shares. The solicitation of proxies by this Circular is being
made by or on behalf of the management of Fennec and its board of directors (the &#8220;<B>Board</B>&#8221;) and the total cost of this
solicitation will be borne by Fennec.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your name appears on a share certificate, you
are considered a &#8220;registered shareholder&#8221;. See the &#8220;Registered Shareholder Voting&#8221; subsection below for details
on how to vote. If your Common Shares are not registered in your name and are held in the name of a nominee, you are considered a &#8220;non-registered
shareholder&#8221; (for example, your Common Shares are listed in an account statement provided to you by your securities broker). If
this is the case, see the &#8220;Non-Registered Shareholder Voting&#8221; subsection below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Registered Shareholder Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your name appears on a share certificate,
you are considered as a &#8220;registered shareholder&#8221;. You may appoint someone else to vote for you as your proxy holder at
the Meeting by using the form of proxy sent to you by Broadridge. The persons named in the form of proxy are directors or officers
of the Corporation. As a shareholder, you have the right to appoint as proxy holder a person other than those whose names are
printed as proxy holders in the form of proxy, by inserting the name of your chosen proxy holder in the blank space provided for
that purpose in the form of proxy. In either case, the completed form of proxy must be delivered to Broadridge by following one (1)
of the methods below, prior to the Meeting at which it is to be used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A person acting as proxy holder need not be
a shareholder of the Corporation. Make sure that the person you appoint is aware that he or she is appointed and participates in the
Meeting, otherwise your vote will not be taken into account. You can choose from among three different ways to vote your Common
Shares by proxy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>By Telephone:</I> Call
the toll-free number indicated on the form of proxy and follow the instructions. If you choose to vote by telephone, you cannot appoint
any person other than the directors or officers named on your form of proxy as your proxy holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>On the Internet:</I>&#9;Go
to www.proxyvote.com and follow the instructions on the screen. If you choose to vote via the Internet, you can appoint a person other
than the directors or officers named in the form of proxy as your proxy holder. This person does not have to be a shareholder. Make sure
that the person you appoint is aware that he or she has been appointed and participates in the Meeting, otherwise your vote will not be
taken into account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>By Mail:</I> If you have
elected to receive paper materials, complete your form of proxy and return it in the envelope provided. If you return your proxy by mail,
you can appoint a person other than the directors or officers named in the form of proxy as your proxy holder. This person does not have
to be a shareholder. If the Shareholder is a corporation, the proxy must be executed by an officer or properly appointed attorney. Fill
in the name of the person you are appointing in the blank space provided on the form of proxy. Complete your voting instructions on the
form of proxy, and date and sign the form. Make sure that the person you appoint is aware that he or she has been appointed and participates
in the Meeting, otherwise your vote will not be taken into account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The deadline for receiving duly completed forms
of proxy or a vote by telephone or over the Internet is 1:00 p.m. (EDT) on June 25, 2021 or, if the Meeting is adjourned or postponed,
not later than 48 hours (excluding weekends and statutory holidays) before the time of the reconvened Meeting.</B> The proxy deadline
may be waived or extended by the Chairman of the Meeting, in his sole discretion without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How Proxies Will be Voted</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Shares represented by a proxy at the
Meeting will be voted for or withheld from voting in each of the election of directors, appointment of auditors and authorizing the Board
to fix the auditors remuneration, and for or against the advisory vote on the compensation of our named executive officers (together,
the &#8220;<B>Ordinary Matters</B>&#8221;), in each case accordance with the instructions of the Shareholder. If no choice is specified
in the proxy or the instructions are not certain, the persons named in the form of proxy accompanying this Circular will vote FOR all
of the matters proposed by management at the Meeting and described in the Notice of Meeting and in the discretion of the person appointed
on all other matters (if any) upon which the Shareholder appointing the proxy is entitled to cast a vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The form of proxy accompanying this Circular,
when properly completed and executed, confers discretionary authority upon the persons named therein with respect to any amendment or
variation to the matters identified in the Notice of Meeting and with respect to other matters which may properly come before the Meeting.
Management of Fennec and the Board knows of no matters to come before the Meeting other than those referred to in the Notice of Meeting.
However, if any other matters (other than the election of directors not currently named in this Circular) that are not now known to management
of Fennec or the Board should properly come before the Meeting, the Common Shares represented by proxies given in favour of the persons
named in the form of proxy accompanying this Circular will be voted on such matters in accordance with the discretion of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-Registered Shareholder Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This section applies to beneficial holders
of Common Shares who are not registered holders. The information set forth in this section is of significant importance to many holders
of Common Shares, as a substantial number of Shareholders do not hold Common Shares in their own name.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only registered holders of Common Shares, or
the persons that they appoint as proxies, are permitted to attend and vote at the Meeting. In many cases, Common Shares are
beneficially owned by a shareholder and are registered in the name of an intermediary such as a bank, broker or other nominee. <FONT STYLE="font-size: 10pt">If
your Common Shares are not registered in your name and are held in the name of a nominee, you are considered a &#8220;non-registered
shareholder&#8221;. For example, if your Common Shares are listed in an account statement provided to you by your securities broker,
those Common Shares will, in all likelihood, not be registered in your name. Such Common Shares will more likely be registered in
the name of a depository or of such broker or an agent of such broker. Without specific instructions, brokers and their agents or
nominees are prohibited from voting shares for their clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-registered shareholders are either &#8220;objecting
beneficial owners&#8221; or &#8220;OBOs&#8221;, who object that intermediaries disclose information about their identity and ownership
in the Corporation or &#8220;non-objecting beneficial owners&#8221; or &#8220;NOBOs&#8221;, who do not object to such disclosure. The
Corporation does not send proxy-related materials directly to OBOs or NOBOs and intends to pay for an intermediary to deliver to OBOs
and NOBOs the proxy-related materials. If you are a non-registered shareholder, there are two ways that you can vote your Common Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Provide Voting Instructions
to your Broker</I>. Applicable securities laws require your nominee to seek voting instructions from you in advance of the Meeting. Accordingly,
you will receive or have already received from your nominee a request for voting instructions for the number of Common Shares you hold.
Every nominee has its own mailing procedures and provides its own signature and return instructions, which should be carefully followed
by non-registered shareholders to ensure that their Common Shares are voted at the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Attending the Virtual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All Shareholders are encouraged to attend the
Meeting online, which will be conducted via live audio webcast. The Meeting online enables registered shareholders to participate in the
Meeting and ask questions, all in real time. Registered shareholders can vote at the appropriate times by completing a ballot online during
the Meeting. <B>If you are a registered shareholder and wish to vote at the Meeting, you do not need to complete or return the form of
proxy.</B> However, even if you plan to participate in the Meeting, you may vote your Common Shares in advance, so that your vote will
be counted if you later decide not to participate in the Meeting. Shareholders and proxyholders can access the Meeting by visiting www.virtualshareholdermeeting.com/FENC2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To participate in the Meeting, you will need
the 16-digit control number included on your proxy or voting instruction form or on the instructions that accompany your proxy
materials. The control number located on the form of proxy or voting instruction form or in the email notification you received is
your control number. If you participate in the Meeting online, it is important that you are connected to the Internet at all times
during the Meeting in order to vote when balloting commences. It is your responsibility to ensure connectivity for the duration of
the Meeting. You should allow ample time to check into the Meeting online and complete the related procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Record Date and Entitlement to Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Record Date for the purpose of determining
Shareholders entitled to receive the Circular and to vote at the Meeting has been fixed as 5:00 p.m. EDT on May 17, 2021 (the &#8220;<B>Record
Date</B>&#8221;). Each Shareholder at the close of business (5:00 p.m. EDT) on the Record Date is entitled to attend the Meeting in person
or by proxy and to cast one vote for each Common Share held by such Shareholder on the Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Quorum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the Corporation&#8217;s articles,
the quorum for the transaction of business at any meeting of shareholders shall be two or more persons present in person or represented
by proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Securities and Principal Holders of
Voting Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As at May 10, 2021, there were 26,002,853 Common
Shares issued and outstanding. Each Common Share carries the right to one vote at the Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership of the Common Shares in
the following table is determined in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the
&#8220;<B>SEC</B>&#8221;). Under these rules, a person is deemed to beneficially own a Common Share if that person has or shares
voting power or investment power with respect to that share, or has the right to acquire beneficial ownership of that share within
60 days, including through the exercise of any option, warrant or other right or the conversion or any other security. Shares
issuable under stock options and warrants are deemed outstanding for computing the percentage of the person holding options or
warrants but are not outstanding for computing the percentage of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As at May 10, 2021, the directors and Named Executive
Officers (defined below under &#8220;Executive Compensation&#8211;Summary Compensation Table&#8221;) of Fennec and, to the knowledge of
the directors and Named Executive Officers of Fennec, after reasonable enquiry, their respective associates, as a group, beneficially
owned, directly or indirectly, or exercised control or direction over 349,851 Common Shares (approximately 1.35% of all outstanding Common
Shares on such date) and options and warrants to purchase 2,029,800 Common Shares (approximately 7.80% of the aggregate of all outstanding
Common Shares on such date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the number of Common
Shares beneficially owned as of May 10, 2021 by: (1) each director and Named Executive Officer; (2) all directors and Named Executive
Officers as a group; and (3) each person known by us to own 5 percent or more of the outstanding Common Shares. The percentage of beneficial
ownership for the following table is based upon 26,002,853 Common Shares outstanding as of May 10, 2021. Except as indicated below, the
security holders listed possess sole voting and investment power with respect to the shares beneficially owned by that person. The address
for each listed shareholder who is a director or a Named Executive Officer is c/o Fennec Pharmaceuticals Inc., PO Box 13628, 68 TW Alexander
Drive, Research Triangle Park, North Carolina 27709.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Name</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common shares</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common shares Options <BR>
Exercisable Within 60 <BR>
Days</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Common shares<BR>
 Purchase Warrants<BR>

    Exercisable Within<BR>
 60 Days</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total Stock and Stock Based Holdings <SUP>(1)</SUP></B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>% <BR>
Ownership<SUP>(1)</SUP></B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; font-size: 10pt; text-align: left">Adrian J. Haigh</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">233,579</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">233,579</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">0.89</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Khalid Islam</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">313,825</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">313,825</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.19</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Andrade</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">153,273</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">283,611</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">436,884</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.66</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Marco Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,545</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,545</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.44</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Jodi Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Chris A. Rallis</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">191,850</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">191,850</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.73</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Shubh Goel</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">116,668</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">116,668</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.45</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Rostislav Raykov</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">196,578</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">734,722</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">931,300</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.48</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">All Officers and Directors as a Group</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">349,851</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">2,029,800</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">2,379,651</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">9.68</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Southpoint Capital Advisors, LP.<SUP>(2)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,077,214</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,077,214</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.68</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Essetifin SpA<SUP>(3)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,993,694</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,993,694</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15.36</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Sonic Fund II, LP<SUP>(4)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,495,753</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,495,753</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9.60</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Avoro Life Sciences Fund<SUP>(5)</SUP></FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,670,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,670,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6.42</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">For purposes of this table &#8220;beneficial ownership&#8221; is determined in accordance with Rule 13d-3
under the Securities Exchange Act of 1934, as amended, pursuant to which a person or group of persons is deemed to have &#8220;beneficial
ownership&#8221; of any Common Shares that such person or group has the right to acquire within 60 days after May 17, 2021.&nbsp;For purposes
of computing the percentage of outstanding Common Shares held by each person or group of persons named above, any shares that such person
or group has the right to acquire within 60 days after May 17, 2021 are deemed outstanding but are not deemed to be outstanding for purposes
of computing the percentage ownership of any other person or group. As of May 17, 2021, there were 26,002,853 Common Shares issued and
outstanding.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Southpoint Capital Advisors, LP, 623 Fifth Avenue, Suite 2503, New York, New York 10022.&nbsp;John S.
Clark, II holds dispositive power over the shares owned by Southpoint Capital Advisors, LP.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Essetifin SpA, Via Sudafrica 20, Rome, Italy 00144. Mario Artali holds dispositive power over the shares
owned by Essetifin SpA.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">Sonic Fund II, LP, 400 Hobron Lane, Suite 3709, Honolulu, HI 96815. Lawrence Kam holds dispositive power
over the shares owned by Sonic Fund II, LP.</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Avoro Life Sciences Fund, 110 Greene Street, Suite 800, New York, NY 10012. Scott Esptein holds dispositive
power over the shares held by Avoro Life Sciences Fund.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approval Requirements and Eligible Voting Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The election of our directors is subject to our
Majority Voting Policy. See <I>Election of Directors</I> below. Each of the other Ordinary Matters must be approved by a simple majority
of the votes cast by Shareholders, present in person or by proxy at the Meeting. For these purposes, any spoiled votes, illegible votes,
defective votes, abstentions, and broker non-votes will not be considered votes cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than the Ordinary Matters discussed elsewhere
in this Circular, management of Fennec does not intend to present and does not have any reason to believe that others will present, at
the Meeting, any item of business other than those set forth in this Circular. If, however, any other business is properly presented at
the Meeting and may properly be considered and acted upon, proxies will be voted by those named in the applicable form of proxy in their
sole discretion, including with respect to any amendments or variations to the matters identified herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ORDINARY MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Presentation of Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audited financial statements of the Corporation
for the fiscal year ended December 31, 2020, together with the report of the auditors thereon, will be placed before the Meeting. Shareholders
who wish to be added to the mailing list for the annual financial statements and Management&#8217;s Discussion and Analysis should complete
the appropriate sections of the proxy or contact the undersigned at PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, North
Carolina 27709 Attention: Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Election of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of directors of Fennec to be elected
at the Meeting is six (6). The following are the names of the persons for whom it is intended that votes will be cast for their election
as directors of the Corporation pursuant to the proxy which is hereby solicited, unless the Shareholder directs therein otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Dr. Khalid Islam</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Mr. Adrian Haigh</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Mr. Chris A. Rallis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Dr. Marco Brughera</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Dr. Jodi Cook</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Mr. Rostislav Raykov</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The term of office for each such person will be
until Fennec&#8217;s next annual meeting of Shareholders or until such person&#8217;s successor is elected or duly appointed. <B>In the
event that prior to the Meeting any vacancies occur in the slate of nominees submitted above, it is intended that discretionary authority
shall be exercised to vote the proxy hereby solicited (unless otherwise directed as aforesaid) for the election of any other person or
persons as directors. Fennec management is not now aware that any of such nominees would be unwilling to serve as a director if elected.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends that Shareholders
vote FOR the election of the above-named director nominees. The persons named in the enclosed form of proxy will vote FOR the election
of each of the director nominees to hold office until the close of the next annual meeting of Shareholders, unless a Shareholder has specified
in the proxy that his or her Common Shares are to be withheld from voting in respect thereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec has adopted a majority voting policy in
director elections that will apply at any meeting of Shareholders where an uncontested election of directors is held. Pursuant to this
policy, if the number of proxy votes withheld for a particular director nominee is greater than the votes for such director, the director
nominee will be required to submit his or her resignation as a director to the Chair of the Board promptly following the applicable Shareholders&#8217;
meeting. Following receipt of resignation, the Governance and Nominating Committee will consider whether or not to accept the offer of
resignation and make a recommendation to the Board. Within 90 days following the applicable Shareholders&#8217; meeting, the Board shall
publicly disclose in a news release their decision whether to accept the applicable director&#8217;s resignation or not, including the
reasons for rejecting the resignation, if applicable. The Board shall accept the resignation absent exceptional circumstances. A director
who tenders his or her resignation pursuant to this policy will not be permitted to participate in any meeting of the Board or the Governance
and Nominating Committee at which the resignation is considered. A copy of the majority voting policy may be found on the Fennec website
at <U>www.fennecpharma.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the name of each
of our executive officers and directors, such person&#8217;s principal occupation or employment, all other positions with Fennec and any
significant affiliate thereof now held by such person, if any, the year in which such person became a director of Fennec and such person&#8217;s
age.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation has an Audit Committee, a Compensation
Committee, and a Governance and Nominating Committee. The current members of such committees are noted below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Name and Province/State and Country of Residence, Position</B></FONT></TD>
    <TD STYLE="width: 34%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Current Principal Occupation and Principal Occupation for Previous Five Years</B></FONT></TD>
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Director Since</B></FONT></TD>
    <TD STYLE="width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Common Shares Held</B></FONT></TD>
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Options to Acquire Common Shares </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: left"><FONT STYLE="font-size: 10pt">Shubh Goel, New Jersey, USA</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: left"><FONT STYLE="font-size: 10pt">CCO of Fennec Pharmaceuticals Inc.; previously VP of Commercial Strategy and Operations at Odonate Therapeutics, Inc.; previously Executive Director, Global Early Commercialization at Celgene Corporation</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">200,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Robert Andrade, Texas USA</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Financial Officer</P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">CFO of Fennec Pharmaceuticals; previously senior analyst Magnetar Capital; previously Portfolio Manager Millennium Partners</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">153,273</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">380,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chris A. Rallis, North Carolina, USA</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director<SUP>(1)(2)</SUP></P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">Executive in-residence at Pappas Capital; previously, CEO of ImmunoBiosciences</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">August 2011</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">191,850</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rostislav Raykov, New Jersey, USA</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Executive Officer, Director</P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">CEO of Fennec Pharmaceuticals Inc.; previously Portfolio Manager Alchem Partners; previously Portfolio Manager John Levin &amp; Company</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">July 2009</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">196,578</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">924,999</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Marco Brughera, Milano, Italy</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director<SUP>(2)(3)</SUP></P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">CEO of Leadiant Biosciences SpA; previously Global Head Rare Disease and R&amp;D at Sigma-tau; VP Preclinical Development at Nerviano Medical Sciences.</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">August, 2016</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">115,545</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify">Adrian J. Haigh, Sintra, Portugal</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director<SUP>(1)(3)</SUP></P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">Senior Vice President and General Manager of EMEA Region at PTC Therapeutics; previously Chief Operating Officer at Gentium GmbH; previously Regional VP Commercial Operations at Biogen Idec</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">April 2014</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">233,579</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: justify">Dr. Khalid Islam, Lugano, Switzerland</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chairman of Board, Director<SUP>(1)</SUP></P></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">Founder/co-founder of Sirius Healthcare Partners GMbH; previously Chairman and CEO of Gentium S.p.A.; previously CEO of Arpida AG</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">April 2014</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">313,825</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; padding-left: 5.75pt; text-align: left"><FONT STYLE="font-size: 10pt">Dr. Jodi Cook, Pennsylvania, USA, Director<SUP>(2)(3)</SUP></FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-size: 10pt">Former SVP, Head of Gene Therapy Strategy PTC Therapeutics, Inc, Former COO Agilis Biotherapeutics, Former Assistant Professor of Audiology Mayo Clinic</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">September, 2019</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><FONT STYLE="font-size: 10pt">40,000</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Member
of the Audit Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Member
of the Compensation Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Member
of the Governance and Nominating Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Shubh Goel</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&nbsp;Goel has been employed by us since
September&nbsp;2019. <FONT STYLE="background-color: white">Ms.&nbsp;Goel is a proven leader with 20 years of global commercial
experience successfully building and executing the launch of several oncology products. Most recently, she served as Vice President
of Commercial Strategy and Operations at Odonate Therapeutics,&nbsp;Inc. Prior to Odonate, Ms.&nbsp;Goel previously served in
multiple leadership positions at Celgene Corporation, including serving as Executive Director, Global Early Commercialization and
previously as Head of U.S. Marketing, Oncology. While at Celgene, </FONT>she oversaw the successful execution of the U.S. launch of
Abraxane&reg; in pancreatic cancer and had overall responsibility for marketing the U.S. solid tumor franchise. Ms.&nbsp;Goel
received a B.Sc. degree in biochemistry from the University of Bath.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Robert Andrade</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Andrade has served as Chief Financial
Officer since November&nbsp;2015. Mr.&nbsp;Andrade was previously Chief Financial Officer and Director of Fennec from September&nbsp;2009
until August&nbsp;2013. In addition to his role with Fennec, Mr.&nbsp;Andrade was a private investor in 2015, and a senior analyst at
Magnetar Capital from 2013 - 2014. Mr.&nbsp;Andrade graduated from University of Southern California, where he earned a Masters of Arts
degree and Bachelor of Arts degree in economics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Chris A. Rallis</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Rallis has&nbsp;served as&nbsp;a director
of Fennec since August&nbsp;2011. Mr.&nbsp;Rallis has been an executive-in-residence at Pappas Capital, a life&nbsp;science venture capital
firm since January&nbsp;2008.&nbsp;Previously, Mr.&nbsp;Rallis was the&nbsp;President and Chief Executive Officer of ImmunoBiosciences,&nbsp;Inc.
(&#8220;IBI&#8221;), a vaccine&nbsp;technology company formerly located in Raleigh, North Carolina from April&nbsp;2006 through June&nbsp;2007.&nbsp;Prior
to joining IBI, Mr.&nbsp;Rallis served as an executive in residence (part-time) for Pappas Capital,&nbsp;and as a consultant for Duke
University and Panacos Pharmaceuticals,&nbsp;Inc.&nbsp;Mr.&nbsp;Rallis is the former President&nbsp;and Chief Operating Officer (&#8220;COO&#8221;)
and director of Triangle Pharmaceuticals,&nbsp;Inc.,&nbsp;which was acquired by Gilead Sciences in January&nbsp;2003 for approximately
$465&nbsp;million.&nbsp;Prior to assuming the role of President and COO in March&nbsp;2000, he was&nbsp;Executive Vice President, Business
Development and General Counsel. While at&nbsp;Triangle, Mr.&nbsp;Rallis&nbsp;participated in 11 equity financings generating gross proceeds&nbsp;of
approximately $500 million.&nbsp;He was also primarily responsible for all business&nbsp;development activities which included a worldwide
alliance with Abbott&nbsp;Laboratories and the in-licensing of ten compounds. Before joining Triangle in&nbsp;1995, Mr.&nbsp;Rallis served
in&nbsp;various business development and legal management roles with Burroughs Wellcome Co. over a 13-year period, including Vice President
of Strategic Planning&nbsp;and Business Development. Mr.&nbsp;Rallis also&nbsp;serves on the board of Tenax Therapeutics,&nbsp;Inc., a
biopharmaceutical company located in Morrisville, North Carolina.&nbsp;Mr. Rallis' term on the Tenax board expires on June 10, 2021 and
he is not standing for re-election. Mr.&nbsp;Rallis received his A.B. degree in&nbsp;economics from Harvard College and a J.D. from Duke
University. As a result of these and other professional experiences, Mr.&nbsp;Rallis possesses particular healthcare industry knowledge
and experience which strengthens the Board&#8217;s collective qualifications, skills, and experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Rostislav Raykov</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Raykov has served as a director and as
Chief Executive Officer of Fennec since July&nbsp;2009.&nbsp;From January&nbsp;2006 to December&nbsp;2007, Mr.&nbsp;Raykov was a portfolio
manager for Alchem Investment Partners. Prior to founding Alchem, Mr.&nbsp;Raykov was a portfolio manager and securities analyst for John
A. Levin&nbsp;&amp; Co. Event Driven Fund (2002-2005). Prior to joining John A. Levin&nbsp;&amp; Co., Mr.&nbsp;Raykov was a securities
analyst for the Merger Fund at Tiedemann Investment Group (1999-2002) and an investment banking analyst at Bear Stearns (1998-1999).&nbsp;&nbsp;Mr.&nbsp;Raykov
earned a B.S. in Business Administration from the University of North Carolina at Chapel Hill. As a result of these and other professional
experiences, Mr.&nbsp;Raykov has financial expertise and experience with the Corporation as it has developed within the drug development
industry and, as such, is able to provide the Board with unique insight and guidance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dr. Marco Brughera</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Brughera has been a director of Fennec
since August&nbsp;2016. Since January&nbsp;2011, Dr.&nbsp;Brughera has been CEO of Lediant Biosciences SpA and has held several positions
for the Sigma-Tau Group, including CEO and Global Head of Sigma Tau Rare Disease, President of Sigma-Tau Research and President of Sigma-Tau
Pharmaceuticals.&nbsp;He drove the commercial revival of a lead oncology product line resulting in its successful sale for a total of
around $900M.&nbsp;He also successfully out-licensed the Defibrotide US rights to Jazz Pharmaceuticals. From 2004 to 2010, Dr.&nbsp;Brughera
served as the Vice President of Preclinical Development at Nerviano Medical Sciences (NMS), a pharmaceutical oncology-focused integrated
discovery and development company.&nbsp;He also served as the Managing Director at Accelera, an independent contract research organization
with the NMS Group.&nbsp;From 1999 to 2004, Dr.&nbsp;Brughera held several senior level positions in the areas of research and development
with Pharmacia and Pfizer. Prior to 1999, he held various positions at Pharmacia&nbsp;&amp; Upjohn and Farmitalia Carlo Erba SpA, an Italian
pharmaceutical company. He currently serves on the Board of Exelead and Naicons and previously was Board member of Soligenix, Lee&#8217;s
Pharmaceuticals and Gentium. His knowledge in particular, of clinical drug development in Europe, deepens the Board&#8217;s collective
qualifications, skills and experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<!-- Field: Split-Segment; Name: A01 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Adrian J. Haigh </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Haigh has been a director of Fennec since
April&nbsp;2014. Mr.&nbsp;Haigh has been Senior Vice President and Head of International Operations at PTC Therapeutics since September&nbsp;2014.
Previously Mr.&nbsp;Haigh served as Chief Operating Officer at Gentium GmbH from 2011 until 2014. Prior to joining Gentium, Mr.&nbsp;Haigh
served as Regional VP Commercial Operations at Biogen Idec where he managed several affiliates&nbsp;and also the global distributor business
and prior to that was the General Manager of Amgen Nordis and Portugal. He served as the Executive Vice President of Global Marketing
and Corporate Planning at EUSA Pharma and joined EUSA from Amgen where he led the international oncology franchise. Mr.&nbsp;Haigh previously&nbsp;has
held senior commercial and marketing positions at SmithKline Beecham, Schering Plough, Organon and Novo Nordisk. He has been director
at Arch Biopartners Inc. since August&nbsp;21, 2014. He received a Bachelor of Arts with Honors in Economic History from Huddersfield
Polytechnic, West Yorkshire, England and a Diploma in Marketing from the Institute of Marketing. As a result of these and other professional
experiences, Mr.&nbsp;Haigh has extensive international oncology development expertise which strengthens the Board&#8217;s collective
qualifications, skills and experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dr. Khalid Islam</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext">Dr.&nbsp;Islam
has been a director of Fennec since April&nbsp;2014 and is our current Chairman of the Board. Dr.&nbsp;Islam was the Chairman and CEO
of Gentium S.p.A. (a Nasdaq-listed company; 2009-2014) where he led the transition from a loss-making to a cash-flow positive and profitable
company. Under his leadership, the company value increased from US$25 million leading to a successful all cash US$1 billion merger with
Jazz Pharmaceuticals, plc. Subsequent to the sale of Gentium, Dr.&nbsp;Islam has been involved from both an advisory and board level in
several public and private healthcare related companies. From 1999-2008, Dr.&nbsp;Islam was President and CEO of Arpida AG where he transitioned
the early-stage start-up to a SWX-listed company and raised US$300 million in the IPO and follow-ons. From 1987-1999, he held various
positions in HMR&nbsp;&amp; MMD (now Sanofi-Aventis). From 1977-1987, Dr.&nbsp;Islam worked in academia at Imperial College (Univ. of
London) and in Milan University, where he was a contract professor. Dr.&nbsp;Islam is a graduate of Chelsea College and received his Ph.D.
from Imperial College, University of London. He holds several patents and has published over 80 articles in leading journals. He is an
advisor to the venture group Kurma Biofund (Paris). He is a founder/co-founder of Sirius Healthcare Partners GmbH (Zurich), PrevAbr LLC
(D.C.), BioAim LLC (L.A.)&nbsp;&amp; Life Sciences Management GmbH (Zug). Dr.&nbsp;Islam is Board Chair at Minoryx Therapeutics (Spain)
and Gain Therapeutics (Switzerland), a public company. He currently serves on the board of Gain Therapeutics (GAIN) and Processa Pharmaceuticals
(PCSA), both of which are publicly traded. In the past, he has served as Chairman of the Board of Directors of Immunomedics (USA), Pcovery
Aps (Copenhagen), Adenium Aps (Copenhagen) and C10 Pharma AS (Oslo) and on the board of </FONT><FONT STYLE="color: #414D53; background-color: white">Karolinska
Development (Sweden) and MolMed S.p.A. (Italy)</FONT><FONT STYLE="color: windowtext">. Dr.&nbsp;Islam&#8217;s extensive international
pharmaceutical expertise in transitioning companies from development to production strengthens the Board&#8217;s collective qualifications,
skills and experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dr. Jodi Cook</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Cook has been a director of Fennec since
September&nbsp;2019. Dr.&nbsp;Cook previously served as SVP and Head of Gene Therapy Strategy at PTC Therapeutics from August&nbsp;2018
until February&nbsp;2020. Previously she was one of the founding members and Chief Operating Officer of Agilis Biotherapeutics, a clinical-stage
company focused on gene therapies for rare diseases of the central nervous system, from December&nbsp;2013 until its acquisition by PTC
Therapeutics in August&nbsp;2018. While at Agilis she led the sale of the company to PTC in a deal that represented significant value
to all parties. Dr.&nbsp;Cook&#8217;s career spans a wide range of experiences including VP of Clinical Research at InSound Medical and
Director of Audiology at Songbird Hearing, both successful biotech start-up companies within the hearing industry. She has been Assistant
Professor of Audiology and Director of the Hearing Aid Program at Mayo Clinic. Dr Cook earned a BA from Loyola University in Maryland,
M.Aud. from University of South Carolina, and PhD from Arizona State University in Hearing Science. She completed a clinical fellowship
at Johns Hopkins School of Medicine in Baltimore, MD. Her extensive scientific, clinical and executive business experience strengthens
the Board&#8217;s collective qualifications, skills and expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Appointment of Auditors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Haskell &amp; White LLP have served as the
Corporation&#8217;s auditors since May 12, 2017. Shareholders will be asked to vote for the appointment of Haskell &amp; White LLP
as auditors of the Corporation, to hold office until the next annual meeting of Shareholders of the Corporation or until a successor
is duly elected or appointed, at a remuneration to be fixed by the Board of Directors. Approval of the ordinary resolution requires
the affirmative vote of a majority of the votes cast in respect thereof by holders of Common Shares represented at the Meeting. The
person designated in the enclosed form of proxy intends to vote FOR the appointment of Haskell &amp; White LLP as auditors of the
Corporation, unless instructed otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Options: NewSection; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends that Shareholders
vote FOR the appointment of Haskell &amp; White LLP as auditors of the Corporation at the Meeting. The persons named in the enclosed form
of proxy will vote FOR the appointment of Haskell &amp; White LLP as auditors of the Corporation until the end of the next annual meeting
of the Shareholders or until a successor is duly elected or appointed and the authorization of the directors to fix their remuneration,
unless a Shareholder has specified in the proxy that his or her Common Shares are to be withheld from voting in respect thereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Advisory Vote on Executive Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the requirements of Section
14A of the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), and the related rules of the SEC, our
Shareholders have the opportunity to cast a vote to approve, on an advisory or non-binding basis, the compensation of our named executive
officers as disclosed in this Circular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For information on the Corporation&#8217;s executive
compensation programs and how they reflect the Compensation Committee&#8217;s philosophy and are linked to the Corporation&#8217;s performance,
see &#8220;Compensation Discussion and Analysis&#8221;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are asking for Shareholder approval of the
compensation of our named executive officers as disclosed in this Circular in accordance with SEC rules, which disclosures include the
disclosures under &#8220;Compensation Discussion and Analysis&#8221;, the compensation tables and the narrative discussion following the
compensation tables. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our
named executive officers and the policies and practices described in this Circular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This vote is advisory and therefore not binding
on the Corporation, the Board or the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is the text of the advisory vote
on executive Compensation resolution to be considered at the Meeting (the &#8220;<B>Advisory Executive Compensation Resolution</B>&#8221;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that the compensation
paid to the Corporation&#8217;s named executive officers, as disclosed in this Circular pursuant to Item 402 of Regulation S-K, including
the &#8220;Compensation Discussion and Analysis&#8221;, the compensation tables and narrative discussion be, and hereby is, APPROVED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends that Shareholders
vote FOR the Advisory Executive Compensation Resolution. The persons named in the enclosed form of proxy will vote FOR the Advisory Executive
Compensation Resolution, unless a Shareholder has specified in the proxy that his or her Common Shares are to be withheld from voting
in respect thereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE COMPENSATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation Discussion and Analysis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This discussion relates to the Named Executive
Officers listed in the Summary Compensation Table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mandate of the Compensation Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is the task of the Compensation Committee to
periodically review Fennec&#8217;s compensation structure with respect to its Named Executive Officers, including its Chief Executive
Officer, to ensure that Fennec continues to attract and retain qualified and experienced individuals to its management team and to motivate
these individuals to perform to the best of their ability and in Fennec&#8217;s best interests. The Compensation Committee determines
the compensation of the Named Executive Officers, evaluates and approves the compensation plans, policies and programs of the Corporation
and recommends to the Board from time to time other incentive compensation plans that it determines should be considered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In reviewing executive compensation, the
Compensation Committee relies on the advice of the Chief Executive Officer regarding other executive officers and allows him to
participate in the Committee&#8217;s deliberations on those executive officers. The Chief Executive Officer, however, is not allowed
to participate in the Committee&#8217;s deliberations on his compensation. The Compensation Committee may not delegate any of its
responsibilities to another entity or to an individual without the approval of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>General Compensation Philosophy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The key components of executive officer compensation
are salaries, cash incentive awards and stock options. Fennec&#8217;s policy with respect to the compensation of Named Executive Officers
is to establish annual goals with respect to corporate development and the individual areas of responsibility of each Named Executive
Officers and then to review total compensation with respect to the achievement of these goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Salary and Non-Equity Incentive Awards</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is Fennec&#8217;s policy that the base salaries
paid to its Named Executive Officers reflect, in addition to the criteria set out above, the individual&#8217;s responsibility, experience
and achievements. Each year the Compensation Committee sets a series of objectives for each executive and for the executive team as a
whole to determine the opportunity for cash incentive awards. These objectives are prioritized and assigned potential values in light
of overall company objectives, including with respect to scientific, clinical, regulatory, intellectual property, business and corporate
development, and financial objectives. The Compensation Committee reviews both base salaries and cash incentive awards on at least an
annual basis to ensure that the relevant criteria are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stock Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The annual compensation considerations also include
the awarding of stock options and other equity awards. The granting of options to the Named Executive Officers under the Stock Option
Plan serves three primary purposes: (1) to recognize significant performance during the past year; (2) to provide long-term incentives
for future efforts, since the value of the options is directly dependent on the market valuation of the Corporation; and (3) to retain
individuals, as the options typically vest over time. When determining whether and how many new option grants will be made, the Compensation
Committee takes into account the amount and terms of any outstanding options. The Compensation Committee generally considers the granting
of options twice annually to all eligible employees, including executive officers. The Committee, in its discretion, may grant options
at other times during a fiscal year to a Named Executive Officer for performance or other reasons. Fennec does not require its Named Executive
Officers to own a specific number of Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Analysis of Named Executive Officer Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee is charged with annually
reviewing and approving corporate goals and objectives relevant to each of the Named Executive Officer&#8217;s compensation, evaluating
each officer&#8217;s performance in light of those goals and objectives, and fixing and determining each Named Executive Officer&#8217;s
level of salary and award of cash incentive payments and options based on this evaluation. In determining the long-term incentive component
of each Named Executive Officer&#8217;s compensation, the Compensation Committee considers the Corporation&#8217;s performance and relative
shareholder return, the value of similar incentive awards to other similarly situated executive officers at companies in the peer group,
the awards given to the Named Executive Officer in past years, and such other factors as the Compensation Committee considers relevant.
Specifically, the Compensation Committee&#8217;s review and evaluation includes measurement of the following areas:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the achievement of corporate objectives, such as financings, partnerships and other business development,
and consideration of those achievements in light of budgetary constraints and other challenges facing the Corporation;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the Corporation&#8217;s financial condition;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the Corporation&#8217;s share price and market capitalization; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the advancement of our product candidates, both preclinical and clinical.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Compensation Consultant</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2020, the Compensation Committee
retained Radford, an Aon company (&#8220;<B>Radford</B>&#8221;), to provide assistance in reviewing the compensation of the Named
Executive Officers and the directors. In part on the basis of Radford&#8217;s recommendations, Mr. Raykov&#8217;s base salary in
2021 has been increased to $442,900 or a 3% annual increase from 2020, Mr. Andrade&#8217;s base salary in 2021 has been increased to
$320,845 or a 3% annual increase from 2020 and Ms. Goel&#8217;s base salary in 2021 has been increased to $370,800 or a 3% annual
increase from 2020. Radford further recommended that upon FDA approval, Mr. Raykov and Mr. Andrade shall be subject to a 12%
increase. Radford&#8217;s provided similar services in the prior year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 14; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Benchmarking</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Radford&#8217;s engagement included conducting
a review of Fennec&#8217;s peer group of companies to ensure the ongoing suitability and applicability of such group, as certain of Fennec&#8217;s
compensation matters are compared against the peer group. Based on the review by Radford and in consultation with the Compensation Committee
and the Board, a peer group consisting of the following 20 companies was chosen on the basis of the following characteristics in relation
to Fennec: (i) operating in the biotechnology and pharmaceutical industries; and (ii) market capitalization, employee size and stage of
development: AcelRx Pharmaceuticals, Aldeyra Therapeutics, Anavex Life Sciences, AVEO Pharmaceuticals, Catalyst Biosciences, Chimerix,
Cidara Therapeutics, Geron, Kadmon, Kala Pharmaceuticals, MediciNova, MEI Pharma, Palatin Technologies, Paratek Pharmaceuticals, SCYNEXIS,
Sesen Bio, SIGA Technologies, Strongbridge Biopharma, Trevena and Verastem. This peer group was used to help evaluate compensation design
precedents and trends, and for guiding the calibration of competitive pay levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Compensation Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board considers and assesses, as necessary,
the implications of risks associated with Fennec&#8217;s compensation policies and practices and devotes such time and resources as it
believes are appropriate given Fennec&#8217;s size and stage of development. The Corporation&#8217;s practice during the fiscal year ended
December 31, 2020 of compensating its officers through a mix of base salary, short term and long term incentives was designed to mitigate
risk by: (i) ensuring that the Corporation retains such officers; and (ii) aligning the interests of its officers with the short-term
and long- term objectives of the Corporation and its shareholders; (iii) providing an appropriate balance of risk and reward consistent
with the risk profile of our Company; and (iv) providing compensation that does not encourage excessive risk-taking behavior by the executive
team. During the fiscal year ended December 31, the Board did not identify any risks arising from the Corporation&#8217;s compensation
policies and practices that the board believed were reasonably likely to have a material adverse effect on the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation Committee Report</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has reviewed and discussed
the Compensation Discussion and Analysis contained in this Circular with management and, based on that review and discussion, the Compensation
Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Circular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Submitted by:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE COMPENSATION
COMMITTEE OF THE BOARD OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;Dr. Marco Brughera,
Chair</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;Chris Rallis</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;Dr. Jodi Cook</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation Committee Interlocks and Insider
Participation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Marco Brughera, Chris Rallis, and Dr. Jodi
Cook are the current members of the Compensation Committee. None of these individuals was at any time during 2020 or at any other time
an officer or employee of ours. No interlocking relationship exists between any member of our Compensation Committee and any member of
any other company&#8217;s board of directors or compensation committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has determined that each member of the
Compensation Committee is &#8220;independent&#8221; under applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets out certain information
respecting the compensation paid to our Chief Executive Officer, our Chief Financial Officer and out Chief Commercial Officer (collectively,
<B>&#8220;Named Executive Officers&#8221;)</B> for the fiscal years ended December 31, 2020 and December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">Name and Principal Position</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Year</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Salary ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Bonus ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Option<BR>
 Awards ($) <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left">Rostislav Raykov, CEO</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: center">2020</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">430,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,694,216</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2,124,216</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2019</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">488,692</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">157,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">830,944</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,476,536</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Andrade, CFO</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2020</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">311,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">847,108</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,158,858</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2019</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">325,211</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">438,555</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">863,766</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Shubh Goel, CCO<SUP>(2)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2020</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">360,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">169,422</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">529,422</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2019</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">98,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">816,538</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,029,538</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Represents the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. Dollar
value amounts are based on individual grants to each of Mr. Raykov and Mr. Andrade of 250,000 and 150,000 and 125,000 and 80,000 options,
respectively, on May 15, 2020 and April 4, 2019, respectively, at an exercise price of $6.93 and $4.38 per common share, respectively.
Grants to Ms. Goel were for 25,000 and 175,000 options granted on May 15, 2020 and September 9, 2019, respectively, at an exercise price
of $6.93 and $4.74, respectively. All option grants expire 10 years after the grant date. One-third of these options shall vest and may
be exercised one year after the grant date (the &#8220;Vesting Commencement Date&#8221;). The remaining two-thirds of the options shall
vest monthly at a rate of 1/24th of the remaining grant and shall be exercisable as of the last day of each following month after the
Vesting Commencement Date. As of the third anniversary of the grant date, all of the options shall be vested.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Ms. Goel was hired as our Chief Commercial Officer in September 2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Rostislav Raykov</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Raykov has been employed by us since July
2009.&nbsp;Pursuant to an employment agreement dated May 3, 2010 between Mr.&nbsp;Raykov and Fennec, Mr. Raykov is employed as our Chief
Executive Officer and: (a) received an initial annual salary in the amount of $140,000, subject to annual adjustment by our Board of Directors,
(b) upon approval by shareholders of our amended stock option plan, was granted options to purchase up to 5.0% of our Common Shares estimated
by us to be outstanding upon completion of the 2010 Rights Offering, and (c) may receive annual bonuses at the sole discretion of the
Board.&nbsp;If Mr. Raykov&#8217;s employment terminates due to a change of control of Fennec, Mr. Raykov&#8217;s remaining unvested options
shall immediately vest and be fully exercisable. If Mr.&nbsp;Raykov is dismissed from employment by us for any reason other than &#8220;for
cause&#8221;, we are obligated to pay Mr. Raykov severance compensation equal to twelve months of salary. The initial term of the agreement
was for one year and the agreement automatically extends for additional one-year periods unless terminated by either party in accordance
with the agreement. Effective January 1, 2018, Mr. Raykov&#8217;s salary was increased to $350,000 per year with subsequent increases
to $400,000 in 2019, $430,000 in 2020, and $442,900 in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Robert Andrade</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Andrade has been employed by us since November
2015. Mr. Andrade is employed as Fennec&#8217;s Chief Financial Officer.&nbsp;Pursuant to an employment agreement dated November 13, 2015,
Mr. Andrade (a) received an initial annual salary in the amount of $165,000, and (b) may receive annual bonuses at the sole discretion
of the Board.&nbsp; If Mr. Andrade&#8217;s employment terminates due to a change of control of the Fennec, Mr. Andrade&#8217;s remaining
unvested options shall immediately vest and be fully exercisable. If Mr. Andrade is dismissed from employment by us for any reason other
than &#8220;for cause&#8221;, we are obligated to pay Mr. Andrade severance compensation equal to six months of salary. Effective January
1, 2018, Mr. Andrade&#8217;s salary was increased to $250,000 per year with subsequent increases to $290,000 in 2019, $311,750 in 2020,
and $320,845 in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Shubh Goel</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Goel has been employed by us since
September 2019. Pursuant to an employment agreement dated September 9, 2019, Ms. <FONT STYLE="color: windowtext">Goel is employed as
Fennec&#8217;s Chief Commercial Officer and: (a) received an initial annual salary in the amount of $360,000, subject to annual
adjustment by our Board of Directors, and (b) may receive annual bonus of up to 40% of her base salary per twelve month period, at
the discretion of the CEO and the Board of Directors. </FONT>If Ms. Goel&#8217;s employment is terminated by us for any reason other
than &#8220;for cause&#8221;, we are obligated to pay Ms. Goel (i) severance in the amount of three months of her base salary or if
such termination occurs either (a) after the second anniversary of her employment or (b) as a result of a Change of Control, a
severance in the amount of six months, (ii) prorate share of any target bonus earned by Ms. Goel and, (iii) accelerated vesting of
stock options. The initial term of the agreement was for one year and the agreement automatically extends for additional one-year
periods unless terminated by either party in accordance with the agreement. Ms. Goel&#8217;s salary was increased to $370,800 per
year in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 16; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to their employment agreements, Mr. Raykov,
Mr. Andrade and Ms. Goel are a party to a confidentiality and intellectual property agreement with the Corporation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the employment agreements for each of Mr. Andrade
and Mr. Raykov &#8220;for cause&#8221; is generally defined as (1) material breach of the terms of the employment or intellectual property
agreements; (2) failure to perform the duties inherent in their position in good faith and in a reasonable and appropriate manner; or
(3) acts of fraud or embezzlement or other intentional misconduct which adversely affects our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payments on Termination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides details regarding
the estimated incremental payments from the Corporation to each of the current Named Executive Officers assuming termination without cause
on December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Severance</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Estimated Bonus</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Value of benefits</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; font-size: 10pt; text-align: justify">Rostislav Raykov, CEO</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">430,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">430,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">Robert Andrade, CFO</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">155,875</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">155,875</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Shubh Goel, CCO</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">90,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">90,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payments on Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides details regarding
the estimated incremental payments from the Corporation to each of the current Executive Officers upon change of control.<B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify">Name</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Change of Control</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Multiple</B></P></TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Estimated Bonus<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Value of benefits</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; font-size: 10pt; text-align: justify">Rostislav Raykov, CEO</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24%; font-size: 10pt; text-align: right">2 X</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">1,030,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">1,030,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">Robert Andrade, CFO</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">1.25 X</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">448,594</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">448,594</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 58.95pt; text-align: justify"><FONT STYLE="font-size: 10pt">Change of control payments are calculated based on the two-year annualized average salary plus cash bonus as calculated as of December 31, 2020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the payments above, an incentive
plan has been established pursuant to which, upon completion of a change in control transaction, 1% of the transaction value (up to a
maximum of $2,000,000) be set aside and paid to key personnel upon completion of such change in control transaction, with 50% of such
incentive pool being payable to the CEO and the balance to other key personnel as determined by the CEO in consultation with the Compensation
Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Equity Grants, Exercises and Holdings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information concerning
the number and value of unexercised options held by each Named Executive Officer as of December 31, 2020. All executive awards, with the
exception of those expiring June 27, 2027, February 6, 2028,April 4, 2029 and May 15, 2030, vest and are exercisable immediately. The
current stock option plan provides for grants denominated in US and CAD dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Number of Options</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">Name</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Granted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Exercisable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Option Exercise Price</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Expiration Date</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; font-size: 10pt; text-align: left">Rostislav Raykov</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">250,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">6.93</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 15%; font-size: 10pt; text-align: center">05/15/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">150,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">87,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.83</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/04/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">97,222</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8.38</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">02/06/2028</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/27/2027</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">150,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">150,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.45</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">07/05/2026</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.69</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/31/2024</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">83,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">83,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.59</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">01/24/2024</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,666</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,666</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.72</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/23/2023</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.05</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/20/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Andrade</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">125,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/15/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">80,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">46,666</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.83</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/04/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48,611</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8.38</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">02/06/2028</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/27/2027</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.45</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">07/05/2026</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Shubh Goel</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/15/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">175,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">77,778</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">USD$</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.74</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">09/09/2029</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Split-Segment; Name: A02 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Executive Incentive Plan Awards &#8211; Value
Vested or Earned During the Year</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the value of executive
options on the vesting date that vested during 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Name </B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Number of Options <BR>
Vested During Year</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Option-Based Awards</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Value Vested During the Year<BR>
 (USD$)<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Non-Equity Incentive Plan <BR>
Compensation &ndash; Value Earned <BR>
During the Year (USD$)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; font-size: 10pt; text-align: left">Rostislav Raykov</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">134,726</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">181,241</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Andrade</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">70,279</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">95,950</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Shubh Goel</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">77,778</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">125,272</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">282,783</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">402,463</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">-</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The value of the vested option-based awards
represents the aggregate dollar value that would have been realized if the options under the option-based award had been exercised on
the vesting date. The dollar value was computed by determining the difference between the closing market price of the Common Shares on
the Nasdaq at the deemed exercise on the vesting date and the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following table summarizes the compensation earned
by our non-executive directors for the year ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fees paid in Cash</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock Awards</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Option Awards<SUP>(1)(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Dr. Islam</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">85,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">150,406</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">235,406</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">120,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">160,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Mr. Haigh</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">120,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">160,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">120,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">195,325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Mr. Rallis</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">42,500</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">120,325</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">162,825</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">282,500</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">631,706</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">914,206</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt">(1)</TD><TD STYLE="text-align: left">Represents the aggregate grant date fair value computed in accordance with FASB ASC Topic 718.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt">(2)</TD><TD STYLE="text-align: left">Detail of grants are presented in the following table:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Date of Grant</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Options Granted</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Exercise Price<BR>
 $USD</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Mr. Rallis</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2020</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">20,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">6.17</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2020</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Mr. Haigh</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2020</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2020</FONT></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Dr. Islam</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">August 13, 2020</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">105,000</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The annual compensation considerations for non-executive
directors also include the awarding of stock options. We believe that granting of options to the non-executive directors serves three
primary purposes: (1) to recognize the significant time and effort commitments during the past year; (2) to provide long-term incentives
for future efforts since the value of the options is directly dependent on the market valuation of the Corporation; and (3) to retain
quality individuals. When determining whether and how many new option grants will be made, the Compensation Committee takes into account
the amount and terms of any outstanding options. We do not require our non-executive directors to own a specific amount of our Common
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of Adrian J. Haigh, Dr. Khalid Islam, Dr.
Marco Brughera, Dr. Jodi Cook, and <FONT STYLE="color: #010101">Chris A. Rallis </FONT>has entered into an Independent Director Agreement
with the Corporation, which provides for cash compensation as set forth by the Compensation Committee commensurate with that member&#8217;s
responsibilities. The Compensation Committee may also remunerate members in the form of a grant of options to purchase shares of our Common
Shares.&nbsp;The options immediately vest when granted and are otherwise subject to the terms and conditions of our stock option plan,
as amended, or our Equity Incentive Plan. The Independent Director Agreements also provide for the reimbursement of such director&#8217;s
reasonable travel and related expenses incurred in the course of attending board meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Equity Grants, Exercises and Holdings </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information concerning
the number and value of unexercised options held by each Director as of December 31, 2020. All Director awards vest and are exercisable
immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Outstanding Equity Awards at December
31, 2019 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;<B>Name</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Number&nbsp;of&nbsp;Securities</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Underlying&nbsp;Unexercised</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Options&nbsp;(#)&nbsp;Exercisable</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Option</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Exercise&nbsp;Price&nbsp;(USD$)</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Option</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Expiration&nbsp;</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Date</B></P></TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Value of<BR>
 Unexercised in-<BR>
the-Money<BR>
 Options (USD$)<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUB>(1)</SUB></FONT></B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Adrian Haigh</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">133,333</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2.31</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 10%; font-size: 10pt; text-align: center">04/25/2024</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">685,332</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.69</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/31/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.44</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/09/2026</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">51,332</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/27/2027</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/08/2028</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.26</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/18/2029</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/13/2030</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">Chris Rallis</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.50</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/18/2021</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,831</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.60</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/04/2022</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">57,081</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,259</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.54</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/17/2022</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,980</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,111</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.45</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/17/2022</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">77,777</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,762</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.05</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/20/2022</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,477</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,166</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.40</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/03/2023</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,038</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,700</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.94</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/17/2023</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,667</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,208</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.96</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/06/2023</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,666</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.72</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/23/2023</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">112,162</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,144</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.59</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">01/24/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,424</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,329</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.31</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/25/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,251</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,389</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3.60</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/15/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,348</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,792</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.79</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/04/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,351</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,960</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.55</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/07/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,604</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.69</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/31/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,992</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.51</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">03/16/2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,840</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,173</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.30</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">05/11/2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,191</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,127</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.35</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/03/2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,848</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,062</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.23</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/10/2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,266</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,098</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.44</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/09/2026</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,531</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,246</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.44</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/09/2026</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">51,332</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1pt">06/27/2027</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/08/2028</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.26</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/18/2029</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">53,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/13/2030</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Khalid Islam</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">133,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.31</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">04/25/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">685,332</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.69</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/31/2024</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.13</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/11/2025</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">316,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,492</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.44</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/09/2026</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">102,665</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/27/2027</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">58,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/08/2028</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.26</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/18/2029</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">79,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/13/2030</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Marco Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">35,545</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.11</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">12/30/2026</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">189,810</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.10</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/27/2027</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">47,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10.93</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/08/2028</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4.26</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">06/18/2029</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">63,800</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/13/2030</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Jodi Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5.40</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">11/13/2029</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">41,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6.17</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">08/13/2030</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,600</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Calculated using the closing price of our Common Share on December 31, 2020 USD$7.45 on the Nasdaq which
was the last trading day for the year 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Incentive Plan Awards &#8211; Value
Vested During the Year</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the value of director
options on the vesting date that vested during 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Name </B></P></TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Number of Options <BR>
Vested During Year</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Option-Based Awards</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Value Vested During the Year (USD$)<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Non-Equity Incentive Plan <BR>
Compensation &ndash; Value Earned<BR>
 During the Year (USD$)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; font-size: 10pt; text-align: left">Adrian Haigh</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">20,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Chris Rallis</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Khalid Islam</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Marco Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Dr. Jodi Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">105,000</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">-</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">-</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The value of the vested option-based awards
represents the aggregate dollar value that would have been realized if the options under the option-based award had been exercised on
the vesting date. The dollar value was computed by determining the difference between the closing market price of the Common Shares on
the Nasdaq at the deemed exercise on the vesting date and the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each non-management member receives an annual
base retainer of $35,000. The Chairman of the Board shall receive an additional annual fee of $50,000 and includes all activities of the
Chairman. The Chair of the Audit Committee receives an additional annual fee of $7,500. Chair of any other Committee shall receive an
additional annual fee of $5,000. These annual base retainer and annual cash fees are to be paid quarterly and are in lieu of any per-meeting
fees. Board members shall also be reimbursed for any out of pocket expenses for attending Board or Committee meetings or any other meeting
at the Corporation&#8217;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2020 Equity Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 22, 2020, Fennec&#8217;s shareholders
approved our 2020 Equity Incentive Plan (the &#8220;<B>2020 Plan</B>&#8221;), which replaced our prior Stock Option Plan which was last
approved by our shareholders on June 19, 2019 (the &#8220;<B>Prior Plan</B>&#8221;). Options granted under the Prior Plan continue to
be governed by the terms of the Prior Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total number of Common Shares that may be
the subject of awards and issued under the 2020 Plan, together with the Prior Plan (collectively, the &#8220;<B>Plans</B>&#8221;), is
twenty-five percent (25%) of the total number of all issued and outstanding Common Shares from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board believes that equity based incentive
awards can play an important role in the success of the Corporation by encouraging and enabling the employees, officers, non-employee
directors and consultants of the Corporation and its subsidiaries upon whose judgment, initiative and efforts the Corporation largely
depends for the successful conduct of its business to acquire a proprietary interest in the Corporation. The Board believes that providing
such persons with a direct stake in the Corporation assures a closer identification of the interests of such individuals with those of
the Corporation and its shareholders, thereby stimulating their efforts on the Corporation&#8217;s behalf and strengthening their desire
to remain with the Corporation. The 2020 Plan is designed to enhance the flexibility to grant different types of equity awards (i.e. not
just stock options) to our officers, employees, non-employee directors and consultants and to ensure that we can continue to grant equity
awards to eligible recipients at levels determined to be appropriate by the Board or the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of May 17, 2021, options for an aggregate of
2,902,144 Common Shares have been granted and remain issued and outstanding under 2020 Plan or the Prior Plan, as applicable (representing
approximately 11.2% of the currently issued and outstanding Common Shares). The 2020 Plan has 3,598,569 unallocated equity awards (representing
approximately 13.8% of the currently issued and outstanding Common Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%; text-align: left">26,002,853</TD><TD STYLE="text-align: justify; width: 90%">Shares outstanding</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%; text-align: left">6,500,173</TD><TD STYLE="text-align: justify; width: 90%">25.0%</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%; text-align: left">2,902,144</TD><TD STYLE="text-align: justify; width: 90%">11.2%&nbsp;&nbsp;&nbsp;&nbsp;Options issued</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10%; text-align: left">3,598,569</TD><TD STYLE="text-align: justify; width: 90%">13.8%&nbsp;&nbsp;&nbsp;&nbsp;Equity Awards Available</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Option grants outstanding under the Prior Plan
continue to be subject to the terms of those plans and if those awards subsequently are exercised, expire, are forfeited or canceled,
or are settled in cash, the Common Shares subject to those awards will be available for new awards under 2020 Plan, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The major features of the 2020 Plan are summarized
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Plan Shares</I>. The maximum number
of Common Shares that may be issued in connection with any awards granted under the under the 2020 Plan, together with the Prior Plan,
is twenty-five percent (25%) of the total number of all issued and outstanding common shares from time to time. Shares of common stock
that are forfeited, cancelled, held back upon the exercise or settlement of an award to cover the exercise price or tax withholding, reacquired
by us prior to vesting, satisfied without the issuance of common stock or otherwise terminated (other than by exercise) under the Prior
Plan or the 2020 Plan are added back to the shares of common stock available for issuance under the 2020 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Administration</I>. The 2020 Plan
will be administered by the Compensation Committee. The Compensation Committee has full power to select, from among the individuals eligible
for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific
terms and conditions of each award, subject to the provisions of the 2020 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Eligibility.</I> All full-time
and part-time officers, employees, non-employee directors and consultants are eligible to participate in the 2020 Plan, subject to the
discretion of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Stock Options</I>. The 2020 Plan
permits the granting of (i) options to purchase common stock intended to qualify as incentive stock options under Section 422 of the
Code and (ii) options that do not so qualify. Options granted under the 2020 Plan will be non-qualified options if they fail to qualify
as incentive options or exceed the annual limit on incentive stock options. Incentive stock options may only be granted to employees
of the Corporation and its subsidiaries. Non-qualified options may be granted to any persons eligible to receive incentive options
and to non-employee directors and consultants. The option exercise price of each option will be determined by the Compensation Committee
but may not be less than 100% of the fair market value of the common stock on the date of grant. Fair market value for this purpose will
be the last reported sale price of the shares of common stock on the Nasdaq Capital Market on the date immediately preceding the grant
date. The exercise price of an option may not be reduced after the date of the option grant, other than to appropriately reflect changes
in our capital structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">The term of each option will be fixed
by the Compensation Committee and may not exceed ten years from the date of grant. The Compensation Committee will determine at what time
or times each option may be exercised. Options may be made exercisable in installments and the exercisability of options may be accelerated
by the Compensation Committee. In general, unless otherwise permitted by the Compensation Committee, no option granted under the 2020
Plan is transferable by the optionee other than by will or by the laws of descent and distribution or pursuant to a domestic relations
order, and options may be exercised during the optionee&#8217;s lifetime only by the optionee, or by the optionee&#8217;s legal representative
or guardian in the case of the optionee&#8217;s incapacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">Upon exercise of options, the option
exercise price must be paid in full either in cash, by certified or bank check or other instrument acceptable to the Compensation Committee
or by delivery (or attestation to the ownership) of shares of common stock that are beneficially owned by the optionee and that are not
subject to risk of forfeiture. Subject to applicable law, the exercise price may also be delivered to the Corporation by a broker pursuant
to irrevocable instructions to the broker from the optionee. In addition, the Compensation Committee may permit non-qualified options
to be exercised using a net exercise feature that reduces the number of shares issued to the optionee by the number of shares with a fair
market value equal to the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">To qualify as incentive options, options
must meet additional federal tax requirements, including a $100,000 limit on the value of shares subject to incentive options that first
become exercisable by a participant in any one calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Stock Appreciation Rights</I>.
The Compensation Committee may award stock appreciation rights subject to such conditions and restrictions as the Compensation Committee
may determine. Stock appreciation rights entitle the recipient to shares of common stock equal to the value of the appreciation in the
stock price over the exercise price. The exercise price is the fair market value of the common stock on the date of grant. The term of
a stock appreciation right may not exceed ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Restricted Stock</I>. The Compensation
Committee may award shares of common stock to participants subject to such conditions and restrictions as the Compensation Committee may
determine. These conditions and restrictions may include the achievement of certain performance goals or continued employment with us
through a specified restricted period. During the vesting period, restricted stock awards may be credited with dividend equivalent rights,
but dividend equivalents payable with respect to restricted stock awards with vesting tied to the attainment of performance criteria or
service shall not be paid unless and until such conditions are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Restricted Stock Units</I>. The
Compensation Committee may award restricted stock units to participants. Restricted stock units are ultimately payable in the form of
shares of common stock (or cash, if so provided in the specific award) subject to such conditions and restrictions as the Compensation
Committee may determine. These conditions and restrictions may include the achievement of certain performance goals or continued employment
with the Corporation through a specified vesting period. In the Compensation Committee&#8217;s sole discretion, it may permit a participant
to make an advance election to receive a portion of his or her future cash compensation otherwise due in the form of a restricted stock
unit award, subject to the participant&#8217;s compliance with the procedures established by the Compensation Committee and requirements
of Section 409A of the Code. During the deferral period, the deferred stock awards may be credited with dividend equivalent rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Unrestricted Stock Awards</I>.
The Compensation Committee may also grant shares of common stock that are free from any restrictions under the 2020 Plan. Unrestricted
stock may be granted to any participant in recognition of past services or other valid consideration and may be issued in lieu of
cash compensation due to such participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Dividend Equivalent Rights</I>.
The Compensation Committee may grant dividend equivalent rights to participants, which entitle the recipient to receive credits for dividends
that would be paid if the recipient had held specified shares of common stock. Dividend equivalent rights granted as a component of another
award (other than a stock option or stock appreciation right) may be paid only if the related award becomes vested. Dividend equivalent
rights may be settled in cash, shares of common stock or a combination thereof, in a single installment or installments, as specified
in the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Cash-Based Awards</I>. The Compensation
Committee may grant cash bonuses under the 2020 Plan to participants. The cash bonuses may be subject to the achievement of certain performance
goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Change of Control Provisions</I>.
The 2020 Plan provides that upon the effectiveness of a &#8220;sale event,&#8221; as defined in the 2020 Plan, all outstanding awards
may be assumed, substituted or otherwise continued by the successor entity. To the extent that the successor entity does not assume, substitute
or otherwise continue such awards, upon the effective time of the sales event the 2020 Plan and all outstanding awards that remain unexercised
or settled will terminate. When a sales event occurs and outstanding awards are not assumed, substituted or continued, except as may be
otherwise specifically provided in an award certificate, all options and stock appreciation rights with time-based vesting conditions
or restrictions that are not vested or exercisable immediately prior to the effective time of the sale event may become fully vested and
exercisable as of the effective time of the sale event at the discretion of the Compensation Committee, all other awards with time-based
vesting, conditions or restrictions may become fully vested and non-forfeitable as of the effective time of the sale event at the discretion
of the Compensation Committee, and all awards with conditions and restrictions relating to the attainment of performance goals may become
vested and non-forfeitable in connection with a sale event in the Compensation Committee&#8217;s discretion or to the extent specified
in an award certificate. In addition, the Corporation may make or provide for payment, in cash or in kind, to participants holding options
and stock appreciation rights equal to the difference between the per share cash consideration paid in the sales event and the exercise
price of the options or stock appreciation rights. The Compensation Committee shall also have the option to make or provide for a payment,
in cash or in kind, to grantees holding other awards in an amount equal to the per share cash consideration paid in the sales event multiplied
by the number of vested shares under such awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Adjustments for Stock Dividends,
Stock Splits, Etc</I>. The 2020 Plan requires the Compensation Committee to make appropriate adjustments to certain limits in the 2020
Plan and to any outstanding awards to reflect stock dividends, stock splits, extraordinary cash dividends and similar events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Tax Withholding</I>. Participants
in the 2020 Plan are responsible for the payment of any federal, state or local taxes that the Corporation is required by law to withhold
upon the exercise of options or stock appreciation rights or vesting of other awards. Subject to approval by the Compensation Committee,
participants may elect to have their tax withholding obligations satisfied by authorizing the Corporation to withhold shares of common
stock to be issued pursuant to exercise or vesting. The Compensation Committee may also require awards to be subject to mandatory share
withholding up to the required withholding amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><I>Amendments and
Termination</I>. The Board of Directors may at any time amend or discontinue the 2020 Plan and the Compensation Committee may at any
time amend or cancel any outstanding award for the purpose of satisfying changes in the law or for any other lawful purpose.
However, no such action may adversely affect any rights under any outstanding award without the holder&#8217;s consent. To the
extent required under Nasdaq or TSX rules any amendments that materially change the terms of the 2020 Plan will be subject to
approval by our Shareholders. Amendments shall also be subject to approval by our Shareholders if and to the extent determined by
the Compensation Committee to be required by the Code to preserve the qualified status of incentive options. Subject to any
additional requirements of the rules of Nasdaq or the TSX, the following amendments to the 2020 or awards issued thereunder shall
not be made without the prior approval of Nasdaq or the TSX, and approval of the Shareholders: (i) other than customary adjustments
resulting from certain corporate changes, amendments to the 2020 Plan that would increase the percentage of Common Shares issuable
under the 2020 Plan, (ii) any amendment that would increase the number of Common Shares issuable to insiders under the 2020 Plan,
(iii) any amendment that would change the eligible participants in the plan to permit the introduction of non-employee directors on
a discretionary basis; and (iv) amendments to amending provision of the 2020 Plan. Examples of the amendments that may be made by
the Board without shareholder approval include, without limitation, amendments related to (a) the vesting provisions of the 2020
Plan or any award granted under the 2020 Plan, (b) the early termination provisions of the 2020 Plan or any option granted under the
2020 Plan, (c) the addition of any form of financial assistance by the Corporation for the acquisition by all or certain categories
of participants, and the subsequent amendment of any such provision which is more favorable to such participants, (d) the addition
or modification of a cashless exercise feature, payable in cash or Common shares, which provides for a full deduction of the number
of underlying Common Shares from the Stock Option Plan reserve, (e) changing the maximum percentage of Common Shares which are
reserved for issuance under the Stock Option Plan to a maximum number of Common Shares not exceeding the number of Common Shares
which then represents the maximum percentage previously approved by the Corporation&#8217;s security holders; (f) the suspension or
termination under applicable laws (including, without limitation, the rules, regulations and policies of the TSX); and/or (g)
general housekeeping matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For U.S. federal income tax purposes, an optionee
who is granted an incentive stock option under the 2020 Plan will generally not recognize taxable income either at the time the option
is granted or upon its exercise, although the exercise will increase the optionee&#8217;s alternative minimum taxable income by an amount
equal to the difference, if any, between the fair market value of the shares at the time of exercise and the option's exercise price,
and therefore may subject the optionee to the alternative minimum tax. Upon the sale or exchange of the shares more than two years after
grant of the option and more than one year after exercising the option, any gain or loss will be treated as long-term capital gain or
loss. If these holding periods are not satisfied, the optionee will recognize ordinary income at the time of sale or exchange equal to
the difference between the exercise price and the lower of (i) the fair market value of the shares at the date of the option&#8217;s exercise
or (ii) the sale price of the shares. Fennec will be entitled to a deduction in the same amount as the ordinary income recognized by the
optionee. Any gain or loss recognized on such a premature disposition of the shares in excess of the amount treated as ordinary income
will be characterized as long-term or short-term capital gain or loss, depending on the optionee&#8217;s holding period with respect to
such shares. Options that do not qualify as incentive stock options under the 2020 Plan are referred to as nonstatutory options. Generally,
an optionee will not recognize any taxable income at the time he or she is granted a nonstatutory option. Upon its exercise, however,
the optionee will generally recognize taxable ordinary income measured as the excess of the then fair market value of the shares acquired
over the exercise price of the option. Any taxable income recognized in connection with an option exercise by an optionee who is also
one of our employees will be subject to tax withholding by us. Fennec will be entitled to a tax deduction in the same amount as the ordinary
income recognized by the optionee with respect to shares acquired upon exercise of a nonstatutory option. Upon resale of such shares by
the optionee, any difference between the sales price received and the fair market value for the shares on the date of exercise of the
option will be treated as long-term or short-term capital gain or loss, depending on the optionee&#8217;s holding period with respect
to such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board does not grant options or other equity
awards according to a prescribed formula or target. Rather awards to eligible participants and the proposed grant size, take into consideration
such factors as their position, scope of responsibility and historic and recent performance, previous grants, the value of the awards
in relation to other elements of the individual&#8217;s total compensation and shareholdings, and market information. Therefore, future
options that may be granted to employees, officers, directors and consultants under the 2020 Plan are not determinable at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prior Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Stock Option Plan as last ratified by Shareholders
on June 18, 2019 was adopted to develop the interest and incentive of eligible employees, directors and other service providers of the
Corporation in the Corporation's growth and development by giving eligible Participants (as defined below) an opportunity to purchase
Common Shares on a favorable basis, thereby advancing the interests of the Corporation, enhancing the value of the Common Shares for the
benefit of all Shareholders and increasing the ability of the Corporation to attract and retain skilled and motivated individuals in the
service of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext">Although no
further awards will be granted under the Prior Plan, t</FONT>he maximum number of Common Shares that were issuable under the Prior
Plan was a rolling maximum equal to 25% of the issued and outstanding Common Shares from time to time. Within the above aggregate
limit of 25% of the issued and the issued and outstanding Common Shares from time to time, the Prior Plan contains no limits on the
number or percentage of such options that may be granted to insiders of the Corporation or to any one person. The Board currently
has the right, in its sole discretion, to alter, amend or discontinue the Prior Plan from time to time and at any time. However, no
such amendment or discontinuation may alter or impair the rights or increase the obligations under the Prior Plan of Participants
without the consent of the Participants. Further, any amendment to the Prior Plan is subject to prior regulatory approval. The Prior
Plan&#8217;s amending procedures explicitly provide that shareholder approval is not required to implement any amendments, save and
except for amendments related to (i) the maximum number of Common Shares or any other shares of the Corporation which are reserved
for issuance under the Prior Plan (and under any other share compensation arrangement of the Corporation); (ii) a reduction in the
exercise price for options held by insiders; and (iii) an extension to the term of options held by insiders. Examples of the
amendments that may be made by the Board without shareholder approval include, without limitation, amendments related to (a) the
vesting provisions of the Prior Plan or any option granted under the Prior Plan, (b) the early termination provisions of the Prior
Plan or any option granted under the Prior Plan, (c) the addition of any form of financial assistance by the Corporation for the
acquisition by all or certain categories of Participants, and the subsequent amendment of any such provision which is more favorable
to such Participants, (d) the addition or modification of a cashless exercise feature, payable in cash or Common shares, which
provides for a full deduction of the number of underlying Common Shares from the Prior Plan reserve, (e) changing the maximum
percentage of Common Shares which are reserved for issuance under the Prior Plan to a maximum number of Common Shares not exceeding
the number of Common Shares which then represents the maximum percentage previously approved by the Corporation&#8217;s security
holders; (f) the suspension or termination under applicable laws (including, without limitation, the rules, regulations and policies
of the TSX); and/or (g) general housekeeping matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Participation in the Prior Plan was limited to
directors, employees and service providers who were designated by the Compensation Committee (each, a &#8220;<B>Participant</B>&#8221;).
Board nominees or other associates or affiliates of the Corporation&#8217;s largest shareholder, Southpoint Capital Advisors, were not
eligible to participate in the Prior Plan. Subject to the terms of the Prior Plan, the Compensation Committee determined the Participants
designated to participate in the Prior Plan, the number of Common Shares such Participant was entitled to purchase and the price at which
the Common Shares may be purchased and the applicable vesting period. The option price at which the Common Shares may be purchased under
the Prior Plan was the fair market value of the Common Shares of the Corporation at the time of grant, which under the Prior Plan is the
closing price of the Common Shares on the TSX or Nasdaq on the trading day immediately preceding the date of grant (if the Common Shares
are then listed on the TSX or Nasdaq).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum term of any option granted under the
Prior Plan was ten (10) years. Options that have been granted under the Prior Plan must be exercised within a period of ten (10) years
from the date of grant, failing which the Participant's right to purchase such Common Shares lapses. The Prior Plan provides that should
the expiry date of any vested stock option of a Prior Plan participant fall on, or within nine (9) trading days immediately following,
a Black-Out Period, the expiry date of such a vested stock option will automatically be the date that is ten (10) trading days from the
date the relevant Black-Out Period ends. Unless otherwise determined by the Compensation Committee and specifically set forth in the stock
option agreement executed by the Participant, options vest and may be exercised by the Participant as to one-third on each of the first,
second and third anniversaries of the date of grant. The Compensation Committee may, however, in its sole discretion by written notice
to any Participant, accelerate the vesting of all or any of the options of a Participant. The Participant's rights under the options granted
under the Prior Plan are not assignable or transferable by the Participant. The Corporation does not currently have any arrangements in
place for financial assistance to facilitate the purchase of securities by Participants under the Prior Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Participant&#8217;s right to exercise options
ceases following any of the following events (each of which, a &#8220;<B>Participant Termination Date</B>&#8221;): (i) if an employee,
such Participant&#8217;s employment with the Corporation or any of its subsidiaries is terminated for any reason; (ii) if a director,
such Participant ceases to be a director on the Board for any reason; or (iii) if a service provider, such Participant ceases to provide
services to the Corporation. In such case, the Participant, or the Participant's legal representative, as the case may be, may only exercise
such options that are then vested any time prior to the earlier of: the original expiry date of such option, or within 30 days of the
Participant Termination Date, or if specifically approved by the Board, such later date which may not be more than three (3) years following
the Participant Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For U.S. federal income tax purposes, an optionee
who has been granted an incentive stock option under the Prior Plan will generally not recognize taxable income either at the time the
option is granted or upon its exercise, although the exercise will increase the optionee&#8217;s alternative minimum taxable income by
an amount equal to the difference, if any, between the fair market value of the shares at the time of exercise and the option's exercise
price, and therefore may subject the optionee to the alternative minimum tax. Upon the sale or exchange of the shares more than two years
after grant of the option and more than one year after exercising the option, any gain or loss will be treated as long-term capital gain
or loss. If these holding periods are not satisfied, the optionee will recognize ordinary income at the time of sale or exchange equal
to the difference between the exercise price and the lower of (i) the fair market value of the shares at the date of the option&#8217;s
exercise or (ii) the sale price of the shares. Fennec will be entitled to a deduction in the same amount as the ordinary income recognized
by the optionee. Any gain or loss recognized on such a premature disposition of the shares in excess of the amount treated as ordinary
income will be characterized as long-term or short-term capital gain or loss, depending on the optionee&#8217;s holding period with respect
to such shares. Options that do not qualify as incentive stock options under the Prior Plan are referred to as nonstatutory options. Generally,
an optionee will not recognize any taxable income at the time he or she is granted a nonstatutory option. Upon its exercise, however,
the optionee will generally recognize taxable ordinary income measured as the excess of the then fair market value of the shares acquired
over the exercise price of the option. Any taxable income recognized in connection with an option exercise by an optionee who is also
one of our employees will be subject to tax withholding by us. Fennec will be entitled to a tax deduction in the same amount as the ordinary
income recognized by the optionee with respect to shares acquired upon exercise of a nonstatutory option. Upon resale of such shares by
the optionee, any difference between the sales price received and the fair market value for the shares on the date of exercise of the
option will be treated as long-term or short-term capital gain or loss, depending on the optionee&#8217;s holding period with respect
to such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Stock Option Burn-Rate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets out information with
respect to the burn-rate calculations for the Stock Option Plans as at December 31, 2020, 2019 and 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: justify">Description</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Percentage</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 10%; font-size: 10pt; text-align: left; padding-bottom: 1pt">Burn Rate</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">The total number of options issued in 2020 divided by the weighted average number of outstanding Common Shares for 2020</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2.97</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">The total number of options issued in 2019 divided by the weighted average number of outstanding Common Shares for 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.70</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; padding-bottom: 1pt">The total number of options issued in 2018 divided by the weighted average number of outstanding Common Shares for 2018</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.61</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;<B>&nbsp;</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Split-Segment; Name: A03 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Directors&#8217; and Officers&#8217; Liability
Insurance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec has liability insurance for its directors
and officers. We indemnify our directors and officers to the fullest extent permitted by law for their acts and omissions in their capacity
as a director or officer of Fennec, so that they will serve free from undue concerns for liability for actions taken on behalf of Fennec.
This indemnification is required under our corporate charter. We also maintain an insurance policy intended to help us meet our obligations
under our indemnification covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><BR>
Indebtedness of Directors and Executive Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 13(k) of the Securities Exchange Act of
1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), prohibits Fennec from making or arranging an extension of credit to its directors
or executive officers in the form of a personal loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No individual, who is or was a director, executive
officer or employee of Fennec, nor any proposed nominee for election as a director of Fennec, nor any associate of any one of them: (i)
is or, at any time since the beginning of Fennec&#8217;s most recent completed financial period, has been indebted to Fennec or any of
its subsidiaries; or (ii) was indebted to another entity, which indebtedness is, or was at any time during Fennec&#8217;s most recent
completed financial period, the subject of a guarantee, support agreement, letter of credit or other similar arrangement or understanding
provided by Fennec or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Interest of Informed Persons in Material Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the BCBCA and our articles,
directors who have a material interest in any person who is a party to a material contract or a proposed material contract with Fennec
are required to disclose that interest and abstain from voting on any resolution to approve that contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the knowledge of Fennec, no informed person
or proposed nominee for election as a director of Fennec and no associate or affiliate of the foregoing persons has or has had any material
interest, direct or indirect, in any transaction since the commencement of Fennec&#8217;s last completed financial period or in any proposed
transaction which has materially affected or would materially affect Fennec or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with regulations of the SEC, Fennec
must disclose in this Circular any transaction or series of transactions in Fennec&#8217;s last two completed fiscal years to which Fennec
was a party and in which any director or executive officer of Fennec, or any of their immediate family members, had a direct or indirect
material interest if the amount involved exceeds the lesser of $120,000 or one (1) percent of the average of the Corporation&#8217;s total
assets at year-end for the last two completed fiscal years (a &#8220;<B>Related Party Transaction</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Performance Graph </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following line graph compares the percentage change, from December 31, 2015 to December 31, 2020, in cumulative total shareholder return
for $100 (CAD$ for TSX and US$ for AMEX) invested in our </FONT>Common Shares <FONT STYLE="font-family: Times New Roman, Times, Serif">with
cumulative total return of the AMEX Composite, the AMEX Biotechnology Index and the S&amp;P/TSX Composite Total Return Index.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Options: NewSection; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="tm212691d1_def14aimg0010.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Equity Compensation Plan Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides certain information
with respect to securities authorized for issuance under equity incentive plans as of December 31, 2020 (share amounts are in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Plan Category</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(a) <BR>Number&nbsp;of&nbsp;securities&nbsp;to&nbsp;<BR>
 be issued <BR>upon&nbsp;exercise&nbsp;of&nbsp;outstanding <BR>options&nbsp;warrants&nbsp;and&nbsp;rights&nbsp;(*)</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(b) <BR>Weighted-<BR>
average&nbsp;exercise&nbsp;price&nbsp;of <BR>outstanding&nbsp;options,&nbsp;warrants&nbsp;<BR>
 and rights</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">(c) <BR>Number&nbsp;of&nbsp;securities&nbsp;remaining <BR>available&nbsp;for&nbsp;future&nbsp;issuance&nbsp;under <BR>equity&nbsp;compensation&nbsp;plans <BR>(excluding&nbsp;securities&nbsp;reflected&nbsp;in <BR>Column&nbsp;(a))</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Equity compensation plan</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 25%; font-size: 10pt; text-align: justify">approved by shareholders</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">2,952</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24%; font-size: 10pt; text-align: right">USD $ 4.82</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">3,549</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: right; padding-left: 5.75pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">2,952</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right; padding-left: 5.75pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">3,549</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* <FONT STYLE="font-family: Times New Roman, Times, Serif">The
Corporation&#8217;s equity incentive plan allow for the issuance of stock options denominated in both U.S. dollars and Canadian dollars.&nbsp;This
table presents the number and weighted-average exercise price of outstanding options by the currency associated with the original grants.&nbsp;At
December 31, 2020, we had 3.0 million stock options denominated in U.S. dollars with a weighted-average exercise price of $4.82 and no
stock options denominated in CAD.&nbsp;There were a total of 3.1 million stock options outstanding with a combined weighted-average exercise
price of USD$3.59 (Canadian denominated exercise prices were converted using the December 31, 2019 exchange rate of 0.768174 CAD/USD).
At December 31, 2020, we had 3.5 million stock options available for future issuance. There were also 0.04 million warrants outstanding
with an exercise price of $6.80.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT ON CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec believes that good corporate governance
is important to ensure that Fennec is managed for the long-term benefit of its shareholders. In connection with Fennec&#8217;s commitment
to comply with the standards of applicable securities legislation, Fennec has continued to review Fennec&#8217;s corporate governance
practices and policies and has compared them to developing practices and regulation in Canada and the United States. In particular, Fennec
has considered developing rules and guidelines for corporate governance practices and policies, and related disclosures, promulgated by
the Canadian Securities Administrators, the SEC as well as the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec&#8217;s Board has adopted a Mandate of
the Board of Directors, Corporate Governance Guidelines and a Code of Business Conduct and Ethics applicable to all officers, directors
and employees of Fennec. The Board also has established charters for each of the Audit Committee, Governance and Nominating Committee
and Compensation Committees and has appointed an Independent Chairman of the Board. Each of the various committee charters and other corporate
governance documents are regularly reviewed with a view to determining if any updates are necessary or advisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set out below is a description of certain corporate
governance practices of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Shareholder Communications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders who wish to communicate with members
of the Board of Directors, including the independent directors individually or as a group, may send correspondence to them care of the
Chief Executive Officer at our principal executive offices. Such communication will be forwarded to the intended recipient(s). Fennec
currently does not intend to have the Chief Executive Officer screen this correspondence, but it may change this policy if directed by
the Board due to the nature or volume of the correspondence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors is composed of a majority
of independent directors. The Board applies the definition of independence found in Canadian National Instrument 58-101 and National Policy
58-201 and the applicable rules of Nasdaq. The Board has determined that five of the current six directors are &#8220;independent&#8221;,
being Dr. Cook and Messrs. Rallis, Brughera, Haigh and Islam. Only one director has a material relationship with the Corporation and therefore
is not independent. Mr. Raykov, Chief Executive Officer of the Corporation is considered to have a material relationship with the Corporation
by virtue of his executive officer position. Fennec is of the view that the composition of its Board reflects a diversity of background
and experience that are important for effective corporate governance. Other directorships held by Board members are described in this
Circular under the heading &#8220;Ordinary Matters &#8211; Election of Directors.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the financial year ended December 31, 2020,
the Board devoted a portion of five meetings to discuss in the absence of directors who are not &#8220;independent,&#8221; and certain
of the Committees also conducted executive sessions where all participants were independent directors. In order to facilitate open and
candid discussion among its independent directors, the Corporate Governance Guidelines provide that independent directors should meet
at least annually without the presence of management or non-independent directors, that the Chairman or Lead Independent Director is authorized
to call additional meetings of the independent directors and that the Chairman or Lead Independent Director is authorized to act as the
presiding director at such meetings and to develop the agenda for such meetings. In addition, each Board member is free to suggest the
inclusion of items on any Board or Committee meeting agenda and suggest pre-meeting materials to either the Chair of the Board or the
Lead Independent Director. At any meeting of the Board, each Board member is also free to raise subjects that are not on the agenda for
that meeting. Furthermore, each Board committee, the Chairman and the Lead Independent Director, on behalf of the independent directors
as a group, have the authority to hire legal, accounting, financial or other advisors as they may deem necessary in their best judgment,
without the need to obtain the prior approval of any officer of the Corporation. The Chief Financial Officer of the Corporation will arrange
for payment of the invoices of any such third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 28; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Directors&#8217; Attendance </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fiscal year ended December 31, 2020, the
Board met on fifteen occasions, the Audit Committee met on five occasions, the Compensation Committee met on seven occasions, and the
Governance and Nominating Committee met on four occasions. The following table sets forth the attendance of directors at meetings of the
Board and Committee meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Director</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attendance at</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Board Meetings</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attendance at Audit <BR>
Committee<BR>
 Meetings</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Attendance at Compensation Committee Meetings</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Attendance at Governance/ Nominating Committee Meetings</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Adrian Haigh</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">15/15</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">5/5</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">4/4</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 48%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 1%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 10%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 1%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 10%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 1%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 10%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 1%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 10%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Chris Rallis</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">15/15</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">5/5</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">7/7</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Khalid Islam</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">15/15</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">5/5</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Marco Brughera</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">15/15</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="3" STYLE="font-size: 10pt; text-align: center">7/7</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">4/4</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: justify">Dr. Jodi Cook</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">15/15</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">7/7</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">4/4</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Rostislav Raykov</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">15/15</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board expects management to be responsible
for the day-to-day operations of and to implement the approved strategic business plan within the context of authorized budgets and corporate
policies and procedures. Management is expected to report regularly to the Board in a comprehensive, accurate, and timely fashion on Fennec&#8217;s
business and affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec does not have a formal written policy regarding
attendance of Board members at annual meetings of the shareholders. Fennec, however, strongly encourages all directors to attend such
meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mandate of the Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has the overall responsibility for the
strategic planning and general management of Fennec&#8217;s business and affairs. In fulfilling its responsibilities, the Board is responsible
for, among other things:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">adoption of a strategic plan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">approval of the annual operating and capital expenditure budgets;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">identification of the principal risks of the business and ensuring the implementation of the appropriate
systems to manage these risks;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">succession planning, including appointing and monitoring senior management;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">adoption of a communications policy;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">approval of acquisitions, dispositions, investments and financings that exceed certain prescribed limits;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">integrity of the internal control and management information systems; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.35in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">development of clear position descriptions for directors, including the Chair of the Board, the Chair
of each Board committee and, together with the CEO, a clear position description for the CEO.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board discharges its responsibilities directly
and through committees that have specific areas of responsibility. The frequency of Board meetings and the nature of items discussed during
the meetings depend on the opportunities or risks that Fennec faces. The Board, directly and through its committees, has adopted a process
whereby it assesses the risk factors that must be identified and managed to ensure Fennec&#8217;s long-term viability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board mandate generally describes the
Board&#8217;s expectation of management and provides a list of specific matters for which management must obtain Board approval
prior to implementation. The Board mandate also provides that the Board annually establish performance objectives for the CEO, which
responsibility has been delegated to the Compensation Committee. In addition, the Board receives regular updates from management
concerning the Corporation&#8217;s progress toward achieving corporate goals. The Board has also delegated to the Compensation
Committee responsibility for evaluating the CEO&#8217;s compensation, which evaluation includes review of the CEO&#8217;s
performance against annual performance objectives for the year and input from the Chairman, Lead Independent Director as well as
other directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board Mandate is attached as Schedule &#8220;A-1&#8221;
to this Circular.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Position Descriptions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board Mandate and the Governance and Nominating
Committee Charter provide that the Board is responsible for the development of clear position descriptions for directors, including the
Chair of the Board and the chair of each board committee; and, together with the Chief Executive Officer, a clear position description
for the Chief Executive Officer, which includes delineating management&#8217;s responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Leadership Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 9, 2015, Dr. Khalid Islam was elected
Chairman of the Board. The Board determined that in the best interest of the Corporation the most effective leadership structure at this
time is to separate the roles of Chairman and Chief Executive Officer. As an independent director, Dr. Islam is responsible for overseeing
and ensuring the independence of and separation between management and the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has an active role, as
a whole and also at the committee level, in overseeing the identification and management of our principal risks. The Board of Directors
regularly receives reports from senior management on areas of material risk to our Corporation<B>, </B>including our credit, liquidity,
operational, legal and regulatory risks. In carrying out its responsibilities under its charter, the Audit Committee reviews our major
financial risk exposures and the steps management has taken to monitor and control such exposures, and it also meets periodically with
management to discuss policies with respect to risk assessment and risk management. In addition, the Compensation Committee oversees the
management of risks relating to our executive and non-executive compensation plans and arrangements, and the Governance and Nominating
Committee manages risks associated with the independence of the Board of Directors and potential conflicts of interest. While each committee
oversees certain risks and the management of such risks, the entire Board of Directors is regularly informed through committee reports
about such risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ethical Business Conduct</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2004, Fennec&#8217;s Board adopted
a Mandate of the Board of Directors, Corporate Governance Guidelines and a Code of Business Conduct and Ethics (the &#8220;<B>Code of
Conduct</B>&#8221;) applicable to all officers, directors and employees of Fennec. The Code of Conduct was updated in June of 2019. You
can access the Code of Conduct in the corporate governance section of Fennec&#8217;s website at <B><U>www.fennecpharma.com.</U></B> Fennec
undertakes to provide any person without charge, upon request, a copy of such code by writing to Attn: Code of Ethics Request, Fennec
Pharmaceuticals Inc., 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, North Carolina 27709<FONT STYLE="font-variant: small-caps">.
</FONT>Fennec is committed to adhering to applicable legal requirements and maintaining the highest standards of conduct and integrity.
The Code of Conduct is intended to promote those goals in conjunction with the Corporation&#8217;s Insider Trading Policy, Disclosure
Policy and Audit Committee Complaint Procedures. The Code of Conduct sets out the legal and ethical standards of conduct for personnel
of Fennec and addresses topics such as: reporting obligations and procedures; honest and ethical conduct and conflicts of interest; compliance
with applicable laws and Corporation policies and procedures; confidentiality of corporate information; use of corporate assets and opportunities;
public disclosure and books and records; and non-retaliation. The Board is not aware of any conduct of a director or officer that constitutes
a departure from the Code of Conduct and, as a result, since the beginning of Fennec&#8217;s fiscal year ended December 31, 2020, there
have been no material change reports filed that pertain to such a departure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Code of Conduct provides that the
Governance and Nominating Committee shall monitor and periodically evaluate compliance with the Code of Conduct and its application
to the Corporation&#8217;s business. In addition, the Code of Conduct sets out the procedures adopted by the Audit Committee for the
receipt, retention and treatment of complaints and concerns regarding accounting, internal accounting control, or auditing matters.
In each case, the Code of Conduct provides that the Corporation will not discipline, discriminate against or retaliate against any
employee who reports a complaint or concern in good faith, whether or not the information is ultimately proven to be correct, or who
cooperates in any investigation or inquiry thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to ensure independent judgment in considering
transactions or agreements in which a director or officer has a material interest, the Code of Conduct contains a process that must be
followed regarding the disclosure, consultation and approval of transactions involving potential conflicts of interest. As a first step,
officers and directors must disclose such matters to the Chief Executive Officer and to the Chair or any other disinterested member of
the Governance and Nominating Committee charged with reviewing conflicts of interest. The Board has adopted rules for what activities
constitute conflicts of interest and potential conflicts of interest, as well as procedures for determining whether a relationship or
transaction constitutes a conflict of interest, the current versions of which are attached as appendices to the Code of Conduct. Following
disclosure, any officer or director must avoid or terminate any activity that involves an actual or reasonably apparent conflict of interest
unless it is determined at the appropriate level that the activity is not a conflict of interest or is otherwise not harmful to the Corporation
or improper. Disinterested members of the Governance and Nominating Committee shall make any such determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the BCBCA and our articles,
directors who have a material interest in any person who is a party to a material contract or a proposed material contract with us are
required to disclose that interest and abstain from voting on any resolution to approve that contract. In addition, no director, director
nominee or officer may enter into any transaction or relationship that is disclosable by such person or the Corporation pursuant to the
BCBCA or by the Corporation pursuant to SEC rules without the prior approval of the disinterested members of the Governance and Nominating
Committees, and no such person may directly or indirectly approve, or represent the Corporation or the other party in arranging, the terms
of any transaction between the Corporation and a party with which he/she has any relationship of a type that is disclosable by such person
or the Corporation pursuant to the BCBCA or by the Corporation pursuant to SEC rules. All transactions between the Corporation and a party
with which a director, officer or employee has such a relationship shall be on an arm&#8217;s length basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Orientation and Continuing Education</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Responsibility for the oversight of orientation
for new directors and continuing education programs for all directors with respect to the Corporation&#8217;s business and financial matters,
corporate governance and other appropriate subjects is assigned to the Governance and Nominating Committee under its charter. In this
regard, the Governance and Nominating Committee&#8217;s duties include ensuring the adequacy of the orientation and education program
for new members of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance and Nominating Committee is also
responsible for arranging continuing education for directors in order to ensure that directors maintain the skill and knowledge necessary
to meet their obligations as directors. Given the Corporation&#8217;s limited resources, to date, no formal external continuing education
programs have been sponsored by the Corporation but members of the Board are free to attend such programs as they determine necessary
and in the Corporation&#8217;s best interest. The Corporation also provides directors with the opportunity to meet with senior management
of the Corporation, including the Chief Financial Officer, as well as external advisors, at any time and such personnel and advisers are
regularly invited to present at Board meetings or in connection with Board retreats to provide updates in legal, accounting, governance
and other business developments. Some meetings are held at the Corporation&#8217;s premises, allowing directors the opportunity to gain
additional insight into the Corporation&#8217;s operations. In addition, analyst reports and other information relating to the Corporation&#8217;s
business and the industry in which it operates are presented at Board meetings and strategy sessions and industry-related articles of
interest are distributed to Board members from time to time. Pursuant to each Committee charter, directors are permitted to obtain advice
and assistance from internal or external advisors, including for the purposes of continuing education and developments relevant to board
responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nomination of Directors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has a nominating committee as part of
the Governance and Nominating Committee that is charged with identifying individuals qualified to become Board members. The Governance
and Nominating Committee also recommends to the Board (a) the director nominees for the next annual meeting of shareholders and candidates
to fill vacancies on the Board and (b) the directors to be appointed to Board Committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of its mandate, the Governance and Nominating
Committee (i) develops criteria for selecting directors and, when appropriate, conducts searches for prospective Board members whose skills
and attributes meet those criteria, (ii) considers nominees submitted to the Board by shareholders if appropriate biographical and background
information is provided, applying the same criteria and following substantially the same process in considering candidates suggested by
shareholders as it does in considering other candidates and (iii) prior to recommending a nominee for election, determines that the election
of the nominee as a director would effectively further the policies set forth in the Corporation&#8217;s corporate governance guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with its mandate to review and recommend
to the Board the directors to be appointed to the various committees of the Board and the Chair of each committee, the Governance and
Nominating Committee considers the desired qualifications for membership on each committee, the availability of each director to meet
the time commitment required for membership on the particular committee, and the extent to which there should be a policy of periodic
rotation of committee members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance and Nominating Committee also oversees
the process of evaluations of the Board, its committees and executive management of the Corporation, and make recommendations to the Board
as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Term Limits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation has not adopted term limits for
directors of the Corporation. The Board believes that the need to have experienced directors who are familiar with the business of the
Corporation must be balanced with the need for renewal, fresh perspectives and a healthy skepticism when assessing management and its
recommendations. In addition, as mentioned above the Board undertakes an assessment process that evaluates its effectiveness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While term limits can help ensure the Board gains
fresh perspective, imposing this restriction means the Board would lose the contributions of longer serving directors who have developed
a deeper knowledge and understanding of the Corporation over time. The Board believes that term limits have the disadvantage of losing
the contribution of directors who have been able to develop, over a period of time, increasing insight into the Corporation and its operations
and thereby provide an increasing contribution to the Board as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board and Senior Management Diversity </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation recognizes and embraces the benefits
of having diversity on the Board and in its senior management. Diversity is important to ensure that members of the Board and the Corporation&#8217;s
senior management provide the necessary range of perspectives, experience and expertise required to achieve the Corporation&#8217;s objectives
and deliver for its stakeholders. Accordingly, the Corporation has adopted a Diversity Policy that addresses, among other things, identification
and nomination of women directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation also recognizes that the Board
and its senior management appointments must be based on performance, ability, merit and potential. Therefore, the Corporation ensures
a merit based competitive process for appointments. The Corporation&#8217;s commitment to diversity includes ensuring that diversity is
fully considered in determining the composition of the Board and the appointment of its senior management. Pursuant to the Corporation&#8217;s
Diversity Policy, on an annual basis, the Governance and Nominating Committee will (i) assess the effectiveness of the senior management
appointment process at achieving the Corporation&#8217;s diversity objectives; and (ii) consider and, if determined advisable, recommend
to the Board for adoption, measurable objectives for achieving diversity in senior management. At any given time the Board may seek to
adjust one or more objectives concerning senior management diversity and measure progress accordingly. The Corporation currently has one
female executive officer and one woman on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Short-Selling; Hedging</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Corporation&#8217;s Insider
Trading Policy, which is applicable to its directors, officers and other employees, no such person may engage in short-selling of
the Corporation&#8217;s securities or any trading in exchange-traded options with respect to the Corporation&#8217;s securities. Any
director or executive officer who wishes to enter into another type of hedging arrangement must consult with the Compliance Officer
as legal restrictions and/or public disclosures may be required. In addition, margin loans using the Corporation&#8217;s securities
and other pledges of such securities present the risk that the pledgee will foreclose and sell the securities at a time when the
Corporation&#8217;s personnel are prohibited from trading, with possibly serious collateral consequences. For this reason, such an
arrangement may be risky and should not be undertaken without the prior written approval of the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board is responsible for establishing director
and executive officer compensation and reviews such compensation at least as often as annually. The Board believes that directors should
be fairly compensated for undertaking the responsibilities associated with serving as a director. At the same time, director compensation
should be consistent with market practices generally. The Board delegates to the Compensation Committee responsibility for periodically
assessing market practices for director and executive officer compensation. In addition, the Compensation Committee evaluates director
compensation in the context of evaluating director recruitment and retention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee operates under a written
charter adopted by the Board. The Compensation Committee is currently composed entirely of independent directors: Dr. Brughera (Chair),
Mr. Rallis and Dr. Cook. The Compensation Committee held seven meetings in the fiscal year ending December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to director compensation, the Compensation
Committee of the Board determines the compensation to be paid to Fennec&#8217;s executive officers and periodically reviews Fennec&#8217;s
compensation structure to ensure that Fennec continues to attract and retain qualified and experienced individuals to Fennec&#8217;s management
team and motivate these individuals to perform to the best of their ability and in Fennec&#8217;s best interests. Among other things,
the Compensation Committee considers compensation levels of comparable positions in similarly sized organizations in the biotechnology
industry. The Compensation Committee also administers the Company&#8217;s Equity Incentive Plan and approves new stock option grants or
other equity awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Board Committees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has created audit, compensation, and
the governance and nominating committees to ensure that the Board functions independently of management. It is also customary practice
for directors (i) to regularly receive detailed information describing Fennec&#8217;s performance, and (ii) when necessary, to speak directly
with management regarding additional information required on particular matters of interest. Moreover, directors have access to information
independent of management through Fennec&#8217;s external auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of the Board, the Audit Committee of
the Board retains, oversees and evaluates Fennec&#8217;s independent auditors, reviews the financial reports and other financial information
provided by Fennec, including audited financial statements, and discusses the adequacy of disclosure with management and the auditors.
The Audit Committee also reviews the performance of the independent auditors in the annual audit and in assignments unrelated to the audit,
assesses the independence of the auditors, and reviews their fees. The Audit Committee is also responsible for reviewing Fennec&#8217;s
internal controls over financial reporting and disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee operates under a written charter
adopted by the Board. Multilateral Instrument 52-110 &#8211; Audit Committees requires certain disclosures be cross-referenced with respect
to the Audit Committee when soliciting proxies from Shareholders for the purpose of electing directors. The Corporation is relying on
the exemption found in Part 7 of the Multilateral Instrument applicable to U.S. Listed Issuers. The Audit Committee met five times during
the fiscal year ended December 31, 2020. As required by the rules of the SEC and Canadian securities laws, the Audit Committee is composed
entirely of independent directors, each of whom the Board has determined is &#8220;financially literate&#8221; for purposes of the applicable
laws: Mr. Rallis (Chair), Mr. Haigh and Dr. Islam. In addition, the Board has determined that Mr. Rallis qualifies as an &#8220;audit
committee financial expert,&#8221; as defined in Item 407(d)(5) of Regulation S-K promulgated by the SEC. A copy of the Corporation&#8217;s
Audit Committee Charter is included as Schedule &#8220;A-2&#8221; to this Circular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 33; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Committee Report</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has (1)&nbsp;reviewed and
discussed the audited financial statements with management, (2)&nbsp;discussed with Haskell &amp; White LLP, our independent registered
public accounting firm, the matters required to be discussed by the Statement on Auditing Standards No.&nbsp;61, and (3)&nbsp;received
the written disclosures and the letter from Haskell &amp; White LLP required by the Independence Standards Board Standard No.&nbsp;1,
and has discussed their independence with the independent registered public accounting firm. Based upon these discussions and reviews,
the Audit Committee recommended to the Board that the audited financial statements be included in the Corporation&#8217;s Annual Report
on Form 10-K for the fiscal year ended December&nbsp;31, 2020 that we filed with the SEC on March 30, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Haskell &amp; White LLP served as our independent
registered public accounting firm and audited our consolidated financial statements for the year ended December&nbsp;31, 2020. Though
the Audit Committee does not have formal pre-approval policies and procedures in place, it has pre-approved all of the services performed
by Haskell &amp; White LLP as discussed below, as required by SEC regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Fees</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following presents the aggregate fees for professional
services and other services rendered by our independent auditors, Haskell &amp; White LLP, in fiscal years 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Fiscal&nbsp;Year&nbsp;</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>2020</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Fiscal&nbsp;Year&nbsp;</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>2019</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Audit Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">51,600</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">74,500</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Tax Fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">All Other Fees<SUP>(3)</SUP></FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">2,500-</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: right; padding-bottom: 1pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">91,600</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">77,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 97%; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt"><I>Audit Fees</I> include fees for the standard audit work that needs to be performed each year in order to issue an opinion on the consolidated financial statements of the Corporation.&nbsp;It also includes fees for services that can only be provided by the Corporation&#8217;s auditor such as auditing of non-recurring transactions. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt"><I>Audit-Related Fees</I> include fees assurance and related services that are reasonably related to the performance of the audit or review and are traditionally performed by the independent accountant.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt"><I>All Other Fees</I> include fees for products and services other than Audit Fees, Audit Related Fees and Tax Fees.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee does not have formal pre-approval
policies and procedures; however, prior to their engagement by us, the Audit Committee approved all of the services performed by Haskell
&amp; White LLP as required by SEC regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submitted By:</FONT></TD>
    <TD STYLE="width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris A. Rallis, Chair</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian J. Haigh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Khalid Islam</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Governance and Nominating Committee</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance and Nominating Committee of the
Board develops, recommends and oversees the effectiveness of Fennec&#8217;s corporate governance guidelines. In addition, the Governance
and Nominating Committee oversees the orientation and education of directors and the process of evaluating the Board and its committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance and Nominating Committee of the
Board is charged with nominating activities, including determining desired Board skills and attributes for directors, conducting appropriate
and necessary evaluations of the backgrounds and qualifications of possible director candidates, and recommending director nominees for
approval by the Board or the Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance and Nominating Committee is currently
composed three independent directors: Mr. Haigh (Chair), Dr. Brughera and Dr. Cook. The Governance and Nominating Committee held four
meetings in the fiscal year ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 34; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Retention of Outside Advisors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec&#8217;s Corporate Governance Guidelines
provide that the Board, each Board committee, the Chairman and the Lead Independent Director (if any), on behalf of the independent directors
as a group, shall have the authority to hire legal, accounting, financial or other advisors as they may deem necessary in their best judgment,
without the need to obtain the prior approval of any officer of the Corporation. The Corporation will arrange for payment of the invoices
of any such third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Delinquent Section 16(a) Reports </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 11, 2017, Fennec became subject to
Section&nbsp;16(a) of the Exchange Act. Section&nbsp;16(a) of the Exchange Act requires our directors, certain officers, and persons who
beneficially own more than 10% of our Common Shares to file with the SEC initial reports of ownership and reports of changes in ownership
of our Common Shares and other equity securities. Officers, directors and beneficial owners of more than 10% of our Common Shares are
required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To our knowledge, based solely on our review of
the copies of such reports furnished to us, our officers, directors and beneficial owners of more than 10% of our Common Shares complied
with all Section&nbsp;16(a) filing requirements during fiscal 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-variant: small-caps"><B>SHAREHOLDER
PROPOSALS FOR NEXT YEAR&#8217;S ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The BCBCA permits certain eligible shareholders
of the Corporation to submit shareholder proposals to the Corporation, which proposals may be included in a management proxy circular
relating to an annual meeting of shareholders. Shareholders having proposals that they desire to present at the next year&#8217;s annual
meeting of shareholders should, if they desire that such proposals be included in the Corporation&#8217;s proxy circular relating to such
meeting, submit such proposals in time to be received by Fennec not later than January 17, 2022. To be so included, all such submissions
must comply with the requirements of the SEC&#8217;s Rule 14a-8 and you should pay close attention to that rule. Proposals should be mailed
to the Secretary at Fennec Pharmaceuticals Inc., PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, NC 27709.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-variant: small-caps"><B>ADDITIONAL</B></FONT> <FONT STYLE="font-variant: small-caps"><B>INFORMATION</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial information for the financial year ended
December 31, 2020 is provided in the Corporation&#8217;s consolidated financial statements and management&#8217;s discussion and analysis
(&#8220;<B>MD&amp;A</B>&#8221;), which are included in the Annual Report. Security holders who wish to be added to the mailing list for
the annual and interim financial statements and MD&amp;A should complete the appropriate sections of the proxy or contact the undersigned
at PO Box 13628, 68 TW Alexander Drive, Research Triangle Park, North Carolina 27709.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporation&#8217;s Annual Report on Form
10-K for the fiscal period ended December 31, 2020 (including the consolidated financial statements and MD&amp;A) and other information
relating to the Corporation is available on SEDAR at <U>www.sedar.com</U> and at <U>www.sec.gov</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF THE BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contents of this Circular and its sending
to Shareholders have been approved by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>DATED</B> at Research Triangle Park, North
Carolina this 14<SUP>th</SUP> day of May, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BY ORDER OF THE BOARD OF DIRECTORS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>/s/ Rostislav Raykov</I></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rostislav Raykov</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<!-- Field: Split-Segment; Name: A04 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SCHEDULE &#8220;A-1&#8221;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>FENNEC PHARMACEUTICALS
INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Mandate of the
Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.35in">A.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Responsibilities</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors (the &#8220;<B>Board</B>&#8221;)
of Fennec Pharmaceuticals Inc. (the &#8220;<B>Company</B>&#8221;) is responsible for the stewardship of the Company. All directors shall
act honestly and in good faith with a view to the best interests of the Company and exercise the care, diligence and skill that a reasonably
prudent person would exercise in comparable circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board retains plenary authority and power
to do all lawful acts and things as are not by law or otherwise directed or required to be exercised or done by the shareholders of the
Company or in some other manner. In carrying out its responsibilities, the Board of Directors (or the committees of the Board of Directors
duly constituted by the Board of Directors to the extent such delegation is permitted by law and is specifically made by the Board of
Directors) shall have the following specific responsibilities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">1.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the adoption of a corporate strategic plan that includes the periodic review and approval of business
plans, which take into account, among other things, the opportunities and risks of the business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">2.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the identification of the principal risks of the Company&#8217;s business and ensuring the implementation
of appropriate systems to manage these risks;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">3.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the adoption of processes for succession planning, the periodic review of succession plans for key members
of senior management, including the Chief Executive Officer (the &#8220;<B>CEO</B>&#8221;), and the appointment and training of, and monitoring
the performance and compensation of senior management, including officers of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">4.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the adoption of a communications policy and the periodic review of such policy;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">5.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the establishment of adequate systems of internal controls and management information systems;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">6.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the adoption of corporate governance guidelines or principles applicable to the Company, including with
respect to: (i) the size and composition of the Board; (ii) the orientation of new directors; (iii) the provision of continuing education
to directors; (iv) the compensation and tenure of directors; (v) the periodic assessment (at least annually) of the performance of the
Board, its committees and directors, this Mandate, the Charter for each committee of the Board; and (vi) the position description(s) applicable
to each individual director, as well as the competencies and skills each individual director is expected to bring to the Board;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">7.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the oversight of the maintenance by management of practices and processes to ensure compliance with applicable
laws and appropriate ethical standards, including the adoption by management of corporate policies and procedures and the adoption of
a written code of business conduct and ethics applicable to directors, officers and employees of the Company containing standards that
are reasonably designed to deter wrongdoing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">8.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">to the extent feasible, satisfying itself as to the integrity of the CEO and other senior officers and
that the CEO and other senior officers create a culture of integrity throughout the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">9.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the submission of matters or questions requiring the approval of shareholders to the shareholders for
approval;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">10.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the approval of the submission to the shareholders of any amendment to the articles of the Company or
the approval of any adoption, amendment or repeal of any articles or bylaws of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">11.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the recommendation of candidates for election or appointment to the Board of Directors, including the
review of nominations recommended by shareholders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">12.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the approval of the annual objectives of the Company and the Chief Executive Officer, and the assessment
of the performance of the Company and the Chief Executive Officer against the approved objectives;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">13.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the approval of an annual operating budget for the Company and its subsidiaries on a consolidated basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">14.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the authorization of the issuance of securities of the Company as required in accordance with applicable
laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">15.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the declaration of dividends on shares of the Company or the approval of the purchase, redemption or other
acquisition of shares issued by the Company as required in accordance with applicable laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">16.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the oversight of the reliability and integrity of accounting principles and practices followed by management,
financial statements and other financial reporting, and disclosure practices followed by management;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">17.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the oversight of the qualifications and independence of the independent auditors of the Company and the
approval of the terms of their audit and non-audit service engagements as required in accordance with applicable laws and the requirements
of any stock exchanges on which the Company lists its securities and of securities regulatory authorities, as adopted or in force or amended
from time to time, and the assessment of the performance of the independent auditors, the filling of a vacancy in the office of the independent
auditor between shareholders' meetings, and the recommendation of the annual appointment or, if appropriate, the removal, of the independent
auditors of the Company to the shareholders of the Company for their approval in accordance with applicable laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">18.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the approval of the annual audited consolidated financial statements of the Company and, as required in
accordance with applicable laws, the approval of the quarterly unaudited consolidated financial statements of the Company and overview
of the accounting principles and practices followed by management;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">19.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the approval of prospectuses, annual information forms, annual reports on Form 20-F, 40-F or 10-K or other
applicable form, as the case may be, and proxy circulars and proxy statements sent to shareholders of the Company and the review of managements'
discussion and analyses of financial condition and results of operations, and other material disclosure documents as determined by the
Board of Directors from time to time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">20.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the establishment and periodic review of the Company&#8217;s measures for receiving feedback from security
holders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">21.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the development of clear position descriptions for directors, including the Chair of the Board, a &#8220;Lead
Independent Director&#8221; and the chair of each board committee; and, together with the CEO, a clear position description for the CEO,
which includes delineating management&#8217;s responsibilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">22.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the oversight of the management of environmental risks and practices, charitable activities and other
social responsibility matters; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">23.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">to the extent not otherwise referred to above, the review and approval of all proposed transactions and
matters described below under the heading &#8220;B. Decisions Requiring Prior Approval of the Board&#8221;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and, where applicable, in accordance with the
requirements of the <I>Canada Business Corporations Act</I>, the stock exchanges on which the Company lists its securities and securities
regulatory authorities, as adopted or in force or amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In discharging its duties and responsibilities,
the Board of Directors is expected to be fully diligent in its oversight to avoid fraud or abuse. Accordingly, the Board may conduct such
examinations, investigations or inquiries, and engage such special legal, accounting or other advisors, at the expense of the Company,
at such time or times and on such terms and conditions as the Board of Directors considers appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.35in">B.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Decisions Requiring Prior Approval of the Board</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to such other approvals as required
by applicable law or the stock exchanges on which the Company lists its securities and securities regulatory authorities, the Board (or
the committees of the Board duly constituted by the Board to the extent such delegation is permitted by law and is specifically made by
the Board of Directors) shall review and approve:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">1.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the strategic plan, financial plans and operating budget of the Company on at least an annual basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">2.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the quarterly and annual financial statements of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">3.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">all material capital expenditures not part of the approved operating budget, all mergers and acquisitions, and all material investments and dispositions of the Company;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">4.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">all material borrowings and banking arrangements of the Company;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">5.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">all financing by the Company including the issuance of debt, equity and derivative instruments; for greater certainty, this includes the approval of all off-balance sheet financings by the Company or by special purpose entities or affiliates;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">6.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">the purchase and redemption of securities;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">7.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">any changes to the articles or by-laws of the Company;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">8.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the hiring and, if necessary, the termination of the Chief Executive Officer;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">9.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the compensation paid to senior management and directors, including the issuance of stock options and non &#8211; arm&#8217;s length consulting arrangements;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">10</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">any other material matters outside the ordinary course of the Company's business including all major strategic and policy decisions; and</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">11.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">any other matter specified by the Board as requiring its approval.</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><B>C.</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>Expectations of Management</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CEO, through the Senior management, is responsible for the day-to-day operations of the Company and for providing the Board, directly
or through the Chair of the Board, the appropriate committee or the Lead Independent Director, with timely, complete and accurate information
on such operations. The Board expects management to propose and, after Board approval, implement the Company's strategic plan and to be
accountable for the Company's financial and competitive performance. The Board expects the Company's resources to be managed in a manner
consistent with enhancing the value of the Company and with consideration for ethics and corporate social responsibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board may request that certain members of
senior management attend all or any portion of a Board or committee meeting and may schedule presentations by managers who can provide
additional insight based on their personal involvement in the matter or their particular expertise. Each director shall have complete
access to any member of senior management. The Chief Financial Officer and the General Counsel of the Company shall each have access to
meet separately with the Audit Committee and Governance Committee respectively, the Chairman and Lead Independent Director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board may reasonably rely on the information
provided to them by the Company&#8217;s senior management personnel and outside advisors and auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><B>D.</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>Measures for Receiving Shareholder Feedback</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has developed a Disclosure Policy to facilitate consistent disclosure practices aimed at informative, timely and broad dissemination
of material information to the market in compliance with applicable securities laws and the rules and policies of any exchange on which
the Company&#8217;s securities are listed. The Disclosure Policy Committee established under the Disclosure Policy is responsible for
overseeing and monitoring communications with, and responses to inquiries from, both institutional and individual investors and the financial
community consistent with the objectives of the Company&#8217;s Disclosure Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Company spokespersons as appointed by the Disclosure
Policy Committee from time to time are available to shareholders by telephone, fax and e-mail and the Company maintains up-to-date material
of interest to shareholders and investors on the Company&#8217;s web site at www.Fennecpharma.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><B>E.</B></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><B>General.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors shall review and assess
the adequacy of the mandate of the Board on an annual basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nothing in this Mandate is intended, or may be
construed, to impose on any member of the Board a standard of care or diligence that is in any way more onerous or extensive than the
standard required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SCHEDULE &#8220;A-2&#8221;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>FENNEC PHARMACEUTICALS
INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.1pt 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Audit
Committee Charter</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Purpose</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The purpose of the Audit Committee (the
&#8220;Committee&#8221;) of the Board of Directors (the &#8220;Board&#8221;) of Fennec Pharmaceuticals Inc. (together with its subsidiaries,
the &#8220;Company&#8221;) is to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Assist the Board in fulfilling its responsibility
to oversee the Company&#8217;s accounting and financial reporting processes and audits of the Company&#8217;s financial statements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Review the financial reports and other financial
information provided by the Company, the Company&#8217;s disclosure controls and procedures, and its internal accounting and financial
controls;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Assume direct responsibility for the appointment,
compensation, retention (and where appropriate, replacement), and oversight of the work of the outside auditor in preparing or issuing
an audit report or related work;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Oversee the independence of the outside auditor and
approve all auditing services and permitted non-audit services provided by the outside auditor;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Receive direct reports from the outside auditor and
resolve any disagreements between management and the outside auditor regarding financial reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Carry out the specific responsibilities set forth
below in furtherance of this stated purpose.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Committee Membership and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Resources and Authority</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">In discharging its oversight role, the
Committee is granted all responsibilities and authority required by MI 52-110 and SEC Rule 10A-3, including without limitation the authority
to investigate any matter brought to its attention with full access to all books, records, facilities and personnel of the Company and
the authority to engage independent legal, accounting or other advisors to obtain such advice and assistance as the Committee determines
necessary to carry out its duties. The Committee may request any officer or employee of the Company or the Company's outside counsel to
attend a meeting of the Committee or to meet with any member of, or consultants to, the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Company shall provide the Committee
all appropriate funding, as determined by the Committee, for payment of compensation to any such advisors and any outside auditor, as
well as for any ordinary administrative expenses of the Committee that it determines are necessary or appropriate in carrying out its
responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Key Responsibilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The Committee&#8217;s role is one of
oversight, and it is recognized that the Company&#8217;s management is responsible for preparing the Company&#8217;s financial statements
and that the outside auditor is ultimately accountable to the Board and the Committee, as representatives of the stockholders, and is
responsible for auditing those financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The following functions shall be the
common recurring activities of the Committee in carrying out its oversight role. The functions are set forth as a guide and may be varied
and supplemented from time to time as appropriate under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Appointment of Outside Auditor. The
Committee shall have direct responsibility for the appointment, compensation, retention (and where appropriate, replacement), and oversight
of the work of any registered public accounting firm selected to be the Company&#8217;s outside auditor for the purpose of preparing or
issuing an audit report or performing other audit, review or attest services for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Appointment and Performance Evaluation
of Chief Financial Officer and Internal Auditor. The Chair of the Committee shall participate in the identification of candidates for
the positions of Chief Financial Officer and Lead of the Company&#8217;s internal auditing function, if any, and shall advise management
with respect to the decision to hire a particular candidate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Disclosure Controls and Procedures.
The Committee shall review periodically with management the quality and adequacy of the Company&#8217;s disclosure controls and procedures.
The Committee must be satisfied that adequate procedures are in place for the review of the Company&#8217;s public disclosure of financial
information extracted or derived from the Company&#8217;s financial statements and must periodically assess the adequacy of those procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Internal Controls. The Committee shall
discuss periodically with management and the outside auditor the quality and adequacy of the Company&#8217;s internal controls and internal
auditing procedures, if any, including any significant deficiencies in the design or operation of those controls which could adversely
affect the Company&#8217;s ability to record, process, summarize and report financial data and any fraud, whether or not material, that
involves management or other employees who have a significant role in the Company&#8217;s internal controls, and discuss with the outside
auditor how the Company&#8217;s financial systems and controls compare with industry practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Accounting Policies. The Committee shall
review periodically with management and the outside auditor the quality, as well as acceptability, of the Company&#8217;s accounting policies,
and discuss with the outside auditor how the Company&#8217;s accounting policies compare with those in the industry and all alternative
treatments of financial information within U.S. and Canadian generally accepted accounting principles that have been discussed with management,
the ramifications of use of such alternative disclosures and treatments and the treatment preferred by the outside auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Pre-approval of All Audit Services
and Permitted Non-Audit Services. The Committee shall approve, in advance, all audit services and all permitted non-audit services to
be provided to the Company by the outside auditor; provided that any non-audit services performed pursuant to an exception to the pre-approval
requirement permitted under applicable laws shall not be deemed unauthorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify">Annual Audit. In connection with the
annual audit of the Company&#8217;s financial statements, the Committee shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">request from the outside auditor a formal written
statement delineating all relationships between the auditor and the Company consistent with Independence Standards Board Standard No.
1 and such other requirements as may be established by the Public Company Accounting Oversight Board, discuss with the outside auditor
any such disclosed relationships and their impact on the outside auditor&#8217;s objectivity and independence, and take appropriate action
to oversee the independence of the outside auditor.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">approve the selection and the terms of the engagement of the outside auditor.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with management and the outside auditor the
audited financial statements to be included in the Company&#8217;s Annual Report filed on the System for Electronic Document Analysis
and Retrieval (&#8220;SEDAR&#8221;) and with the SEC, and review and consider with the outside auditor the matters required to be discussed
by Statement on Auditing Standards (SAS) No. 61.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with management and the outside auditor any
press releases in respect of the audited financial statements before the Company first publicly discloses this information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">perform the procedures set forth below in &#8220;Financial
Reporting Procedures&#8221; with respect to the annual financial statements to be reported.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with management and the outside auditor the
Company&#8217;s critical accounting policies and practices.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">recommend to the Board whether, based on the reviews
and discussions referred to above, the annual financial statements should be included in the Company&#8217;s Annual Report filed on SEDAR
and with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Interim Reports. In connection with
the Company&#8217;s preparation of its interim financial information to be included in the Company&#8217;s Quarterly Reports filed on
SEDAR and filed with the SEC, the Committee shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with the outside auditor the Company&#8217;s
interim financial information and the matters required to be discussed by SAS No. 61.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">perform the procedures set forth below in &#8220;Financial
Reporting Procedures&#8221; with respect to the interim financial information to be reported.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">by action of a majority of the Committee or through
the Committee Chair, review with the outside auditor, prior to filing, the Company&#8217;s interim financial information to be included
in the Company&#8217;s Interim Reports filed on SEDAR and filed with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">by action of a majority of the Committee or through
the Committee Chair, review with the outside auditor any interim press releases in respect of the interim financial statements before
the Company first publicly discloses this information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Financial Reporting Procedures. In
connection with the Committee&#8217;s review of each reporting of the Company&#8217;s annual or interim financial information, the Committee
shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">discuss with the outside auditor whether all material
correcting adjustments identified by the outside auditor in accordance with U.S. and Canadian generally accepted accounting principles
and the rules of the SEC and CSA are reflected in the Company&#8217;s financial statements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with the outside auditor all material communications
between the outside auditor and management, such as any management letter or schedule of unadjusted differences.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">review with management and the outside auditor any
material financial or other arrangements of the Company which do not appear on the Company&#8217;s financial statements and any transactions
or courses of dealing with third parties that are significant in size or involve terms or other aspects that differ from those that would
likely be negotiated with independent parties, and which arrangements or transactions are relevant to an understanding of the Company&#8217;s
financial statements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.55in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.2in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">resolve any disagreements between management and
the outside auditor regarding financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Hiring Policies. The Committee shall
review and approve the Company&#8217;s hiring policies regarding partners, employees and former partners and employees of the present
and any former outside auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Charter. The Committee shall review
and reassess at least annually the adequacy of this Charter and recommend any proposed changes to the Board for approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Reports. The Committee shall report
its activities to the full Board on a regular basis and make such recommendations to the Board with respect to the above and other matters
as the Committee deems necessary or appropriate. The Committee shall also prepare and submit to the appropriate authority or body any
other report required by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B>Complaint Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Any issue of significant financial misconduct
shall be brought to the attention of the Committee for its consideration. In this connection, the Committee shall establish procedures
for (i) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls
or auditing matters and (ii) the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting
or auditing matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page </FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="tm212691d1_card.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="tm212691d1_card2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm212691d1_def14aimg0010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212691d1_def14aimg0010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (U P$# 2(  A$! Q$!_\0
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M^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]H_\
MOH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#OH4?:8/\ GM'_ -]"@"6BHOM,'_/:
M/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\ /:/_
M +Z%'VF#_GM'_P!]"@"6BHOM,'_/:/\ [Z%'VF#_ )[1_P#?0H EHJ+[3!_S
MVC_[Z%'VF#_GM'_WT* ):*B^TP?\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_ #VC
M_P"^A1]I@_Y[1_\ ?0H EHJ+[3!_SVC_ .^A1]I@_P">T?\ WT* ):*B^TP?
M\]H_^^A1]I@_Y[1_]]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_P ]
MH_\ OH4?:8/^>T?_ 'T* ):*B^TP?\]H_P#OH4?:8/\ GM'_ -]"@"6BHOM,
M'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\
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MM,'_ #VC_P"^A1]I@_Y[1_\ ?0H EHJ+[3!_SVC_ .^A1]I@_P">T?\ WT*
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M&"/K3>CLPZ7/2:*XG3[JSUOQ'ISWMA;QZQ:K*EU&T8+*Z[=K GDKR2I]ZO\
MB6XEEUW0M(+O':7DLC3E&*EPBY"9'8GKZT=@[G3T5QVNVMOX?O\ 1I])MH[<
M7-XMK/;PJ%29&!SE1P2,=<9K,TC3=.-WJ]NWA>.\B.J-")EBBVPH=HP.=X R
M3P,>X["U_KT_S#;^O7_(]$HK&\1W\VC^'9I;-1Y_R0P;N0&8A03GTS7*7UR^
MAV6H636GDZP]NC?V@)O.>5&D",Q8@%2"?N]!VZ4;O0/4]$HKF;2WAT?Q?;V%
MA&(K6XL6>6).F]& #_4AB">_%4/%MD\&N6VM6$8%Y90-<.$4 S(K*&4GO\I.
M*.P':T5Y_P"+;R+7[>T:W<2:=!<6S/W65Y&&%/T0Y(_VA6CIUO!K/B?6+:_M
MXY+33O*@MK1US$BE<[MG0GT.. .*+!<Z^BN"N+>&/4M?T0P)/IL5C]KABE4.
MMM)M(PN>GJ!V[56U#&C:%=Z#JRK<64EJ\FF7$RAL,%)\LD]&'8^E"U';7^OZ
MZGHU%<-XJ\.Z19Z T\.G6PEDN;?Y_*7*@NB[1QPN!T]S3_%?A_2;+3(YK?2X
M"7O;?]U'$@'+@$*#@#<, \@'C-!-_P#,[:BN&U6"WO/$WAQ+CP^UJHE>,&=(
M2&58R0HV,W /(!X%:'CJUMIM*M99;..YD2\@5044L07&5!;CGIU ]:/\Q_Y?
MY_Y'4T5QOABTBN=<U6YMK5+#3]OV:73" #Y@ZNR#Y5R..,Y%9FB:?I_DZE$_
MA5+U/[2EB$ZQ0[8T+@8Y.\!0<\+Q0!Z+17%>,=!TR#1I;H64+W$EU!F61 S
M;T7:"1G&!C'UH\3>'-&M8+.2+3K6,2ZC;JRB)0H!8!@!C@$8R.AQ0M0.UHK
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M$][>W=^;=M\*7)3;&W]["JN3[MFM>B@#%D\-07$6I0W5Y=W,.H<RQR>7A3@
M%<("" !Z]/6B;PY#)J-E>17MW;FR3RX(HO+V*I !&"A)R ._TQ6U10!EZ1HJ
MZ0]TR7UU<?:93,XG\O[YZD;5'7 XZ5)8Z2+*_O+S[9<SO=$%EEV87'0+A0<
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M>.(3^8DL+;X9XFVO$WJI_H<BEM=-,$BR3WMS>2+D(TY0;?H$51GW(S[U>HH
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MO&VJ(H'E8G&>B GH*SX_%VB2&#_2Y$^T$"$RV\L8ER0!MW*-W)'2@#;HHHH
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MM.EM/<7AGADF.T31D *%)ZD=,#FM>TU'2K_37U"VC:2U7/S?9'!..NU2N6_
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MFH **** "BBB@ HHHH *B7_CZD_W%_FU2U$O_'U)_N+_ #:@"6BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC?XT 2T5%Y"?WI/^_C?XT>0G]Z3_ +^-_C0!+147D)_>D_[^-_C1Y"?WI/\
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M;JR#C/U'0_A765P'BZPGT+68/$NG+@;P+A1TSTR?9AP??ZUT4FIQ]D_EZ_\
M!,*BY'[1?,[^BJNG7\&J:?#>V[9BE7(]0>X/N#Q5JL&FG9FZ=]4%%%%( HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@"*?_ %8_WT_]"%2U%/\ ZL?[Z?\
MH0J6@ HHHH **** "BBB@ J)?^/J3_<7^;5+42_\?4G^XO\ -J ):*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KG_&>I_V9X:N&5L2S_N8_JW7],UT%>?>*R=>\
M9:=H:',41!EP?7YF_P#'1^M;4(J4U?9:_<95I-0TW>AO^"=,_LWPU 67$MS^
M_?\ 'H/RQ714@ 50 , < "EK.<G.3D^I<8J,4D%%%%24%%%% !1110 4444
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M<5W;.'AE7<I_SWJ>O.=!O;KPGKTF@W\H%K*V897&5!/0CG@'H?0_C7H.V?\
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M:S?!GB1[M3H^HDI?V^57?P7 Z@_[0_SWKL*X_P 7^&9;MUUC2@4U&'#,$ZR
M="/]H?K712DI1]G/Y/M_P#&<7%\\?GYG845S?A7Q3%KML()R(]0B&)(SQO\
M]H?U':NDK&<'!\LC2,E)704445)04444 %%%% !1110 4444 %%%% !1110
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M1110 4444 %%%% !1110 5RWC_4/L7AIX5;$ETXB&/3JWZ#'XUU->?\ B/\
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MLRPHHHH **** "BBB@ HHHH BG_U8_WT_P#0A4M13_ZL?[Z?^A"I: "BBB@
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M^<8Q^F*]WJ/R(O.\[RD\W&-^T;L?6KIXJ,+V@B)T'*UY,X;^QO'-Z/W^KQP
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M^><?_?P_X4;I_P#GG'_W\/\ A0!+146Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (4
M2T5%NG_YYQ_]_#_A1NG_ .><?_?P_P"% $M%1;I_^><?_?P_X4;I_P#GG'_W
M\/\ A0!+146Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (4 2T5%NG_YYQ_]_#_A1NG_
M .><?_?P_P"% $M%1;I_^><?_?P_X4;I_P#GG'_W\/\ A0!+146Z?_GG'_W\
M/^%&Z?\ YYQ_]_#_ (4 2T5%NG_YYQ_]_#_A1NG_ .><?_?P_P"% $M%1;I_
M^><?_?P_X4;I_P#GG'_W\/\ A0!+146Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (4
M2T5%NG_YYQ_]_#_A1NG_ .><?_?P_P"% $M%1;I_^><?_?P_X4%YE4DI$ .2
M3(?\* .%\8$ZSXMTK0U.44AI<'^]R?R5<_C7?    # '0"O/O"'FZQXKU37-
MBLH)6/<2,;NF..RC'XUWNZ?_ )YQ_P#?P_X5T5_=Y:?9?BS&CK>?<EHJ+=/_
M ,\X_P#OX?\ "C=/_P \X_\ OX?\*YS8EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_
MPHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+
M=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_
MPHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+
M=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_
MPHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+
M=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_
MPHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+
M=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_
MPHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+
M=/\ \\X_^_A_PHW3_P#/./\ [^'_  H EHJ+=/\ \\X_^_A_PHW3_P#/./\
M[^'_  H )_\ 5C_?3_T(5+4,NXPKN !WKP#G^(5-0 4444 %%%% !1110 5$
MO_'U)_N+_-JEJ)?^/J3_ '%_FU $M%%% !1110 4444 %%%% !1110 4444
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MYK_C1YK_ //O)^:_XU!1+147FO\ \^\GYK_C1YK_ //O)^:_XT 2T5%YK_\
M/O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C0!+147FO
M_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?FO^- $M%1
M>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O)^:_XT 2
MT5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\ \^\GYK_C
M0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:_P#S[R?F
MO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C1YK_ //O
M)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?FO^-'FO\
M\^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O)^:_XT>:
M_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\ \^\GYK_C
M1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:_P#S[R?F
MO^-'FO\ \^\GYK_C0!+147FO_P ^\GYK_C1YK_\ /O)^:_XT 2T5%YK_ //O
M)^:_XT>:_P#S[R?FO^- $M%1>:__ #[R?FO^-'FO_P ^\GYK_C0!+147FO\
M\^\GYK_C1YK_ //O)^:_XT 2T5%YK_\ /O)^:_XT>:__ #[R?FO^- $M%1>:
M_P#S[R?FO^-'FO\ \^\GYK_C0 3_ .K'^^G_ *$*EJ&4EH5)4J=Z\'_>%34
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI^B_V7*S6LGRLX#*_.Y,#\CG<?QQ](4L1S>\E;R%[QKT445TE!1110 4444
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M>&F.386/X "I^J89?#S+YB?(^AQ\/Q N$ W7:/\ [\/^ %7HOB*O_+1;=O\
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M !-TB3 GMKN$GJ=JL!^N?TK5M_&WAZYX7440^DB,GZD8KF+OX<7T)S87\,R
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MR%245FY-[L5PHHHI""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1144=U;S32PQ3Q/+"0)45P60GD;AV_&@"4    8 HHHH **** "BBB@
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M<%U>VDJQYMUD,3!OX]I&_ YR.O%;UQX2TZXTFQT\-<0BQ ^SW$,FR6,XP2&
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M&CPV]R1YBEB%#;MBEB57/? ('X5HT44 %%%% !1110 4444 %%%% &"&OO\
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M7E])!/;B=4CCBN+DS2!5W'+,6;J6Z G@5O44 ]0HHHH **** "BBB@ HHHH
M*P]?^V23Z>+73;FY6"Y2=WC>(# # CYG!SR.V/>MRB@#F[T:A>ZW ;G2+MM/
MM666+RY(</)C[SY<$!<\  \\^E)ITMT]AJFN6=L;NYO)#]FA+!-T:?(G).,=
M6_&NEHH Y&WTZ]CAM[L:;=F]AO/M5P)GA#7!9&1MFURHP", D<#KWK:T:UGA
M%[<W,1ADN[@S>46#%!M50"1D9PN>">M:E%.X!1112 **** (I_\ 5C_?3_T(
M5+44_P#JQ_OI_P"A"I: "BBB@ HHHH **** "HE_X^I/]Q?YM4M1+_Q]2?[B
M_P VH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;J%&_P 1=H]SNU\1:(Z!AJ]C@C(S<(#^1/%30:QI=U,L-OJ5G-*V=J1SJS'
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M%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\
MGG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4
MM% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YY
MQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?
MP_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG
M_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/
M^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?
M_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_
M -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $
M6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\
M?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4
M;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P">
M<?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T
M4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'
M_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#
M_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_
M )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X
M5+10!%NG_P"><?\ W\/^%&Z?_GG'_P!_#_A4M% $6Z?_ )YQ_P#?P_X4;I_^
M><?_ '\/^%2T4 1;I_\ GG'_ -_#_A1NG_YYQ_\ ?P_X5+10!%NG_P"><?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm212691d1_card.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212691d1_card.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***CNKN.RMY)I6VQQJ6
M8XS@ 9- $E% .110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M $X%?+'BK]H__AI']JSP_P##GPU<;_"^CWGV_6;V)CC4&MLR"$'O#YBHI/1R
M?[H!;(_X*,?MF_\ ")Z?<^ /"]VRZO=+MU:[B/\ QZ1,.85/_/1@1D_PJ<=3
M\O+_ /!(KX=--K_BOQ9)'B.WACTJW?\ O,Q$LH_ )%_WU0!]S 8%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA>:F]C>+%!J6GW8N-5<YF(6W_L9EN(6+'$@;<S ;*^J/^'?/@/\ Z#WQP_\
M#S^,?_EG1_P[Y\!_]![XX?\ AY_&/_RSIPDURMV;3;?FW;1K^5:V2UU6NFJE
M%-22;5U;II:^JTW^&]][/3WM/C_]H7_@M)XV^'GQ4^*5GX/NOA3XHTGPHEZ^
MBZ5'9W,NJ-9Q^&DU>'6)Y4O DEDT[+;D)"F?-3$@;AMKQA_P5)^+_P -?'/B
M'P[X@?X0V>M:##=K+8#2[_SH[>+1AJ46NO\ Z7O_ +/FF*V0C6,L)FPLTC#R
MC]*:'_P3&^%?AC4=4O--NOB]I]YKER+S4I[;XO>+89-0G$:1"69EU(&1Q''&
MFYLG:BC. !6E_P .^? ?_0>^.'_AY_&/_P LZ+QY%%+7E2O_ 'K?%YZWWTUV
M5H\M77-=]W\U=67E;R^=_>YOE_X;?\%0OC5\4[OX7Z%9Z#\/[3Q5\9[*>XT>
M)M)U":W\,W-A=W/]JV.H W$;M+;VRVJ9_<YG:0[2I51AZY_P62^)E[\.V\46
MN@^!_".CJU_8V\_B#3[N0:GK&F:?;27>C1;;F(_:;B_FN+6W8;\?8I"(YRP
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M)K">Z-Q;R3?(/M&Z0-+YFQ%3'F;-H^[G)KIJ* "BBB@ HHHH **** "BBB@
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M+R%',=@;&*:()?-;$-;%<EX')9I&5E#*L?T17RO^R_\ L+:Y\$_B9X;UB_\
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ML%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!MGXCTZZTW39X8K,WD-TRQO&]P[2&,VX.]73=N^ZN,GSW3/VL_'G@3PYX?\
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M77/#NGWT]I+837EM'/);2'+V[,H8QL?52<'Z5=HI:6:_I>0.[:?]?T@HHHI
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M]WTYHDG%<TM$%[OEZG1T5YKX;_:<TW6?!:^)K_P_XIT'PY>+ ^F7]Y;0S-K
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M,XR3V\G]Z4E]Z:?S"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'4,I#*PR".]5[_6;/2[BTANKJVMY=0F^SVJ2RJC7,FQGV("?F;8CM@9.$8]
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M6_9]^)_Q6\9W%UXA\,^--.TI;YWL[%?&CNMDUQIVIPS2)*-19WA$DMFI&(L
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MQL!UG[,VJ_%32?CI-HFHVM[I/@Z'6=6D6UNM-N%BN[66XO9EN$E%D464SLH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOX6:/=7VO>-O"^GQ6EO-<LDFI0^<Z0LZ2%(]VYRKQR(0H)#(R]015K2/VB?
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MW\-6TATI=/MX+>Z8Y6UMXX6?4+&S18W,LC1229=_FV]C\6?V&?%/CWXF>/\
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MC6RU*Z\16WV---TLO?,KV]C"9DCD@FW1*=^]EAD*JDA"EEQ7U914VTMY6_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK_7]?/0]NHKQ73?VT=.BB\12:MX;U[3HM$&K7,#HUM.+^UT_[-OD7;+\K/\
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M)EQ]G175RA!TJ:/GAUZ^5FGZM7:72_:]U%./,XQJ;?D[K\[7?EI=VU?K^O?
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M_F"$8W. XX4#&U_]G[X7B*^U35?BY?+I?@>]@CUU9]9TJ*TL]0CL8;1'O'$
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MP/\ C+)='2+;6XM!L+[6UTFUD,%A)J]S?7<=GY-X]M;PG9IUU)'*L4($?EH
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M(&?05)16M2HYMRENVW][;_6WHD8PIJ$5&.R27R7]7]6PHHHJ"PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW]G[]H76?C'\4/&FCWEKINE6G@[4;FP5'C=;K55$I$=S%ER! H5HV?!+S"0
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MOVP?A)^T#XDGT7P%\4OASXWUBUMFO9K'0/$EGJ5S% K(C2M'#(S",-(BEB,
MNHSDBCR$;%I^S_X#L+D30>"?",,RVC6 DCT>W5A;MYFZ'(3/EGS9<IT/F/Q\
MQS/H?P2\&>&+"RM=-\(^&-/M=-O6U&TAMM*@ACM;IHVB:>-54!)3&[H7&&*L
MPS@D5PGB?_@H?^S_ ."?$FH:+K7QR^#NDZQI-S)97UC>^,]-M[FRGC8I)%+&
M\P9)$92K*P!!!! (J]\./VZ/@E\8_&EGX;\(_&+X5^*O$6I;_LFEZ/XLL+Z]
MNMB-(_EPQ2L[;8T=S@'"JQ/ )H_K]?S#7^O2WY:>AW6G_#?P[I'@ZS\.VN@Z
M+:^']/$2VNF16,26=L(F#QA(0NQ=C*K+@#:5!&"*2P^&GAO2KB::U\/Z);37
M&GQ:3*\5C$C2V46_RK9B%YA3S)-L9^5?,; &XY\X\3_\%#_V?_!/B34-%UKX
MY?!W2=8TFYDLKZQO?&>FV]S93QL4DBEC>8,DB,I5E8 @@@@$5>^''[='P2^,
M?C2S\-^$?C%\*_%7B+4M_P!DTO1_%EA?7MUL1I'\N&*5G;;&CN< X56)X!-#
MUO?KN5=_U_7DON.BT_\ 9V^'VD6]A#:>!?!MK#I4S7-DD6BVR+9RMLW21@)\
MC'RX\LN"?+7T&&V_[-_P[M-#;2XO 7@N/39+E;UK1-$ME@:=4,:RE-FWS A*
MAL9"DC.*Y_XC_MT?!+X.>-+SPWXN^,7PK\*^(M-V?:]+UCQ986-[:[T61/,A
MEE5UW1NCC(&592."#1\./VZ/@E\8_&EGX;\(_&+X5^*O$6I;_LFEZ/XLL+Z]
MNMB-(_EPQ2L[;8T=S@'"JQ/ )H)6FW]?U=_>=EXJ^$/A/QU=:;/K?A?P[K$V
MC8.GR7VFPW#6.&1AY1=28\-'&?EQRBGL*N6O@'0;+4X[V'1=)AO(EN42=+.-
M946YD66X 8#($LBJ[C^-E!;) -<#\1_VZ/@E\'/&EYX;\7?&+X5^%?$6F[/M
M>EZQXLL+&]M=Z+(GF0RRJZ[HW1QD#*LI'!!JCX8_X*'_ +/_ (V\2:?HNB_'
M+X.ZMK&K7,=E8V-EXSTVXN;V>1@D<44:3%GD=F"JJ@DD@ $FC_@_CO\ ?U'J
M=0/V7_AFOA]-)'P[\"C2HY3.EE_8-K]G20QB(N(_+VAC&JH3C.U0.@Q6SXA^
M$?A/Q=IT=GJWACP]JEI#:BR2"[TZ&:-+<.CB$*RD",/%&VWIF-#C*C'&?$?]
MNCX)?!SQI>>&_%WQB^%?A7Q%INS[7I>L>++"QO;7>BR)YD,LJNNZ-T<9 RK*
M1P0:H^&/^"A_[/\ XV\2:?HNB_'+X.ZMK&K7,=E8V-EXSTVXN;V>1@D<44:3
M%GD=F"JJ@DD@ $FC^OPM^6GH*W]?C^9Z%#\)O"MM:PV\?AGP_'!;K;K%&NG0
MA8Q;R-+;A1MP!%([NF/N,S$8))HU?X4>%O$":LM_X:\/WRZ]&8M3%QIT,@U%
M"%!6;<I\Q2$08;(PJ^@KF?B[^V#\)/V?O$D&B^/?BE\.?!&L75LM[#8Z_P")
M+/3;F6!F=%E6.:16,9:-U# 8)1AG(-8?AC_@H?\ L_\ C;Q)I^BZ+\<O@[JV
ML:M<QV5C8V7C/3;BYO9Y&"1Q11I,6>1V8*JJ"22  2:+N]PM=6_K38],A\ :
M#;ZC'>1Z+I,=Y"9S'.MG&)$\\AI\-C(\PJ"^/O$#.<5E>)?@1X'\9Z3IMAK'
M@SPIJUCHUN;33[:\TBWGAL82%4Q1*R$1H0B#:H PB\<"L3XN_M@_"3]G[Q)!
MHOCWXI?#GP1K%U;+>PV.O^)+/3;F6!F=%E6.:16,9:-U# 8)1AG(-<K_ ,/-
M?V;?^C@_@?\ ^%UI?_Q^C^OZ^\>NZ_JY[)%X=T^"]M[F.QLTN+.W:T@E6!0\
M,+%"T2G&50E$)4<'8O' KE8?V:OAS;Z?-9Q_#_P3':W%PEW+"NAVHCEF1659
M679@NJNX#'D!V&>36?\ %W]L'X2?L_>)(-%\>_%+X<^"-8NK9;V&QU_Q)9Z;
M<RP,SHLJQS2*QC+1NH8#!*,,Y!KE?^'FO[-O_1P?P/\ _"ZTO_X_1_7XW_/7
MU$M-OZZ?D=]<_LY_#V\TR\L9O ?@V6SU"Z^VW5N^B6S17,^7/G.I3#29DD.X
MY.7;GDYN7_P7\':K'MNO"?AFY7R+2UQ+I<#CR;24S6L?*_<AE)DC7I&Y++@\
MUF_&7]IOX;?LY_V;_P +"^(7@?P'_;'F_8/^$BUVUTO[=Y6SS/*\]T\S9YD>
M[;G;O7.,C/#_ /#S7]FW_HX/X'_^%UI?_P ?HVV_JP:_U]_YZGIC?!KP>WB.
M\U@^%/#9U?4GCDN[XZ9!]INFC=)(VDDV[F*/%&RDDX:-",%1CI*X?XR_M-_#
M;]G/^S?^%A?$+P/X#_MCS?L'_"1:[:Z7]N\K9YGE>>Z>9L\R/=MSMWKG&1GA
M_P#AYK^S;_T<'\#_ /PNM+_^/T=+= \SW"BO.?'W[8/PD^%'AOP[K7BCXI?#
MGPWH_C"V^VZ#?:KXDL[.VUN#;&_FVLDDBK/'MFB;=&6&)4.<,,\K_P /-?V;
M?^C@_@?_ .%UI?\ \?H ]PHKA_&_[3?PV^&?PVTCQEXD^(7@?P_X/\0>3_9>
MNZEKMK::;J7G1--#Y%Q(XCD\R)6D78QW(I89 )KA_P#AYK^S;_T<'\#_ /PN
MM+_^/T >X45P_C?]IOX;?#/X;:1XR\2?$+P/X?\ !_B#R?[+UW4M=M;33=2\
MZ)IH?(N)'$<GF1*TB[&.Y%+#(!-</_P\U_9M_P"C@_@?_P"%UI?_ ,?H ]PH
MKA_&_P"TW\-OAG\-M(\9>)/B%X'\/^#_ !!Y/]EZ[J6NVMIINI>=$TT/D7$C
MB.3S(E:1=C'<BEAD FN'_P"'FO[-O_1P?P/_ /"ZTO\ ^/T >X45YSJW[8/P
MDT'X3Z7X]OOBE\.;+P+K=RUEIWB*?Q)9QZ3?SJ908H;II!%)(##,"JL2##)Q
M\K8Y7_AYK^S;_P!'!_ __P +K2__ (_0![A17#_\--_#;_A3'_"R/^%A>!_^
M%=_]#1_;MK_8O^O^S_\ 'YO\G_7_ +K[_P#K/E^]Q7#_ /#S7]FW_HX/X'_^
M%UI?_P ?H ]PHKA_^&F_AM_PIC_A9'_"PO __"N_^AH_MVU_L7_7_9_^/S?Y
M/^O_ '7W_P#6?+][BN'_ .'FO[-O_1P?P/\ _"ZTO_X_0![A17G.D_M@_"37
MOA/JGCVQ^*7PYO? NB7*V6H^(H/$EG)I-A.QB BFNED,4<A,T("LP),T?'S+
MGE?^'FO[-O\ T<'\#_\ PNM+_P#C] 'J_C[Q_I?PR\,3:QK,T\%A#+# 6@M9
M;J1I)I4AC58XE:1F:21% 53][TKGM(_:0\(ZY<Z%#;WFIM-XCO+K3[.-]&O8
MW6YMXGFE@G#0@V\HCC=@D^QG"_*&KE_&7Q6^'_[3W[/.M:YX/^*7@"[\-^';
MZWO[[Q-9ZE;:KI&E/I\T%_(+F2*=$55C1&?=*A1) Q(&,^0^&OVKOV=[#4=#
MU34_VH?@3?:Y9^)9O$^ISV_BK3+:WOII-.FL!'%$;QS"BQO&1N>0GRCDDMD$
M-6^;Y>NEOU^Y=]*DO=36^OY.WXV1[M<?M=^ ;#0=>U*\U;4--M?#-];:;J/V
M_1;ZSD@N;@1M#$(Y85=V998V^16VJP)P.:?XB_:O\$^$[GQ-#J%QX@M9?"%@
MNJZJK>&M3)M[5I7B$RXMSYJ;HY.8]WRQLWW5+#Q:3X;_  Q_:*_9Y\1>)-#^
M.7A_4]-TO4-8U36O&.AZEIM[I5E/-&))6N68RQ1_9K(Q1@F16C@ZL%<YS]<_
M:E_9O\1>&/BA:W?[4'P3N-2^)-J^G_;Y/%^DYTVU%I]GAA""Y&]49II3RH9Y
MY,!00 XVNK]M?731?.[NULK:/<MK;I??RN]6O\-M.C?5'U!XP^)^C^!M0TFT
MU"2^:[UR1H[."ST^XO99=H!9BL*.4C4%<NX" LH)!(SS+?M8^!5TC6K\:GJ3
MVOA]XEOG31+Y]B2SO;I,@$),L!DBD!GC#1 1LQ<*":\O\2>./A5^TYX3UW6/
M 7QL^&U]8^$6CUGQ!K=MXA77/^$61$<K<PRQWRQ:9^ZBN<N5\MU5]ZNJNI\W
MT;X[_L\V?A+Q+H]Y^U9\";F#5-'BT#2VB\2Z9$=-LXYYYD$F;UO/E_?!2X\L
M$1@A02<J.^O];?K=?CY.'?DNM]/OOK^&OKIYKZH@_:+\'S^+=5T4ZM)!>:+;
MW5U=27%C<06:QVQC%RR7+QB"3RC*@<([%"<'!!Q1\$?M6^ _B-J&@VVCZQ=7
M3^)K:&ZTYVTN[AAF$L+W$<;2/$J1S-#&\GDR%9-HSMP1GP?X7_"SX=?M7_%;
MQAX@\%_';POXWLYIS/JT/A#5+?4+J 3S0RVT-VPN;BU\E?L3(J_98S(B%6+X
MDW\/\.?B#^S5X)\;>!=6O/VKO@WJP\$A9CCQK96DFK7*6\]M')<1Q7XLV5([
MAP/]%\WY(@92%(8IZQCS[Z7\GK>WX?CJ[Z7*UY\OG;S[7[=?\EL?>E%</\&O
MVF_AM^T9_:7_  KWXA>!_'G]C^5]O_X1W7;75/L/F[_+\WR'?R]_ER;=V-VQ
ML9P<</\ \/-?V;?^C@_@?_X76E__ !^@D]PHKSGX1?M@_"3]H'Q)/HO@+XI?
M#GQOK%K;->S6.@>)+/4KF*!61&E:.&1F$8:1%+$8!=1G)%<K_P /-?V;?^C@
M_@?_ .%UI?\ \?H ]PHKSGX1?M@_"3]H'Q)/HO@+XI?#GQOK%K;->S6.@>)+
M/4KF*!61&E:.&1F$8:1%+$8!=1G)%8?B?_@H?^S_ ."?$FH:+K7QR^#NDZQI
M-S)97UC>^,]-M[FRGC8I)%+&\P9)$92K*P!!!! (H ]BHKSGX1?M@_"3]H'Q
M)/HO@+XI?#GQOK%K;->S6.@>)+/4KF*!61&E:.&1F$8:1%+$8!=1G)%8?B?_
M (*'_L_^"?$FH:+K7QR^#NDZQI-S)97UC>^,]-M[FRGC8I)%+&\P9)$92K*P
M!!!! (H ]BKG=<^,/A'PQ;RS:EXI\.Z?%"9!(]SJ4,*QF.5(9,EF&-LLB(V>
MC.JGD@5S?PB_;!^$G[0/B2?1? 7Q2^'/C?6+6V:]FL= \26>I7,4"LB-*T<,
MC,(PTB*6(P"ZC.2*^1_B#\3/AG\-?$GQ-TF/]H3X Z?KWB+Q8-3O[?6/B!8V
M>H^'KFRU6*9;11(DOE@+%+OADB(BN#(V'\QPJO[UGM;\;K]&W\K=2E%67>Z7
MRUN_EI]Y]FS_ +1'P_MOM'F>.O!T?V.&.XN-VM6P\B*39Y;M\_RJ_FQ[2>#Y
MB8SN&9-9^/G@7P[X?TK5M0\:>$K'2]> .FWEQJ]O%;ZCG 'DR,X63.X?=)ZC
MUKY(\%?%+PW^T+\1=<\,^&?C]\'?$&K>-]4TG5+33]#\?Z7JFHF:P33Y+B6.
MVCL@TLPCL)W!!$6,%H5 8CT#XA_M.?L^_#[1],\$1_';X-Z+J/@[Q1#=:I::
MSXYT^&]BG@O3-=I,K2[EN#+YNY65<.2#MQ@79>[YM)^2;5W\OT\])EI%M;V;
M^?+=+YO3^M?H:7XJ>%X+6QG?Q)H*0ZFADLY&U"(+=J)$B+1G=AP))8TRN?FD
M0=6 -9?C9X,;P-_PE \7>&#X:\Q(O[6&J0?8=[,J*OG;MFYF95 SDE@.I%?%
MWA2X^'OQR\5>"_#7A?\ : ^#?Q,UJWAND3PM%XQTVX-R/[3LM1>*V2UA,[I]
MFLIPYD$A4 '!&YAVWQ#^-O@7X<^ I/AM\0/CY\)? ?B[0?$NFZA'I^H>/;)]
M2T+3X;BUNHH7DO$2664PJ61IH,E98P6?'FM-/WHIO1MV]%S)7^YW[:.[6ER6
MENNGXV?^5OFK)ZV^E;'X^^!=3\0:?I-MXT\)7&J:K;)>65G%J]N]Q>0.C2)+
M'&'W.C(CL&4$%48@X!K.@_:L^%UU:VT\?Q)\ R0WDWV>WD7Q!:,L\NQ9/+0^
M9AFV.K8'.U@>A%?+_P ,O%_PO\>>+3\,?AG\7O@3XFL/$'B6S\268L/'5OJ'
MB1C9PP2RPI:Q!S.Q^Q9:;S5*PRR90^7\[?"7B_X??LE^)].\(_$3X_?!NQ\0
M^&-3T;4;V#7?&-C8:K:I%HOV8VS6["+;&"T<L+%5+QSDMR TE1LU=Z?#^-K_
M /@.JVUM?9I"E=77D_O2=OOT]+VZ,^M7^/'@>/Q'8Z.WC+PHNKZH@DL[$ZO;
M_:;M3YF&CCW[G'[J7E0?]4_]TXT-#^)?ASQ/I$.H:;X@T34+"XL$U6*YMKZ*
M:&2S?)2Y5U8@PMM;$@.T[3@\5\-?#WXI?#?689_A_H?QV_9OU]O'GB72[]);
M;X@6L^JQ7,4MN([2TM4#?:'=K:$1GS$97N'(1B@$FM\.]7^&O[$^N^+/ /BW
MXY_ [PSY7@NPT2UT'4O%UK8W^B7KPRRW*O#,RLMK(\Z3Q$@-BX<; H3.=Y>S
ME)+5+1=W9NWWV5^N_5&O+&Z7I?R5TF_N;=NEM3ZUD_:3^'45MI<S>/O!2PZX
MYBTZ0ZY;!=0<,B%83OQ(=TL:X7/,B#JPSIZ3\7O">OZOJVGV/BCP[>W^@AVU
M.V@U*&2;3@C,K&9%8F/:RL#N P5([&OC6+XV_#?Q5GPGX7_:#_9_\?:QX^\*
M6?@1X]3\=Z=]LAG\R:./[+;VD9%WO^V,!#B)G:&)=Y+ED[70/%/@;]B']H";
M_A9WQL^&.AMJ]AJES::5XE\56>FWNGP76K27$4MO%*(VDCG 83/(S;9;55C+
M+NQK**YN6+T][7TO;[[+UOIMKGK[)2^U>.GDTK_=JOE?JD?1^N_&[P7X7T[[
M9J7B[POIUH(;:Y\^ZU6"&/RKAF6WDW,P&V5E8(W1RI"YP:M6/Q2\,ZGHRZC;
M>(M!N-/D%L5NHK^)X6%P5%OAPV/WI==G/S[AMSD5\<_##XJ? _PSXD\/VWP\
M^-/P \1>*6\;W%]IFB2?$2VE.H0W44UE:65NRF:2.2*.=$BACB=!AHU \S>#
MQY<^'?V9-1E\(>/_ (K? OP3<>+M1T_Q=>V^N>,XM+O-/$>J37C1VEM,BFXM
MC(@@29FB^Y(=F5V'.3]V\?+Y75WZV[KM;=E*/O6>VNOH[77KNEO9^3/KK1?C
MKX(\2>#K[Q%IWC+PKJ'A_2\"\U.VU:WEL[3*J_[R57*)\KHWS$<.IZ$4NC?'
M+P3XBU#3[/3_ !AX6OKK5HC<64-OJT$LEY&&=2\:JY+J&CD4E<@&-AU4X^*/
MAO\ '7X.>#?@+XH\'WO[4WP%U#4-:M-)CM-6;Q_I7GVK6UM;PR0[0!'Y<;0,
MT3>62WFD2+D%GU/B'9:%^S?XJU_PC\0_CM\*_ __  F7AF]L)FUGQE9:7JM_
M#<WVK21ZC):W%NI=BUV<^1-#'YL4H'R@(MU$HS<8ZKI]S_6W_!6J*:YHWEIM
M^:OYZ*[\_+9_6Q_:4^'*^%Y-<_X3[P3_ &+#.MJ^H?VY:_94F8%EC,N_:'(!
M(7.2 :FU+]H7P#H]Y]GO/''@^UN/L7]I>5-K-M&_V7RS+]HP7SY7EJS[_N[5
M)S@$U\NWO[?WPQOY_"&M-\9/V4HM8\(^?;IIB?%BT^P7$4UN(S*DWD;H9$90
M%7RG&R21=PS7+_M'_!BQ_9]\,V,?C3XP?"GP9-KEM<)I^D^*?$D.AZ9=3?V?
M<V\TMNTD?G$V\E[%&H!=!"_S(KE")TO;I??Y=O7[MGW,US-*ZULW;S[7_#SW
M5]G]G67Q[\"ZG9Z?<6WC3PG<6^K7;6%C+'J]NZ7MRI"M#$0^'D!(!1<L"<8K
MK*^#+[]KCX5W_P 0)/&%O\>/V8]$\4:CJ\<\MQ9?%BT9--LT%K#)&5,06^-Q
M# 3(LBPA#' J,6C$P^\Z?2_]=/Z_X:[KK_7=_P!?B%%%%( HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R?'7
MC[0OA=X2OO$'B;6M)\.Z#ID?FWFI:G>1V=I:)D#=)+(0B#) RQ R17(?#+]L
M#X2_&O4H[/P;\4?AUXMO)A*T<&B^)+._D<1*K2D+%(Q.Q70M_=#J3C(KT*X4
MR6\BKU92!7YT_!/_ ()[?%[3O#W[,-C<7?B+X<W7P[\*>*M/\0:EHEUHUU=6
M$]Y<0/;6^VZCNH9%E5&RT<;;=O+H3SFY-<VG33UY9/\ -)=]>]D](Q4MW;^E
M_7]7/M6[_:^^$MAX8NM<G^*'P[AT6QM+>_N;^3Q)9K:V]O<.Z6\SR&3:L<KQ
MR*CDX<HP!)!JYXU_:<^&WPV^'>E>,/$7Q"\#Z!X3UWRO[-UO4M=M;73M0\Q#
M)'Y-Q(XCDWH"R[6.Y02,CFOS3^#/_!,[XI>"/A?&OB;P)X[CU[1?"/@^+0;O
MPEKFA?VKI>N:;/JTCS*+NZ2UD2(740=9#M=9SLW,IV_2_P"T/^SQ\=?C]\ ?
MV:X;P>&[7XF>&/$]EJWB^_%K%=Z=I6-,O8)Y_LWVB#SP'F1?+BD^\^0"@(K>
MK'EYE#6TTEYQ;M?Y:M]$K.[N[2E'FUVY7+YJ-^7YO1;MNZLK+F^C]"_:K^%_
MBCXD1^#=,^)'@'4?%\T"W,>AVOB"TFU*2)HA,L@MUD,A4QLKA@N"K!NAS45I
M^UU\)[]_$BP?$_X>3-X-4MX@$?B.S8Z$ VTFZQ)^X&[Y?WFWGCK7Y[?"S_@D
M3\1_@#\?[>WT-M:UCX<Z-XEL(;'[5?:?&WEKX6;3AKPVE9Q+;W3,AMR^UD?*
MPL55ZZCP[^R5\6M.^&7POT;_ (4C;+=_!+X=ZQX3O(9]9TO[#\0;B\M8K1(8
M2DY=;-W1KJ5KI8'! "H[G-3*W*Y0ULM%M?W7+KM9I1:Z\VFJE%5RKGC%O1VN
M^VMGU]7Y6UT:D_OB;X]>!K?Q9'H,GC3PG'KDUU%8IIS:O;B[>XEA:>*$1;]Y
MD>%6D5<99%+ $ FK=G\6_"FH^$-2\06_B;P]/H.CR7$-_J4>HPM9V+V[,DZR
MRAMB-$RLKAB"A4@X(-? 7PY_X)M_$CX:_P#!-GXM?!V^T=O$7C[1[E?$7@CQ
MG::I%!=^(=62WBELYO,DG,MO/:31+;!I2J&&./!(+@>Y?M$_L7:I-^P#X)^'
M?@/1+.YE\$:CH&K3>'KJ\6./Q!'8W<-U=6DLS$HTDY20EY#M>0Y9@"6JYQBG
M9/K#6W25KNV_N:W6[5MGH8TVVE=?S?\ DNV^W/=6;V]Z^Q[AX2_:F^&/CZPT
M&ZT'XC> ]:M?%-W+I^BS6&OVES'J]S$I:6"W9)")I$4$LB990,D"GS_M/_#6
MU^*5UX&D^(?@:/QM8Q&>X\/MKUJ-4MXQ&)2[VWF>:JB,A\E<;3GIS7P%^VI^
MS9^TC^V1^TKI_P 3_#_PAM/#&G_"C04?P=H_BKQ;866L3ZX;R"[>\@_L]KVV
M(V6D5L8YY[<.DK NH)QK?$+]A?XP>+OVVO$?Q(;PU?7?A76O%MIJ2>'I-2TQ
M(X<^%&L/[3#AQ+YEM=,T+1-*4='+K&V%>L9-JGSVUM+3T:4?F]9;:*R;6K6T
M8Q<K-Z6W\[7?W:+NW=I.R3^[/@]^TC\._P!H:VO)O 'C[P7XYAT]@ET_A_6[
M;4UMF/(#F%V"D]@<53O?VLOA7IE_HMK<?$SX?V]UXDOI=,TB&3Q%:))JMW%-
MY$MO;J9,RRI-^[9$RRO\I /%?*'_  3D_99^)?A'Q_\ !_6O%W@&Z^&\?PJ^
M% \!ZH;W4M/NKKQ/>,]HP9!97$Z_98/LTA1IF60M.<1J,D\)\+_V+?C1\$O$
M7@OQ!X1\(^*-%^(D/BC68=5U ZIHUQX9N_#MYXFN;YH+^)[@W(D^SR>="]I&
MSJ\@5]N"%ZITH*M&"E=-M-^DG%/R324G_*G]IJSYU)^RE.VJM9>L>9^MG[JM
MHW:_+>Z_0;6?C'X1\.3^((M0\5>&["7PG9)J.N)<:G#$VC6KAV2>Y#,/)B81
MR$.^%(1L'@X;'\:_!LNK:OIZ^+O#+7WA^PCU75+8:I 9M-LY%+)<SKNS'"RJ
MS"1P%(4D' KY,_X*(_L5_$'XV?M,^$=1\#:;9W/@_P"(-A;^$OBA+)=10O;Z
M3:ZC!?Q2*CL#*707EL50,0+K)&!QX+#^PQ^TM#^T-XR^*;_#WPW'-\6+?Q5H
M&OV=MXMADU2/3+JT6'1TF@:-+5%MC96X_=7<Y/VMSL3Y\<;D_9N:6MIZ><?A
M7I.ZL^FM]CJ4(\ZC?2\=?)_$_6-I*V[O![,_1WQ-^TK\.?!6CV^H:SX_\$Z3
MI]YI9URWN;W7+6WAGT\-&IO%=W :W#30CS0=F94&?F&=3X8?%[PG\;O"L>N^
M"_%'AWQ=H<KM&FHZ+J4.H6KLO#*)8F9"1W&>*_,WXY?L=_'+XZ_"'P;IUI\&
M_$^BW_@GX//X)F@U/6]!W:CJ*WNB2@6YAU"5?+=+.X(:4Q_ZO#!2RY^L/V:?
M@-XTU7XC_'KQMK'AVZ^%\/Q7@L;/2]%GN[2XOK66VLY()-1N#9RRVZS2M(@P
MDLAV6Z%CDX'1B(J$9.G[UE)I=[3:C_X%%)]U>^VW-1DY*//[M^6_E>,6_P#P
M%MJ^SM;<]BLOVM_A3J3>)EM_B=\/;@^"8VE\1"/Q'9M_8**2&:[Q)_HZ@@@F
M3: 0:TG_ &A_A_'JMK8MXY\'K?7HLC;VYUFV\V<7N_['L7?EOM'ER>5@?O-C
M;=V#7YN_%S_@GS\9?BQ^R7X2^']A\+AX9UCX4_"_6O!\MZ-9TPP>-[NZM8;>
M..T*3EUMWDB-R[7BVY#[!M)RPS-!_P""</QS^!OQKU"ZL_!-]XS\&^"_$O@F
M;PH+#6--2_O-%TR;4;B6VQ=742B2U%XL"^:R!UC0@M\QJO9P511<M+Q5_+G<
M7*VZTM))ZVO?9-N?,J4IQ6J4FEYI1:5]GJVKK?2W6WZ=Z?\ '7P1JWV'[+XR
M\*W7]J:I-HEEY6K6[_:[^'?YUI'A_GGC\N3=$N77RVR!M.(;C]H;P!9WMK:S
M>./!\5Q?:R_ARVB?6;97N-409>P12^6N5'6$9<=UKYW^ G[(=Y9_\%&O%?Q>
MOO!>K^&?#NM^&+/4--L=1U*UF&F^(+HO#JC_ &>WGFC2Y:VMK%'E0LC9?:[%
MGKY[_;/_ .";WQB\;?M;>/\ Q/X)\.6NH^&M%:+XE^"2VJ6UO]J\8!M+C>VV
MO(K1AH=.E)D<+'_I;?-G-8WY7'G[-NVMG%ZI=[Q4G'NW!=33E4G)1=M5:_7F
M6GW-Q4NR4WT/T(M/VD_AU?QZR]OX^\%S+X=M)K_5FCURV8:9;PRRPRS3X?\
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M^"5GX$U:S\(Z3\/?^$<U>PDU#PXVC:WJT-Y8F.\T^=7&HC[1&EW+*+LQC<5
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MBLK/DY>NFO9[_FWH]TH[6:'*SDG'I>_GHDO39/R;EO>Z\6^+7[9WB3PW\/\
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MWV?W.]_1K?0^<_\ A\3^U5_TC[^(7_A7?_>ZC_A\3^U5_P!(^_B%_P"%=_\
M>ZOK;P;^T3JVG?L9>!?&VI+I.I^)->T6PN9+>XO'@6_N98%ED2$VUM,TCX#L
MJQPD,%)^502.-U?]OG5_$G@KPO>^%O"^F+?^)KF(I'JFJ-&L,'V[2;=\[(6.
MYEU+KT0IGY\XJ_9OVDJ2WB[/\@>CBFOBV^5_\F?/?_#XG]JK_I'W\0O_  KO
M_O=1_P /B?VJO^D??Q"_\*[_ .]U?07PV_;2\93P6.@:IX5T:_\ %%Y;2ZC:
M7$FO_9K6ZLUDU##RLMI^ZFVV7$2HXQ)DN-K$4_$'[>'C374TJZ\+^$?#L.GZ
MQ>)#9'5-5F$]S$;W2("T@2 B!L:C(NT>;RBMGC8T0]Z7+'??Y/3\_P!>S#JH
MO=Z?.W-^6OW=T>$_\/B?VJO^D??Q"_\ "N_^]U'_  ^)_:J_Z1]_$+_PKO\
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MH>,OB)XF^'/PI\0:M9W45[IO_"4:%:W%G<:W-Y5G:W%PSKG(Q"KR[@XBBQN
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M'OK/4;.T\80S7EC);W:_V5Y\4HB@@*V.^ _9Y[@,V&8ITK.?_@G+\6M-^/\
M?ZE\0/@Z/C;X7TO5KJSTXG4M'>75+1-"M[#3[^47EU$8YE:)?,<?O5=&D13E
M<_=UO_P4F^#^H>&+?5;+7O$&I)>7PT^TLK#PCK%WJ5_(8/M*O!91VK7,T#0#
MS5GCC:%D^8.1S6/\*O\ @JI\'_BCX,\&ZPVH^)/#Q\<(DMC:ZMX<OX9+5)+G
M[+"]TZQ-#;1RSXCCEED6.5SM1W((K#V:Y52[)1\^\?.Z5[=D_1JN9\[KONWY
M:Z->2NE==XKS3X7XQ?LD^/O&W["?PL^'.IZ>_B[XE>&[#3)G\1S36EQ8:?J5
MFULY:XDN)$NBDA1E,UJOGE4;YEWX;ZP\$:]J/B/1'N-4T.]\/W4=S/ +:ZF@
MF>2..5D2<&&1U"2JHD4%MX5P'56!4>3? ?\ X*/?![]IOQQ:^'/ OB75/$&K
MW=N]X(XO#6J11P0*.)9I9+98X8WP0C2LHD965"S @>XUT5*DI-S:^)N7S>CM
MY:6_X)FH\MJ?6*2_X=?._P"6@4445D4%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445\PZ)=>//VG/VE/C!I%G\6/&WPWT7X:ZM8:'8V7AO3]#
MF6\\W3;:]DN)WU#3[J0N6N=@",B!8U^4DDE7ULNU_DFE^;148W5SZ>HKQ_\
M8-^,6M?'?]ECPWXB\131W6MO+?:?=W*1+%]L>TO9[7SBB@*K2"$.54!06(
MP*]@JY1L[&<975PHHKY,\'W7Q&_:7N_B]X@M?C)XZ\ VO@OQ5J?AW2]'T#3-
M!FLA%911[996O=.N)WDD=F9L2JH! 4+C)QE44;WZ1<GZ)Q3_ !DC2,;V_O24
M5ZM-K\(L^LZ*\R_8N^,FI?M#_LC?#/QWK$-O;ZMXN\,V&K7L=N"(EFF@1WV
M\A=Q.!V%>FUT5J4J525*6\6T_EH9TYJ<5-==0HI&.U2?05\&7WQ<^*VI?\$]
M_$W[2$/Q@\966J:7IVJ^([;PC%I6@MX?"6EQ.([-B^G&],31PJK.+H2$LQ5E
MX SCK*WX]OU-(Q<FHQW>R_K0^]**JZ'J)U?1+.[9?+:Z@28J#G;N4''ZU:JI
M1:=F9PDI14ELPKE_$/P0\%^+M,>QU;PAX7U2SD+%[>[TJ":)BTC2ME64@YD=
MG/JS%NI)KJ**FR>Y1S=O\'?"-IIL=G%X5\-QV<4+VZ0)ID*QI$QC+(%VX"L8
M821T/E)_=&,W2OV:OASH6FV5G8_#_P $V=GIMP+RT@@T.UCCM9P%42QJ$ 5]
MJ(-PP<(HSP*[:B@.ECD=9_9_\">(A:"_\&>%;P:?##;6HFTJ!_LL<)8PK'E?
MD$9=BNW&W<<8S6AJ_P +/#'B :1_:'AS0;[_ (1\JVE_:+"*7^S2NW:8=RGR
MR-B8VXQL7T%;U%'_  _S!ZZLY_Q!\)_"WBWPO%H>J^&?#^IZ+!)YL=A=Z=#-
M:QO\WS"-E*@_,W(&?F/J:;=_"#PE?^)+?69_"_AV;6+6;[1!?2:;"US#+B-=
MZR%=RMB*(9!SB-/[HQT5%"T=U_7]60/71G/ZW\)_"OB:&:/4O#/A_4([@R&5
M;G3H95E\QHWDW!E.=[11,V>IC0G)489!\'O"-KIGV&/PMX<CLRAC-NNFPB+:
M8!;%=NW&# !%C_GF GW1BNCHHV5D%W>YS<WP;\(7%C-:R>%?#<EM<R/--$VF
M0F.5W61'9EVX+,LTRDGDB5P>&.:-K^SG\/K$-Y'@7P?;[K22P)BT:W0_9Y/,
M\R'(3_5MYLN5Z'S'R/F.>RHH#MY;'.^!_A!X3^&,MP_AOPSH/A]KQ52<Z=81
M6OG!<[0VQ1G&3UJOI7P,\$Z#9W%O8^#O"MG;W231SQ0:3!&DRS!!*K!4 8.(
MH@P/WA&F<[1CJJ*+L#"U7X7^&==\4+KE]X=T*\UI;<VBZA/81272PD2*8A*5
M+;,2RC;G&)'X^8Y@TSX->#]%.K?8_"GANT_MZ'[/J?DZ9#'_ &C'@KLFPO[Q
M=I(PV1@D5TE%&VP7_K^O1'-S?!OPA<6,UK)X5\-R6US(\TT3:9"8Y7=9$=F7
M;@LRS3*2>2)7!X8YK:K\ O FN^%+'0;[P5X2O-#TN=KJRTZ?1[>2TLY6#AI(
MXBA1'(DD!90"?,;U.>MHH#R.2N?@'X%O;N^N)O!7A*:XU1B][(^CV[/>,4>,
MF0E,N2DDBY;/RR,.A(+_ /A1/@?[%;VO_"&^%?L]JD<<$7]DV^R%8YQ<QJJ[
M,*$G595 Z2*'&&&:ZJBA:6MT K:1HUGX?L1:V%I;6-LKO((K>)8XPSL7=MJ@
M#+,S,3W+$GDU9HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M\L?^#13_ )1N>-O^RE7_ /Z:]*K]3J_+'_@T4_Y1N>-O^RE7_P#Z:]*K]3J"
MI;GP7_P<3_\ )D/A+_LI7AW_ -*'K[TKX+_X.)_^3(?"7_92O#O_ *4/7WI0
M+H%%%% @KE_C?_R1;Q?_ -@2]_\ 1#UU%<O\;_\ DBWB_P#[ E[_ .B'H ^-
M?^#:;_E#O\-?^OS6?_3I=5]Y5\&_\&TW_*'?X:_]?FL_^G2ZK[RH'+<\T_:Y
M_97\._MG? G5/A_XGO-<TS3=4E@N%OM&NEM=0L989DECD@E97".&0#.T\$CO
M7F&M?\$H/ACKGB/49I+KQ1#X?U""<?\ "-07-O'I5M=S:3_8[WT>(?/6?[#^
MZ \XQ#[XCW_-7KG[2GPS_P"%K?#%=-CTFSU>ZMM6TS4;:*X2-O)>WOH)O.4R
M<*Z*C,""&R..<5VNGW\M[+=+)975FMO,8HVE:,BY7:I\Q-C,0N25PX5LJ?EQ
M@DC\,HK[5[^:LEKW].EDUJM'SM.,ENMO+KI]WXM==?GKX._\$P_ /P:_:!TW
MXF6]]JFM^++#3H;"2]U72=%EN;MXK0627!N8[!+J)_LZJA2WFBA;&3$6+$Y6
MH?\ !)/X<ZIXN_M2?6_&TD5GK UG1M/^U6@M?#TC:Q!K-S%;?Z-YGEW%Y;QM
M()GE8*"L;1#BOJ.OEWQ1\'/%UC\6?'FL6O@./44U#Q?HVM65]:6^GQ7M_:V[
M:694^TR7JN0OV>8B*2*,?N\AR2H;2G4DZ\&W:VJ?:\E_\DWZ)K8SE&U)Q6VB
MMWLFE^5OGW.@UO\ X)V>';GX0^!_"6C^,O'GA=OA[XCNO%&CZQILFGR:A%=W
M!O/,#_:;2:!H\7TP ,.0 G.02>?^'_\ P2.^%OPV\<:/KVG7?BUI](NXK\P7
M%]#+#?SK9ZC:R23DP[W:8:I=22$.,R%2-J@J:6H_ OQ1K.H>,[B]^&]O>:=J
MWB>'6KO3VM].CN_$FGY0O92W'VUEF(.&$,R11'R2AD*MDZ/QQ_90M?B*D.I>
M'_ACH^CW2>"==TNW@DM=.AN+.\FFLS;(&C=D4L(YV#(Y50QR5+8,4US12EIS
M:M=O<O\ G[O35?(J4O?:7V4TGY<TE^-V^MN;3J4?@_\ \$AOAY^S_IVAKX)U
MWQ)X6U3PWJ;7^GZMI>F:#:7B0M;FV>SE,>G+'=1/$2&DN4EN2?F\_< 0_1_^
M"1O@#1K#0;%?%'CZ;2=%BMK*:PDN;#R=7L;34&U"RLKDK:"1H;:X9F1D=)65
MBLLDH)%<UXP_8\UOQUX1NM!_X5^VF:E>VFH6?BCQ#'?6<3^,H[BX7 $D<WGL
M6_UP,ZQF'R]B9S79:#\#?B%+\#OB=HOB+34UK4M1\46<T2?;("?%^DVL&FQ2
M;\E4CDNX+6:-XY=B[W8$B,ABHOG?-+>R=WWNH^NB=]KM<S2=VPCHW!:)NSM_
MX$GVWOK>R:CK?EMJ?#7_ ()I>"?A=XX^%.N66M>*KJ3X.Z7/I>A07 L!YBS+
M,LCSSQVJ7,F5F8>4)E@)2-C$74-7T17RU\*/V7-6M_VE;?Q1'X'\/^#_  ;9
MR7\^GZ1J%C:7DFF.YTO+VZ6]P8K26:2VN9=T7F*/O,%DD91E?'3]F;Q'XX\5
M_$5M%^'_ )&N:U?7UY:>*_M%A#]LLWT.*T^P[A-]H;S9QMV2HL0\OS"P*1[M
M%[RC=[IOT?-;\;N7>RT3T1:7/4?,^RO\OTV[7>^[/KJBOAN#]CKQYX;O]0G?
MP/X=UB+5-7CU$Q0Z?8R(R)K&H3L+V*6[B%Y(8;F&1'\Q H#KM5AB3VGX:_!&
MW'COQ&OBSX6V>J7FM7#S0>([BWTVXACLF@ BL65IFGB$(#0^5&CQ<[@[;W(Q
MN^64NJOIWM;\[NWII<RYG=*V]OE>]_NLK^JO;4][HKXQLOV.=5\+_#+2]'A^
M&.GWFM-X)TC2M%U*V?3XU\%ZM%N^T7!+2*T;"5H)S+:B1Y/LV#DI'NHZ9^Q]
MXN\)Z%KWVWP+;ZY?7GV34=+BTJTTL6+W<,FIMLU.VNKI4NB1<)OF5@Q$L6P1
M/#O&M2*C*U[J[5_1K7[KOY:7N4MVOZ_R^Z[[I'VY15?2?._LJU^T10P7'E+Y
ML<3;HXWP,JIP,@'@''2K%3)6=B8RNDPHHHI%!1110 4444 %%%% !1110 44
M44 %>"ZO^S'\1/!7QH\;^*_AEX^\$^';;XA7-KJ.KV/B3P9=:ZRWD%K':"2"
M6#4[/8C0PQ91D<[E8AL-M'O5%*VM_E\NWX+[D4I-*QP/[,7P(M_V:?@=H?@V
MWOY-5.EB:6XO7B\G[7<3S27$\@CRVQ6EE<A-S;00,G&3WU%%5*3;NR(Q25D%
M?.DO[)OQ-\!ZWX\A^'7Q(\"Z#X:\>ZO=:[<V>O\ @:ZUF]L[JZC1)_*N(M5M
M4\LLF]5:%BI8@LPP!]%T5#@G=OJFGZ-IM?>E]Q:DU:W1IKU2:3^YO[SD?@%\
M&]-_9X^!_A'P'H\MQ<:7X.TBUT>UEN"#++'!$L:LY'&X[<G'&377445K4J2G
M-SGJV[OU9G&*C%1CL@(W"ODS4/\ @GQ\0'^ &L?!FS^)W@VW^$>LI>:>]G+X
M&N9?$$6G7<TDDL"WXU58/-"RNBRFS( VDHQ!S]9T5"TES?U]VS+4FMO^#]Y#
M864>F6,-O""L5O&L: G.%48'\JFHHH;;=V3&*BK+8*\/_P"'@W@/_H _'#_P
MS'C'_P"5E>X44#/#_P#AX-X#_P"@#\</_#,>,?\ Y64?\/!O ?\ T ?CA_X9
MCQC_ /*RO<** /#_ /AX-X#_ .@#\</_  S'C'_Y64?\/!O ?_0!^.'_ (9C
MQC_\K*]PHH \/_X>#> _^@#\</\ PS'C'_Y64?\ #P;P'_T ?CA_X9CQC_\
M*RO<** /#_\ AX-X#_Z /QP_\,QXQ_\ E91_P\&\!_\ 0!^.'_AF/&/_ ,K*
M]PHH \/_ .'@W@/_ * /QP_\,QXQ_P#E91_P\&\!_P#0!^.'_AF/&/\ \K*]
MPHH \/\ ^'@W@/\ Z /QP_\ #,>,?_E91_P\&\!_] 'XX?\ AF/&/_RLKW"B
M@#P__AX-X#_Z /QP_P##,>,?_E91_P /!O ?_0!^.'_AF/&/_P K*]PHH \/
M_P"'@W@/_H _'#_PS'C'_P"5E'_#P;P'_P! 'XX?^&8\8_\ RLKW"B@#P_\
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M9I)&P!EG8LQY)))-7JJ=N9\NW]>I,;\JYM_Z] HHHJ2@HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'P7_P<3_\ )D/A+_LI7AW_ -*'K[TKX+_X
M.)_^3(?"7_92O#O_ *4/7WI0/H%%%% @KE_C?_R1;Q?_ -@2]_\ 1#UU%<O\
M;_\ DBWB_P#[ E[_ .B'H ^-?^#:;_E#O\-?^OS6?_3I=5]Y5\&_\&TW_*'?
MX:_]?FL_^G2ZK[RH'+<****!!7S=\3/$'A7Q1\4O$EOJWPJ^&NK6\TTND2:W
MX@GAC-_-:6]K?,EUNLY=ENB#<KEGP]JGR*"K+](UPNL_LW>$M<\8W^OR6NKV
M^K:E\TT]GKE_9X?$*F1%AF58Y&2WB1G0*S(I4DJS S9WOY/[]+/[K_>.^WJO
MNZKUV_K5<3^R=\3['QGJ++IOA?PYX=TW5M#MM4L?[(4;'C6XN;=EW!$WPYC6
M6%]D>Y+@Y16#9[;]IGQY_P *Q^ _B;Q OAN/QA)I5KY\6BR2I$-2D#KLBWNK
M*I+%<$J0#CZUH?#7X*^&_A'YQT&QDM7G@CMI))KJ6YE>.-Y9 &DE9G8F2>:1
MF8EG>5V8DG-;7BKPK8>-M!GTO5+?[58W.WS(][)NVL&'*D'AE!X/:JJ:WY?/
M\W;\+==28Z/7;3\E?[W=_,^:V_:C^'4?QGT;P[H?POM]>MM6L8M7M]2TRSL5
MD2^U&X@EDB*2F,+(4N(KJ>0R!CO0[78\>M>/_$2>!_'WA+P[X5\(^']2\17F
MF7@LS=W TVWTW3+<VRS(LL<$S@&22T40J@5MN21L&7:#^R/\//"^IPWFG>'5
ML[J"_N]3CDBO;A66XNI4FFD_UG=XX\#H@154*H K=\6_!7P_XXL]'BU"/53-
MH *V-Y;:Q>6M]""@1@;J*59W#@+O#.0Y52V2 0XVY$NMW?T=[+Y7MMJNS=P_
MY>N3U5OG?O\ /23U=G?=6/GK1_BOX!^'7Q"U./4/@C8P^(K'6$T+1KS0]#TQ
M3J,<5UIEO&D,LDT;@02W%H29!$H%N"@)C KL/@KJOPQ^.'Q!DV_"O0=.\1:9
M8BY:^N=+T\LL;-L B<D7#J>09%C\K<KIO+*17I-S^SEX-O=5LKZ;29)KS3[M
MK^"5[VX9EG::WG9SF3YB9;2W;YLC]WCHS GA_P#9V\)^%];_ +0LK+4([I;&
M?38B^K7DL=K;SM&TRPHTI2$NT49+1A6)4'.:2;5.*>Z3OVORI?C*]_*V^P[7
ME)OJ_P#VZZ^Z-K>=^ECE?V=/C+H/QSUOQ%91>%;#16\+ZL^I:2W[N7^TK:X:
MXC35H\(OEFXD2]&068C<Q8^817G-[\2OA[!^TSXGT63X3_#[4-3\*+<R27]I
M)8?VS&BPV,KS2I<10QP1/]M*[WNLL8S@'<=OM/@O]E_P#\-=7L;[PWX;L_#M
MUI]JEDC:4\EDL\*$%$G6)E6?!'!E#D9;^\<U_B#^R;X!^*.H?;-:T6>:\_M'
M^U?M%OJ=W:3"XVVZ[@\,J,!_HEL=@.W= C8W#-/3F\K-?/1)_==M;7=MM4;M
MW[I_+=K[]NO5Z[_)OPV^-/@_P3\6_$7CBR\)V_B32_&5PI(.D6:ZDD933BJH
MMI&(II VNWZLV)'F78OFL,LWVK\)/&]A\1_AOI&M:79MI^FWT :UMS+;2^5&
M"54!K>22+&!P$<X'!P00..TS]BKX;Z/IUO;6VAWT8M6#Q3?VW?FY1Q]DQ)YQ
MF\S?FRM3O+;LQ9SEF+=UX!^'^D_#'PTFDZ+;S6]BDTUR1+<RW,LDLTKS2R/)
M*S.[-([L2S$Y:KYER6ZZ?<EM]]QU-6I+>VOF^_W)+_AC:HHHK,04444 >1_&
M?XG?#_0/C9X8\-ZC8:+?_$;7+2;^QC+-:VMY:0D,A=9Y665%9F*!;<22G+,L
M;!7*]5^SWKFB^(O@EX9NO#VF?V+H_P!@CAMM.XSIXC_=M <$@F-E9"02"5SD
MT>/?@'X8^(WB>WUS4;&1M9LXXD@NH[F5%4PR^? SQ!O*F,4W[Q/-1PC$D8R<
M['P[\!Z?\+_ VE^'M+68:?I%NMM"9I#)*X4<L[GEG8Y9F/)))HIZ0L][_*UW
M;\];]=4]6@EK.ZVLO6]E>_Z6Z;GE?[0WC?P7IO[0WP]\/^,_ OA_7+74['4;
M^W\1ZG;P3CP]-:M;2HN)(R4$K#<)%==LD$0P2RE<_P#9#_:0T/\ :8N[B2W^
M&MUX7O+&"]NFN9HK5H8X;G4KN'86!6837)LOM$J>5M!*AI'89/I?Q<_9[\'?
M'BPDM?%NBQZS;S6C6#QR3RQJT+30SE?D9?\ EI;PMGK\F,X+ R^&_@9X8\':
MEJ%YI5C<:?<ZI<I=W;V]_<1^>ZW,]R,XDQM,MQ,2@^5@^T@J HJG90Y9;Z^F
MK?X\K2Z:K6]VQU)/['E^"?Z^NE[=CPGQ/\>O /PK_:'D\,?\*W\&O<>$V.GZ
M<^F&W;6X!+;02IY5J8$6&"6>_6W#_:%4RSC( 9RKK?\ :+\ _!$ZK#X)^#LV
MD^(;&)Y;NRL[#2=)=6-TEK.FX3KYS+Y%N7,/F*%-MN8;DQ[-XW_9F\$_$6_N
M+K5]&:XNKF^.I/-'?7$$GV@VJVF\-'(I7$*1X P \:2 "15<9VH?L?> -6M(
MX+K3=6N(85G"+)X@U%MLDQ<RW S/_P ?#>8_^D?ZW#8#@  3&ZW[:^;_ ,K[
M]]]-4W4LU[OE]R7Y]NVJ[6\<O_C)X!UNZOM-M?A)X?M]4UW6[9-86^TS3F@U
M1#KALG<Y=)+B8.ID\S8\4<CKND)Z[GPV_:"^$/C_ .(;:79?#RWL_$<T]MX?
M.[3-+F:;Y2Y@6>WFD22.WBMXY'"N0BB( %AM7T#Q%^Q9\-_%UJMOJFBW^H6L
M9F9+>XUR_D@C::<7$KK&9]JN\HW%P Q!*YVDBKG@;]D?X?\ PZ\4Z7KFF:+<
MG6-&DNI;*]O-5O+Z:!KF*&&;#3RN2#';PH <A%3"[06S5*RTEM=[=M++R5KI
M[[Z&=2[6F_\ 5WYN]NVQYSX-_;2TGP[J_B[1+/PCI%OH_@=[PSPZ'K5HLMD(
MM1EM=US%<"V@MC,4DF1?.=G"2<9 W4]6_P""F7A:[7PM<:+I^L3PZM?K!?6\
MUHAO%26*]^QQ1HLW%Q=2VR&$-E6C<[MA(QZ9XQ_8Y^'?CN_L[O4-%ODO+&>[
MN8+BRUJ^L9HY+J9IYFWP3(Q)D=V7)^3>X3:&(//>#OV"/ FARZ\=2TNRU*/5
M-4L]0LUA6>U;3ELM/6PLP)/.:226*$.1,6#;WWJ%95(FEM^\Z6^>NOX.ZTW6
MK[Z5+<TO9[/FM?IIIZZ[N]]=%I<LZA^W!X9T/6((-3T?Q-I=C=W5Q:6^IW$-
MO]CG-O<K:7#968NJQW+QQ$NB[C(K)O3+CU+P1XI3QQX,TG6H[2]L(]7LX;U+
M:\14N+<2('"2*I8!QG! ) (/)K@]>_8T^&_BG3-:L=3\/2:A9^((I(;R"XU.
M[EBVR3I<2^4K2D0&2:-)9&BV&1U#,6/->GHBQ(JJH55& !V%4K<NN_\ 7W]-
M=/0B5^;3;^K?K?<6BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?!?_!Q/_P F0^$O^RE>'?\ TH>OO2O@
MO_@XG_Y,A\)?]E*\._\ I0]?>E ^@4444""N7^-__)%O%_\ V!+W_P!$/745
MR_QO_P"2+>+_ /L"7O\ Z(>@#XU_X-IO^4._PU_Z_-9_].EU7WE7P;_P;3?\
MH=_AK_U^:S_Z=+JOO*@<MSAOC%^T!HOP-USP;::Y!J*V_C76#HEM?11H;6QN
M/L\TZ?:&9P45Q R*55LNR @9S7BL/_!8/X+R_#&[\2_;/%FZUT:;6QIJ>';N
M:XGC2U^V"!)8T:U-RUKMN!!Y_F+"XD=40,R^L?M<_LK^'?VSO@3JGP_\3WFN
M:9INJ2P7"WVC72VNH6,L,R2QR02LKA'#(!G:>"1WKS#6O^"4'PQUSQ'J,TEU
MXHA\/ZA!./\ A&H+FWCTJVNYM)_L=[Z/$/GK/]A_= ><8A]\1[_FJ=7"=]]>
M6WIU^=_PONVM(\G/!O;[7W]/5>>EF]=$^Z^$W[='PZ^,7BG0= TW4-9M?$'B
M#3HM1@L=0T&_L_+\RW%R+>266%84N1 ?-^SEQ+Y?[S84(8XOBG_@IK\$_!EW
MKD.H>+KU9/#]T+*<0^'=3N!=S&]2P*69CMV%Z4NY(X'^R^;Y<CA7VFLOX._\
M$P_ /P:_:!TWXF6]]JFM^++#3H;"2]U72=%EN;MXK0627!N8[!+J)_LZJA2W
MFBA;&3$6+$Y6H?\ !)/X<ZIXN_M2?6_&TD5GK UG1M/^U6@M?#TC:Q!K-S%;
M?Z-YGEW%Y;QM()GE8*"L;1#BNA^S=6/2.M_+72W?3^D]#"-U2U^*T?2]O>_'
M;]=SH?C#_P %)/ OPN^#O@GQQIFF>*O'6B^/KRXL]+31+6"WN%-O:W5U<--'
M?S6OE>5'9SAD<B0,FW9NXK(\/?\ !8+]GSQ/H3:A9^--2DAB+><%\+ZL[VZH
MK--*X6V.(80I\V<9BBX+NH92=N?_ ()L_#75O /P[\,:Q;WWB+0_AKXDO/%.
MGV>K):WD-[=7/VPLMS&T&QXT:]D9 H1E:.([B5.[%\;_ /!*_P !>,M#O+*/
M7O&VB-J.I:]>W5SIUS:)-/:ZTZMJ.G'?;.JVLFQ -JB9 BE90<DY:<S[=/+;
M?R>M]+JU];J)HE%\MW_B_P#)M5YZ1LKV=^EKFY%_P4]^!\NM>(K#_A,KA9_"
M[74=X[Z#J203R6LT4$\5K*;<1WDJ2SP)Y=LTKDS1X!WKG3\*_P#!0?X3^.-7
MAT_1]>UC5-0DTR[U>:TMO#&JR7&G6]M)-%-]KC%MNM)1+!-&(;@1RO)&45&;
MBO#OAI_P1JT-YO%4WC;Q)KEQ'<>(=9U+PGI^E7< L_"<5W?V]W#<V^^T$@O%
M-I;$B5YH5,9"J0S;NIU;_@C_ . M<U#3[ZX\8_$4:I8V^L!M3MY]-M=0N[S5
M/M'VR^DN8;))O,;[0Q$".MH"D9^SDH*2MR1;WY;OULVE]]D]=.[NW&I*/O);
MJ32[<J>]_-;:+J[:)2OI_P %9?AF/BA>Z5(^K1^'[72+6Z2_&CZDVJ2ZC/J-
MQ8?V9_9 M/MJSK);DE2F[#'* #<?I^WG6YMXY%#A9%# .A1@#SRI (/L1D5\
M;0_\$/\ X80^"/%&A?\ "4>.&M_&%D+#5':WT1O,B^V37;>7"=.\B%C+,V'B
MB1H]JF,QLH:OL+1-(B\/Z+9V$#3-#8P);QF60R2%44*-S'EC@<D\DU4;>S7-
M\5_PW_#:_5;J^KSJ?Q'R?#_P$OQ=V^W1V=E:HHHJ0"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KR_\ :,_:BM?V>=<\$Z0OA'Q9XTUSX@:I+I6E:?H)L%E,D5K+
M=2-(]Y=6T2HL4,ASO))  !)KU"O,?VA_V0O _P"U/XA\#7OCC2X=>M? .JRZ
MQ9:9>6UO=:?>3O;2VX^T131N'""4NFW:5D1&SQ@BW5^_]?U^*W#H^]G;UMI^
M)Q.O?\%4/@7X8NY;>^\97D,T=^--C4>'-4D^W3;IT)M2EL1=1*]M.C30&2)7
MC*EPV ?4/VA/CQH/[,WP-\3_ !!\2-='0O"NGR:C=):QB2XG51Q'$K%0TCMA
M54L 68#(ZUXIX7_X)._#OPK\5?"_BR/6_&EU<>!M5.I>&K*>ZM/L>A1-)<S/
M90A;=7-N\MT[GS'>0;(U$BHH6O5/VK?V4O"_[9GPNC\%^-)-:;PP^HVVH7ME
MIU\UD=3$#^8D,LJ8E6/S CGRGC?,:X<#(,ZNDNDF]>R6FOJM6UW5DWNZ5E5U
MUBE\V];KIH]$GYW=MEQWB#_@I?\ "/P3\*?!OB[Q%K6L:'8^-]-;5+.U?0KV
M]O;.&-HHYS=Q6D4WV;R99HX9&D(19&";B2,T_B%_P5'^$7PT\7+HNI:AXBAN
MX;ZXM+_SO#]Y:?V='#97UZUX4N(XY)[5H].NE2:U697=,+GDCQ7]IS_@CS=^
M)/">B^'_ (9^)-<LK.:YU.WU74/$'BR2XN;33-0O[2]N;11+8W4MZC36[2#S
M;F"8.>;AT9DKIK[_ ((?_#'6/%FL:UJ'B[XE:AJ&M+<1S2376G!PDUIJEJ07
M6R#RLL>K7&))FDD)CAW.RH5;23BXN4='[VC[W7*O-6>KZN]MDV48Q3Y:KTTU
M77=-^6UTM=+7WT[BZ_X*V? W_A'6OM/USQ5KETL-U/\ V3IG@G6[K5DCMX89
MI))+1;3SH(O+N;=A-,L<3+.A#X.:]D^ /QJTO]HOX*^&?'6BVNK6.D^*M.BU
M*V@U2QDLKN))%W /'( 1[,,JPPRLRE6/@6K_ /!'_P"&VN^.+?6KK7/&<RPZ
MJFL-9EM/"R3KIEMI@Q<"T^UQ(8+5"R0SQK(S/O#IM1?;_AK\ H?A?^SAIWPU
ML_$OB:ZL])T;^P[36+AK5=4A@$9BB8-' D/F1IM"L8>=BE@QW$E3E4)..LO=
MLOD^:_SLEOHK];&<>9S@GHM>;UNK6]%>_F[>9X7K/_!7?P+<_ OQ5X\\.Z+X
MAU;3_!WCBR\&7T-Q;M#+=+<:C%8G4+1(5GDN(,O*T85-\K0.@"MTU?&__!7G
MX*^%OASXA\1Z;?\ C#Q9%X7TY-1U&UT3PAJMQ-8J\YMQ#<,UNL=K.)5<-#</
M'(H1B5 !-<]HG_!%3X4^!O!#^'O"?B+XH>%-->WTB,1V_B,Z@(I],U#^T+6Y
MB%_'<+#)]H,A9(@L)$TG[H,VX$/_  1:^&175&N?$GCJ\N=8T'4-#N;MFTR&
MZE:_NQ>7-X\L-DCRS-<#S%24O;QDMLA0$@U[BC;K=Z^2BK=;:R3?2REU^S3U
M=U_5W?\ !-+K?E;]>Z^(O_!3SX4_#*^AM-2N/%D-[)=V5N]M<^&+_3I$CN9%
MC%PHNXH1-%$S!9?(,CQL=C+O^6N]_9M_:T\ _M<>&KW5O .LW6K6>GR11W N
MM*O-,FC\Z%+B%O)NHHI#')#(DB.%V.K J2*\"\0?\$5_A_XS\=7GB3Q!X[^*
M&O:Q?3">6YN[C2UE9OM$=R07CL$=E\R/Y5=F6-6*1B- JK[=^S)^R#X:_92&
ML?\ ".WVN7G]N6VEVL_]HS12;%T_3X;"$KY<:8+10(SYSERQ&T8433Y>27M/
MBZ6_K^F^R,WS^TLOAM\[_P!/\/.Y\P_\'$__ "9#X2_[*5X=_P#2AZ^]*^"_
M^#B?_DR'PE_V4KP[_P"E#U]Z5)KT"BBB@05R_P ;_P#DBWB__L"7O_HAZZBN
M7^-__)%O%_\ V!+W_P!$/0!\:_\ !M-_RAW^&O\ U^:S_P"G2ZK[RKX-_P"#
M:;_E#O\ #7_K\UG_ -.EU7WE0.6X45X]^VIX"NOBA\,+?P_9^!%\92:M=&U>
MZ,.GS/X;B>&19+V);R6-3,$+1IL)(:4%AL#9]1\.W4DUFT4FGWU@MHPAC^U2
M12-.H13O!1WXR2OS8;*,<8P21U3?]=/\_P ^S%+2WG_7^?X=T:%%%?(O[3_[
M/_Q2^(GQ0\6^+-%\/:?=K<:3=^#[&W.LHEU=:3/8R*Y\EP(5S?R1S%FF#F.V
M5=F3BEK>R_KMY;M>BN^A<(IO5V_K7\+^KLM+W/KJBOCG6/\ @G+JC>(O$DVD
M7&BZ/<3Z%!<Z5J%CID5E]AU8->DQ6921GLH,R0M+M5C-YK_/DN#C_%S]CG7/
MB/X1U;3_  O\*5\#^']2TZ.QN= %YI]O]LG_ +)U:VDN-MO.T0_X^K6#S"XE
M?;\P"1(QM1OIU_KK_E?NTD[DQM9M[6OY[)V2[Z_>FMU8^WJ*^3?!_P"R7KFK
M>,&A\;>%]&\2+X?\96KZ;JM^;6\FO]'BTKR([EP^763>(XY%(!:2)G *E37"
M^&OV-OBA;^!/!/A*\T>1?#_P]1=5TQ3JT+M<7U[:RI<1/^\Z6KO=*H.49+V+
M9GRCMSE*R;2[6\TTG\GKJNC33:948=WTN_7WE;SU2^4D[6/NRBOAGQS^R5\0
MK_X7V]]X>\(V.A^*-+\$7?AE=(M_L6DVNKB[PEQ 8X[J>+?M6.996<9DME!*
M*[ ^R3_!"T^$O@CX[:C8VOAGP!=>*I9#IFMEK>PCC#Z59VZ2/,F#&HNUD^]@
M[LL =P)UE%)-WV4OO4K+[T[]][)[D4??DHO2]OQ2;^YMKY;[I?05%?'^F_LE
MZCXE^*WAG4-#^%_A[X?^$-/GLY+S2-6LK"_M99XM/U&)[O[-:W/EEA]HMH%E
MW^:Q3+)LC0GKOVK_ (>>.M>^,.C^.-+T_1X]'^%L,.HV%Q>ZVMD9FDE_XF6$
M*F/!L4,*M-)$$,TC9*\TI1LTN[^[S>_^?Y$IMIM=DUYMVT7I?7T=K]?I*BOC
M76O@YXCC\'^!Y/$WP]DO= ^&>CVECJL5Y?:3);:O'#,K27$7FW(C\E4MQ)FX
M,38D7Y<JP63P;^R=<>.O!]VUYX5T#5M*DU;0I])LY9K*^BT>UMO$5Y<7%BI#
MLBFUM)$A9(R4_=M'&7"@44X\T;MV]ZWRO;F^[7RLTVBIV53D6JLM?EKY:.R>
MO566Y]C45\8^/_V0_$>OZ7+I>C_#O3]/U]=5U2;5?$\QL9+?Q)8322>1:LJS
M+<2H%>T)AF6-(Q8[$;"Q;M[X(?!+6/AC\6/!]O)X3LVUS2I=0BU"Y*Z8=,MM
M.EO;^9+FPA\\W=D2TJ (D;)LF6*0N8Q+&1LVEW_X/^2WMO?9"EI&3[?U_5KK
M97NSZPHIJR*[,JLI93A@#T[\TZI&%%%% !155-;LY=5-BMY:M?+&9C;B53*(
MPVW?MSG;NXSC&>*M4>8>04455TS7++6K59K.\M;N%I9(!)#*LBF2-F1TR#C<
MK(RD=05(/(- %JBBB@ HK'M?B'H%[X>NM6AUS1YM*L6G2YO4O(VM[=H"PF#R
M [5,91PX)&W:V<8-:Z.LB!E(96&00>"* %HHHH ***;)(L2%F954=23@"@!U
M%%4?$GBG3/!NDMJ&L:E8Z38QND;7-Y<)!"K.X1%+,0,L[*H&>2P Y- %ZBBJ
MO]N60U=-/^V6OV^2)YTMO-7SGC0JKN$SDJI= 3C +J#U%'D!:HHHH **** "
MBBB@ HHJOJNKVNA6$EU?75O9VL6-\T\@CC3) &6) &20/J: +%%%5=0UNSTF
M2%+J\M;9KF588EEE5#+(V=J+D\L<' ')P: +5%%% !11574]<LM$6-KR\M;-
M9I8X(S-*L>^21PB(,GEF=E4#J20!R:/("U115:/6;.75YM/6ZMFO[>%+B6V$
MJF:.-RZH[)G(5FC< D8)1@.AH LT44U)%D'RLK8)!P>A'6@!U%%4=6\4Z9H%
M]I]K?:C8V5UJTQMK&&>X2.2\E"LYCB5B"[!59MJY.%)Z T 7J*JIK=G+JIL5
MO+5KY8S,;<2J91&&V[]N<[=W&<8SQ5JCS#R"BBB@ HHIHD5G90REEZC/(H =
M1135D5RP5E8J<, ?NGK@_F/SH =15!/%.ER>)I-%74K!M8AMEO)+ 7"?:D@9
MBBRF/.X(65E#8P2I&<BI=8UJS\/:;/>:A=VMC9VL;S33W$JQ1Q(JEF9F8@!5
M4$DG@ $T!9WL6J*1'61 RD,K#((/!%+0 445Y'^V'\;]>^"W@[PO#X7725\1
M>-O%.G^%K"ZU2UDN[+3WN6;=<2P1RQ/,J(CX198RS%1N49-*^JBMVTEZR:27
MS;0:).3V2;?DDFV_DDSURBOG[X>_&+XE> _VL]%^&/Q$UCP/XK7Q9X9U#Q!I
MVH>'?#5UH)L&LKBTADBFCGU"\\T2"\1E96CVF-@0VX%?H&KY?=4^CO;Y-Q?X
MIK_@!]IQ?2WXI/\ )H***\5_:@^-'C#PK\4?AKX!\"W'AO2=?^(5QJ#?VMKN
ME3:K9V$%E;><X^S0W-L\DCED4'SE"C<2&X!AL-.I[517AG[.WQJ\<7G[1/CO
MX6^/[WPKKVL>%='TKQ!;:QX?T6XT>VGM[Y[R+R7MIKN[821O9L=XFPPE VJ5
M);W.KE&P=6GNOU2:^]-,***\)^/GQH\>/^TUX1^%?P^O_"/A_4M:\.ZCXGO-
M8\0Z'<:U D%K<6ENMO';P7EHV]VN]QD:4A1'C8Q;*RKN2A'=W_!.3^Y)OY::
MAT<GLOU:2^]M+YGNU%>+_LI_&SQ9XZ\=?$WP3XVF\.ZEXB^&NK6EE)JNAZ;-
MIEEJ4-U8PW<;"VFN+EXG3S61AYSAMH88SM'M%/LUU2?WJX:[,^"_^#B?_DR'
MPE_V4KP[_P"E#U]Z5\%_\'$__)D/A+_LI7AW_P!*'K[TI#Z!1110(*Y?XW_\
MD6\7_P#8$O?_ $0]=17+_&__ )(MXO\ ^P)>_P#HAZ /C7_@VF_Y0[_#7_K\
MUG_TZ75?>5?!O_!M-_RAW^&O_7YK/_ITNJ^\J!RW"BBB@05\>_M<?#[XG:9X
MY\;_ !4TG3H;.'1-$O=#M)K?7/)U!=(-A*[S1QA0B.+YHY]XF$FRT0!-Q K[
M"KY8^*?P1^+&H_'B^UC1=9\7VNA:AK3RHEMJ[W$-K&D&EBWD6U;4+:-( T>H
M!XP'WM*6:&3*,)Y;RMY/]$UZM-KS3?JM*=10]YZZK3O;7\TGL];'&^'_  G\
M4'^,>GZ=:0_$RQC\BWU'2(-0\:?:ET:V%W8"X?4!]K<7?F>7>E%S.RI(%_=[
MALOGX _&'7S;K.GC*S\O1X[.]GG\6+)=2:FP9;V\LYDN"]O!*ICV*AB*["1%
M%_%/IO[-7Q>T7PO;R66L^._[<N=$AM[AKWQM<W,,5W)I.I)<,%>Y901>O989
M!\I563 5C6O%\-OB]XX^(FK>)IK7QQX<2'5+&31M-N?%2+"D(N=.%R98+:[>
M!U,,5V=C[N'? WO@ZW_Y<OSN_FVK=[IV\VKO96QE3Y%=.]VK>5K1U[7:<O*+
MZW=Z-A^RWXZ_X6U<3W7_  GPT^^N8;9M1A\;7$;KI]OK&I31PR.+L3'=;3VF
M" S%0ZLP)96R-#^ ?QRT2^\'V:Z]XU73[?3K.?4WDUXZI=1:H8[/S9I/,U&
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M=:\;]KVXM)I)9I)]/L_*$8LT5559-QD8DKM ;Z!HHJ^;W5#HKV^;<G^+;_X
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M.EU7WE7P;_P;3?\ *'?X:_\ 7YK/_ITNJ^\J!RW.%_:,^+\_P)^%M]XHCM]
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MP\_BB^T./P_KZZQ8/<Q2QRW6G?9XY(8$G*&:.Z="[(Y(B3?-B*5C&%3)[?X
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M?,LY?GW&([X@KLTBJ?H$'(JG%K?^OZN@ZV_KM^::\FK!1114@%%%% !1110
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M?_V!+W_T0]=17+_&_P#Y(MXO_P"P)>_^B'H ^-?^#:;_ )0[_#7_ *_-9_\
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M[8S:A<7%BWFL[2[+:21H8M[.Y;RT7<6.<UU=%#U5GMM\NPHI1V]?GW/.[/\
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MI7P7_P '$_\ R9#X2_[*5X=_]*'K[TH'T"BBB@05R_QO_P"2+>+_ /L"7O\
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M,MQ<6-I \NV6&X2,'RK0'_2%9 .$4/\ ,7+>T?E]_P#\CKZIKJF*5E%/UO\
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MU0J=Q7(7!SC%0:S^TS\/?#OC&]T'4/&GAFQU33;7[9=Q7&HPQ?98_-$69"S
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MU;3_  1/HMQ<:EJFLRW.N:/!96M_#+IMF8M.@AFMG>[BD#8MAF'F$87;ZO\
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M_P"":%]\'=5C\$WWC";P:FC07)T\6FBVVII:^4EQ#$D;>1&DGS)Y<>4&-JC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /@O_@XG_P"3(?"7_92O#O\ Z4/7WI7P7_P<3_\ )D/A+_LI
M7AW_ -*'K[TH'T"BBB@05R_QO_Y(MXO_ .P)>_\ HAZZBN7^-_\ R1;Q?_V!
M+W_T0] 'QK_P;3?\H=_AK_U^:S_Z=+JOO*O@W_@VF_Y0[_#7_K\UG_TZ75?>
M5 Y;A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^"_P#@XG_Y,A\)?]E*\._^
ME#U]Z5\%_P#!Q/\ \F0^$O\ LI7AW_TH>OO2@?0****!!7+_ !O_ .2+>+_^
MP)>_^B'KJ*Y?XW_\D6\7_P#8$O?_ $0] 'QK_P &TW_*'?X:_P#7YK/_ *=+
MJOO*O@W_ (-IO^4._P -?^OS6?\ TZ75?>5 Y;A17/>/OBEH_P -)-)CU:34
M/.UR[-E916>FW-_+/*(I)B-D$;LH$<3L68!1MZY(S3/Q]\"K+)&?&GA,20WZ
M:5(IU>WW1WCEPEL1OXF8QN!&?F)1N.#1_7]?>OO$=;17-:A\9O!^DZOJVGW7
MBSPU:W^@P_:=3MI=3@2;3HL(?,F0MF-<21G<P PZ^HSQ&G?MR?#34[?PY(GB
M;25_X2BZO(;-7U&U#""U6\:2]8>;_P >I6RF(E7(P5)QSM.E_P"OZT?W#L[V
M_K34]<HKB6_:4^'*VTTQ\?\ @D0V\,5S*YURUVQQ2[/*D8[\!7\Q-K'AMZXS
MD5JVGQ<\*:AIFL7UOXF\/36?A\N-4N(]1A:+3=F=WGL&Q%MVMG?C&T^E&VHM
MSH:*\W\.?M=?#CQ+K_B'38?&7AN&;PV%EN6FU:U5);<P13_:HR)"3 !*%,A
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MEE!:/C/GD!L-MQE3[!155%SMN6[U?WI_FD[;$1BHP5-;*]OFN5_@['S3K/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJOO*O@W_ (-IO^4._P -?^OS6?\ TZ75?>5 Y;G#_&/X&:=\;+[PS_:TTO\
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ME:%[9Q*S'S-RRG$I<O[OI&^WYK;=NR;MKV-?:34_:+XI6O\ .R]-%?;L_(]
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MP)]CO(& ,UHC1^89=@8JPDPI&OX5_96UKQ=X(\"W&D_$'1)O#>GV&CQ6C_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#A/OVDO^B3_ __ ,.OJG_S.T?\)]^TE_T2?X'_ /AU]4_^9V@#W"BO#_\
MA/OVDO\ HD_P/_\ #KZI_P#,[1_PGW[27_1)_@?_ .'7U3_YG: /<**\/_X3
M[]I+_HD_P/\ _#KZI_\ ,[1_PGW[27_1)_@?_P"'7U3_ .9V@#W"BO#_ /A/
MOVDO^B3_  /_ /#KZI_\SM<K\0OVF_V@/AMXM\"Z+??"'X.S77Q UR70-.:#
MXJ:DT<,\>FWVHEIBWA\%8_)T^905#'>T8Q@LR@'TU17A_P#PGW[27_1)_@?_
M .'7U3_YG:/^$^_:2_Z)/\#_ /PZ^J?_ #.T >X45X?_ ,)]^TE_T2?X'_\
MAU]4_P#F=H_X3[]I+_HD_P #_P#PZ^J?_,[0![A17S+\=/VF_P!H#]G[X)>,
M?'NM?"'X.W6C^"-#O=?OH;+XJ:D]S+!:P//(L2OX?53(5C(4,R@DC) YKZ:H
M **** "BBB@ HHHH **** "BBB@ HHHH ***^9?@7^TW^T!^T#\$O!WCW1?A
M#\';71_&^AV6OV,-[\5-22YB@NH$GC654\/LHD"R ,%9@"#@D<T ?35%>'_\
M)]^TE_T2?X'_ /AU]4_^9VC_ (3[]I+_ *)/\#__  Z^J?\ S.T >X45X?\
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MAK_U^:S_ .G2ZK[RKX-_X-IO^4._PU_Z_-9_].EU7WE0.6YX?X^_Y21_"?\
M[)KXT_\ 3IX3KW"O#_'W_*2/X3_]DU\:?^G3PG7N% @HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KP_\ :O\ ^2\_LR_]E*O/_4/\2U[A
M7A_[5_\ R7G]F7_LI5Y_ZA_B6@#W"BBB@ HHHH \/_X*:_\ *-S]H/\ [)KX
MC_\ 37<U[A7A_P#P4U_Y1N?M!_\ 9-?$?_IKN:]PH **** "BBB@ HHHH **
M** "BBB@ HHHH *\/_X)E?\ *-S]GS_LFOAS_P!-=M7N%>'_ /!,K_E&Y^SY
M_P!DU\.?^FNVH ]PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH \/_ ."?/_)!M?\ ^RE>/O\ U,-9KW"O#_\ @GS_ ,D&U_\ [*5X
M^_\ 4PUFO<* "BBB@ KP_P#90_Y+S^TU_P!E*L__ %#_  U7N%>'_LH?\EY_
M::_[*59_^H?X:H ]PHHHH **** "BBB@ HHHH **** "BBB@#X+_ .#B?_DR
M'PE_V4KP[_Z4/7WI7P7_ ,'$_P#R9#X2_P"RE>'?_2AZ^]*!] HHHH$%<O\
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M922CF,/)4$G'F>C[=M+O\=$]GOY"=DGY/[U?1_=KY;'<?\)]^TE_T2?X'_\
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M@S_J[+]KK_PNO_M5?H)10%V?GW_PX,_ZNR_:Z_\ "Z_^U4?\.#/^KLOVNO\
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M0%V?GW_PX,_ZNR_:Z_\ "Z_^U4?\.#/^KLOVNO\ PNO_ +57Z"44!=GY]_\
M#@S_ *NR_:Z_\+K_ .U4?\.#/^KLOVNO_"Z_^U5^@E% 79^??_#@S_J[+]KK
M_P +K_[51_PX,_ZNR_:Z_P#"Z_\ M5?H)10%V?GW_P .#/\ J[+]KK_PNO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm212691d1_card2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212691d1_card2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*XN+ZTNT4-P52*%I79.,*'KW:BHJ1<HV3L5&5G=GQ%\-_P!HGXG?$CX8VGQ
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ME@DPK$C?&VU@K##*I'JE% 'E?Q'_ &.O"7Q4\:7FO:IJ_P 5+6^O]GFQ:/\
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M3+G,C(7("J6(50.5_P"'?/@/_H/?'#_P\_C'_P"6=>X44 </\9?V?-!^._\
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M_$:WM?"]M]DLWTKX@:]I-S,FV-,W4]K>1RWDF(E_>7+RODNV[,CEN5_X=\^
M_P#H/?'#_P //XQ_^6=>X44 </XW_9\T'X@?#;2/"E_J'CBWTO0_)^SSZ;XT
MUC3-2D\J)HE\^^MKJ.[N,JQ+>=*_F/AWW. PX?\ X=\^ _\ H/?'#_P\_C'_
M .6=>X44 </XW_9\T'X@?#;2/"E_J'CBWTO0_)^SSZ;XTUC3-2D\J)HE\^^M
MKJ.[N,JQ+>=*_F/AWW. PX?_ (=\^ _^@]\</_#S^,?_ )9U[A10!YSJW[+?
MAG6OA/I?@N;4_B,FCZ1<M=P7$'Q UZWU:1R921-J,=XM[/'^^?$<LSH (P%
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M%W)NBE:)BRH'8E"2!BN"_:E^'4_[0O\ P2NTK3?BQX9\7>'-<O--T:]U/1_
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M^4._PU_Z_-9_].EU7WE0.6X4444""BBB@ HHHH **** "BBB@ HHHH ****
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M:I>?VA<7^E:W?Z7=-.;>.V9EEMIHW3?#%$KJI"OY498,54B&#]COX>P31?\
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M>#?^$(TS3KC1H;EO$MTWB%I4TZ6*=H52U M0;H2?(X9_(PC'< R[#Y_\4/\
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M THW5/D>_O/YWC;_ ,E4KKTMU9I4E%M-+2ZOZ<BC_P"EV?HWU=CRCP__ ,%
MO%WQ$U?26\*_#/2;S1?$FO0^'M(N]3\5M8W$LTFCKJQEG@6RE\J)8=\9VO(Y
MD083:VX>]_!'XF_\+B^$N@^*&L6TM]8M%GEM#,)OLS\AT#X&\!@0&P,C!P,X
M%?3_ -G_ ,)Z9J=G>QZ;,UY8ZR?$$,TM]<32?;C9&P,[%Y"7)MF*$-E23NQO
M^:F^ _@G9?#?Q)Y^EZAJT.AV^DQ:59:$;IWL;/;-++).%8DM+)YBJ68DA8E
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M4M>\-K?C9Z_?^1Y_:?M&>/OAQ\</%S:]X9TNZ\.+J_AS2[]H/%,T_P#8UQJ
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MFV:$[9"6E0E&'K4_[1?P5\2)I_C!_B!\-;V'1[I]-L]6_P"$ALWAM;BXBW-
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M\+>*[J[T2ST[Q5;6ME8R&!W%A*EW,MW<S0)'8Q1-(('#.K+N/VM-\?O EO\
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M+34+"35M%N]0C@6W\06,<JQ/<VWERNX0-)$<3+$Y6:-@I!.*IS;FJD-_?_\
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M#&564LF6&;C\=/\ FW\[)NRZZ)MZ:_(QH5.14ZD-++W7ZR23^<HI:Z>5S@_
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M]K%[=6L<9BC4P106L-U]KD'F9$$D5S:%" 6)NX@57+;<8QYX)KL[][<]KO\
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M?LW?$OX;>+H-<TS3?A[KEQIL_B:RMK74-;NK:.>RU74TU".<R+92&*9"@B>
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M9V,#!B651,J$D+\Z..<9/4U4VW9OLOFK*S\[K6_7<QC:VGG^>VG;:W0^"_\
M@XG_ .3(?"7_ &4KP[_Z4/7WI7P7_P '$_\ R9#X2_[*5X=_]*'K[TJ2^@44
M44""N7^-_P#R1;Q?_P!@2]_]$/745R_QO_Y(MXO_ .P)>_\ HAZ /C7_ (-I
MO^4._P -?^OS6?\ TZ75?>5?!O\ P;3?\H=_AK_U^:S_ .G2ZK[RH'+<Y3XP
M_">#XP^&[.PEU;5M#GT[4K;5;2^TWR/M%O-!('7 GBEB(."I#(>&.,'!'*^
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M5_*^MCIM:_8Q\'^)?"<>AZD^K7VE_P!I:[J4L$DZ 7+:N+Q;N)RJ ^6!?3!
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ME9^FCL]5[KMM9:)6[_\ !5_+5-=.OG?H_ G[-NA_#W6/"-]976K2S>#=(O\
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M?V6? >N:*^G7>@+/9R2ZG,8VNY_OZC,T]XP._(+RL7!!_=G&S9@8N>$?V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?!?\ P<3_ /)D/A+_ +*5X=_]*'K[TKX+
M_P"#B?\ Y,A\)?\ 92O#O_I0]?>E ^@4444""N7^-_\ R1;Q?_V!+W_T0]=1
M7+_&_P#Y(MXO_P"P)>_^B'H ^-?^#:;_ )0[_#7_ *_-9_\ 3I=5]Y5\&_\
M!M-_RAW^&O\ U^:S_P"G2ZK[RH'+<\<_;5_;)L_V(/A5-XTUCP-X^\8>']/A
MFN=4G\,6UG.=(@B4,TTXN+F#Y3G V;SD'@5S/PE_X*.Z%\3OB9\.O"-]\/\
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MMV#_ ()N_%RU_;'A_:-C\4>#_P#A:"^(?[-?1S=7/]A_\(9L\D:>)/L_F_;
M!]H\WR]OFDKG9S6M-0<HIO2^[T=O<LVNC;<D^T;RU<5SJI=1DUOKINOM;/KH
MD^EY<JT4I<GJ^E_\%4_A[JTUOI<>B^-5\93^.V^'O_")/96XUJ._4%VG:/S_
M "Q:"W'V@S^9CRL$ L0M>O\ [2_Q[TW]ESX#>*?B%K&EZWK&D>$+!]2OK72(
M8YKQH$P9&19)(T.Q<N<N/E4XR< _/'Q9_8I\4>"_V_O''[27@OPSX1\1:X/A
M=)H>A:5)-Y-_?Z^DK-')(7$<*QO"(H3*9U?:"O YKZ3T[PIJ'Q%^!D.A^/K?
M2YM4UW0Q9>(8+"-ELGFE@V7*1*[.PCW,X4,S'&,D]:QES?5^:/QVVZ7U27HW
M'F\E-+I=Z+D6(2E\%^G;23^Y24%W<)/R7BDO_!6#X50?M2ZM\)V;7EUG1O![
M>-I]3,$']EM9K;I<F)9/.WF<0.LFTQA=ISNK2^"'_!2CP7\=_$L>DZ?H/C32
M[V3X>6GQ+V:E:6T>W3;EY%BC.R=S]H_=DE?N ,OSDY ^#[C_ (($?&R;]GVX
MTO\ X6%X';XB7'BI[=]<-S=[)?"3Z(NCM:LWV;=]J-NBG;MV;AGS,\U]-?&'
M_@CWX9^.O[7NL>,/%GAKP+XD\$V_PQLO!OAK3]2626YTN_MYIV6?9Y>Q8Q'(
MBAE=FR#\N.35:R@W3UT=N_P3EMZNG!+K*,KV3N9Q33BI>5[;?'".GK%3GY1E
M'1M:[FA?\%D_"?CW5/ FG^#OA7\9O&^J?$#P<GCFRLM'T_2S-9Z<URUMF?SK
M^-5<2*,A"XPR\GD#2O\ _@L5\*=*\2?';1;FQ\7P:U^S[8'4]?L'M+83ZC J
M!G>R_?XEV%D5O,,>&=>QS7R]IO\ P13^)?AK7?@KJ%]X7^ /Q0C^&_PS@\&W
MFF^*M7U&"UBU"._DN?MELT=A(6"HP4%PC?,W P">C_:U_P""*WC_ ./?@/XR
MWOA_Q)X/\._$+QMXSN]7T*]-S<?97T:^TZSLK[3KUOLY90_V<R#8D@#10D,"
M3MTFHJ3Y=OWGW^T4:?RY'S/1W2=G?153BGR<VGP7_P# +S7E[WNK:S>NBN_N
M3X__ +47A_\ 9R_9?UWXLZW9ZQ=^'?#^D#6;BVL8HY+YX2%.U%>1$+_,."X'
MO7S[J/\ P6U^'ND>%IYKKX??%V#Q5;>)=)\+2>$)-+L%UL7.J023V$@!O/L[
M0S)&V&6<D' *BO4OVTOV7=?_ &C?^">OC#X2Z)>:/:^(O$'AE=&M[F^EDCLD
MF"H"SND;.$^4\A">G%>&_'S_ ((N>&?$WP&^'_@KP%I^FZ&MGX^T3Q7XTO+S
MQ!J;7VLV]G%)%.(KXM)=>=M?$0\R,(/NM'@5+BO;2C]GF@EZ.?O/T4;ZZ]-"
M:+O1BY_%RS;]5!.*^<M+:>NEGW]A_P %>_ASK7PZT74]-\,_$;5/%GB#Q#?>
M%;3P+:Z3"_B4ZC8\WD31&<6ZK I#/(9_+ 8?,2<55\4?\%B_A_X5^' U:;P7
M\4)/$T7C&S\"7O@L:7:1>(M.U2[C:6V26.6Z2 QRHN5D29U;<,$\X\J^&'_!
M*_XJ?LZZ?\/]8\$ZO\.;KQ=\'?$GB(>'8]6FNDM/$N@:LX9DU*:. RQ:@F%_
M?(D^_P L;BVXXH?%K_@CW\0/VD;V\\5>.M:\%_\ "8^-OB=X=\5>*;'1M1U"
MST^PT72;>6V6SLKI(UN7N3'*S>:1!EFX*;02XI2<>E^6_2UY03MOIRN3=[\K
M5KNWO5&RYN;ISVMK>RG:^W51M;XM-N9\GJ>C?\%I?!/C;7O#>B>$?AG\9/&7
MB;7X-2DGT/2]+T]+_1)-/N5MKN"[6XO8D62.1U'[MI%(8$,:T/%'_!8CP+X*
M^.6L>"=6\"?%2QA\-ZWI/AW6O$3:;9/H^D7VIQ126L4S)=F<9,R(2L+ -GG&
M&/D_[5'_  1HCU;XT?#74?AG\-?@IXC^'_@?P]J.ER^&/'.JZC#')=W5U'/]
ML$D=M=/++E7W/*VYBY))ZU3\=_\ !';QOXE_:G\6?&6UO?!*^*YO''AKQ/H6
MF7.JWTFC26EE916U[;7=N8#$),J[V\RQ/(A2,[H\L \/RRE!SVO[W_@Q1T\N
M1N6[LE>[?NO.MS14E#>SM_X VK^?-:/37HEJOH/4?^"I_@'2O@=KGQ&GT'QN
MGA/POXZG\!ZW>"RMF_LB:&Z%K)?S 7'%BLA7,BYD"L"8QSCTOX&_M5^'/VB/
MB!X^T/PO;:M>6GP]U&/1[[6S'%_9=[>F,22V]M()"\C0AD$A**JLP +$''S;
M^S1^Q)\9/A;X=^+7PX\5:3\'==^%OQ,\0^)M;>Y76;^75 FIM(\,,EJ]DL)
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M ()?^/?@5\._@%X@\ ZYX/OOBY\((=3.L+KTERFC^*9=7_>:F6GBC::)O/\
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MP%U7&5)X^K_#?B*S\7>'=/U;3IUNM/U2VCN[69/NRQ2*'1A[%2#^-?FAKO\
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MX#^(W@W6OBQKEUH.EZ;K5G9I<64UO;R7!DN?*NI$6)XXSM:-I"20"J\XZ?\
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M?^#:;_E#O\-?^OS6?_3I=5]Y5\&_\&TW_*'?X:_]?FL_^G2ZK[RH'+<^;?\
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M&D6SQ21,;62.TC/F%9.7G\TDHN<\YA\5?\$R_AMX\G^'*Z\==UC3_AKX.OO
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MX3^'.K_''P!XVT'PRPAM[UM!UVVU>!YK::&(SK-#*=FPHTSA2,Y8$8O>+?\
M@M'XH\4?M-_ KP]\/=!\,7W@;X@:-IU]XHU&_AGDNM-N]0L[RZMK2$I,BJZI
M92EPZ.<%>G?W[1_^"5/P]T[PW;6]YKGCG6]</C;3O'VJ>(]2U&&XU;7]1L"/
MLZW4GDB/R%4!/*BCC 7A=I))POAC_P $7?A%\(9X)-#O/&%NUOX[F\?1[KRW
M;;=26DUJMH/W'%G%'/)Y<8^=21ER,@EGR.[]Z\7Y:0A&2]')SDMK.*T2E97)
MQO[JTY6OFW)I_)*,5OI)W;<;OYX^"7_!<;XA:W\0O@+)XS\+^#X? ?Q$\%P:
M[XNU73;>XBD\.W5UJMQIMK*OF7#@6IF6V1PRLRF8MO"C%9US_P %I_BUK#?"
M>WB;X:^&&\=:9XBOK^\F\#:_XD6-]/UB2QACBMM.N3.H>)0S.^Y0P/*@A:^I
M?AG_ ,$>_A/\-O",.@FZ\5Z]H\?P\E^&<EKJEU;R)<:9)=R7;2-Y<"'[0))2
M ZD* %^3(W5S?@7_ ((F>"OA)HGPZMO!?Q2^-'@Z^^&>D:AHFFZGIFHZ7]LN
MK:]O#>3K.9;"1&/F$ %$3"J,Y.2=I.'.GTYI/_MUNIRK_MWW-?.UO=USC?V=
MNMH+YJ,>9]?BES?<G]K3DO 7_!2/XH^-?^"CWBSX/S:C\/=/T3PEJVEV"PIX
M#\07M[K*3Z?%=3D7T4YL[)MS.J?:5& 5R&()/:_\$W/V]_&O[6WQ-\6:3XZO
M/A[X5UK1?M'F?#V/2]0L?%?A\)<^7%)=27,OEW431X)E@A5-SH >U=MX0_X)
MO6'P_P#VE]?^)VA_%CXO:9J'BZ^L-0U_1X;W33I6M26EM';)YR-8F;#)'\^R
M522S8*C &M\$?V -%^$'Q^E^)FJ>.OB1\1O%\>DRZ'I]UXKU&VN%T>REF6:2
M&!;>W@'S,B9:3>^% W#)S%-I<O-_*[^O*M5ZR[[+5<NTIDFXRMO=6]+NZ^ZW
MS23<MUPWA_\ ;P\7ZKX$_:XU233?#:W'P#U'4;/P^JV\VR\2WTJ.\0W8\W+D
MR.0?+,8VX  /->2? W_@JK\2_BK\>OAGX;\22?"_X8Z1XS\->'M8LY/$&D:F
M6\<7%_:1SW<6DW0G6VA:&1_*6&4RRLP[YX]F\0_\$I/#^L^/?B=J]K\4_C!H
MNE_%^>ZN?$WAZPO],72KM[BT^R.0LEB\RXC"D?O3\RC.1D&0?\$H_"=Y_P *
M_P!/U/X@_%;6O!OPU&D/I/A*[U2S_L9I]+ACCM9Y5CM4F9\QK(P658V?)V '
M;48>UH^U[4D_51DJC]6VFEL^MMUM7<7"4:>]ZC7S<7!?)*2?9/2^QXMJ'[;O
M[47A#XQ_'SP[JU]\ [RT^!'A&+Q3=26GA?5H9-6$]E=7$42%M281[6MP&)!W
M G&T\CD/!O\ P5L^-7BS]B_3_B%9W_PIU'Q)XBUSPOHMK9O\/_$>DV6COJLW
MER^8]W=*+X)N7;):R;/D))8.M?9_B7]@OP?XI\>_&;Q%<:EXD2^^.7ARW\,:
MZD=Q"(K2V@MY[='M08B4D*7#DF0R+D+A0,@^8M_P2 T&]_9TM/A?J'QC^.&K
M>&]&N=(NM":ZU#2?M/AUM,?=;"U9=/5<<(&\U9,B-<8YR4]/C_Z=_<IMU%\X
MV2_-=:K.+7[O1^]^,(\OW3YGZ='I;I/V4OVK/B#K/[37CGX+?%S3?!Z^,_">
MCVGB:RUCPJMQ#IFL:;<R21 F"X>22":.2,JRF1PP.0<5X=/_ ,%./C9JG[-.
MO?M)Z3X=^&4GP,T+5;E!X?F6]_X2B^TNVO6LYKP77FBVCE+(\BP& _*NTR9.
M:^H_V7_V(O#?[+_B;Q-XDAUSQAXW\:^,C"NL>)_%6H)>:G=Q0@B& &..**.&
M/<VU(HT&3DY/->;:O_P1_P#AWJ^I:E8_\)7\3K?X<ZQK9\07_P .H=:B7PO=
MW33"X?=$8#<")YAYC0K.(BW\&.*J/Q1OO97?2_,KW6E_=TZ:W=E=..4>6TKK
M2ZLNO+RM-7Z-RLUV6FMK/Y]\??\ !;WQKX \9_M(Z9>>&O"MM8^!;.^D^&VI
MS6UP(-:N[*R@N[BSO5\_+2B&YBE41^5N19,9*DCW'_@I9^UE\9?V7_V2]-^+
M'P]D^&36=K;Z?_:^G>(M'OKN6XFO+BV@0P/!=PB-$,S$APY.!@COI_'S_@CI
M\)?VD/A9\1O"?B*X\5?8_B1XM3QI<75K=6\=UH]^L$-O_H;& K'&88=A619"
M1(_/(V^K?M*_L@>&OVI_V:IOA7X@OM<L_#\WV -<:=-%'>#['/#/%AGC=.6A
M4-\G()Q@X(*?+R4U+=>SOYI+WWZZM>?*I;O0VG?H^?Y:KEMY65_)MK:Q\O\
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M//BE\=/$6B>$;KX-6GBZ#7O"_B2;PXWCK6'F$<[->H8IG6"$HQB!0LSEW7C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFT.REOE1O,,C7"R/%;B6$SND;>7YJCYB&"D8MNR\OQ:2?HVTK[7TW'MJ_/\
M#5KS=M;;VUV/J:BO,_@=^U7X;_:(^('C[0_"]MJUY9_#S48]'OM;:.+^R[V]
M,8DEM[:02%Y&A#()"4559@ 6(..(^&7_  43T+XV_%N;P[X,\ _%#Q1X=L]7
MFT.Z\;V6E6Z^&K>ZA++,OG27"3R(DBE&DB@=-W\1 )$K5I=U=>CM9^CNM?-=
MP>B<NB=GZZZ>NCTWT?9GT'17S[^R1_P4K^'/[:6I?$BU\'Q^((Y/AG>R6MZ=
M0M8X5U2)7FC%W9E9&\VW=[>95=MAW1D%17E?P[_X+J?#'QWX O?$EUX&^+7A
MG35\':AXYTHZOI=BI\1Z=8G%R;0PWDBF1"0-LS19R.<4KV5WVYOE9RO]R;]$
M^Q7*^;EZWY?G=*WWM+YKN?:U%?.7[-G_  4P\)?M#_$O1_!]YX/^(WPW\2>)
M]'_M_P /6GB_3(+9?$5D%5GEM)K>>>)RBNK,A=9 "#MQS6-^T?\ \%;/ /[+
MOQUUWP3XB\*_$:XM_"=IIE_X@\2:=IUK/HVA0:A*8;>2=C<K<;3(-I*0/CW%
M6X24XP:UD[+S>J:^333[--;F<9*2<HZI6?WVM]]U;O=6/J:BODSX8?\ !8CX
M>_$SXSV_A%O"7Q(\/V=]XGU/P=8>)M5T^S70[_4]/$C3P)+%=22KE(G96DB0
M$#D@\5/X._X*]?#[QAJV@W7_  B/Q/TOX?\ BO5UT/0_B!?Z+%%X9U6Y>0Q1
M!)!.;A(Y9 4266!(V./FP02H)RY>7[5K?.UOF[JRW=U8J32O?I>_RO?[K.[Z
M6=]CZLHKY5^'O_!8?X3?$&]^/5N+?Q7H\G[.XNG\1_VC9P1_;H[=YXWDLMDS
M>:OF0,HW^6=SH"!GCC]/_P""ZWPY\1?#3X>^)M$^''QEU]/B19:WJ%AIUAI6
MGM?V5OI$HCO'N(VO55=O+ 1L[%0> ?EJ;JW-TLG?I9IM/TLF_*SN5*G*+<6M
M4W'_ +>5M/75>MU8^VJ*^-](_P""SWACQ;\1/"/AWP[\'?CIXD;Q]ICZWX;O
MK'2]+6UUG3T\LR7<?G:A'(L:^:F1(BOS]VNPA_X*H_#\_ ;1?B7<:)XTL_!N
MJ>,I?!5U?S6=MMT.Y2\>S^U7>VX/EVK3H%$B[R-Z;E7)Q?)*Z5M6[?/F4?\
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M +*5X=_]*'K[TH'T"BBB@05R_P ;_P#DBWB__L"7O_HAZZBN7^-__)%O%_\
MV!+W_P!$/0!\:_\ !M-_RAW^&O\ U^:S_P"G2ZK[RKX-_P"#:;_E#O\ #7_K
M\UG_ -.EU7WE0.6Y\V_\%,?V)=2_;K\ _#CP[976GVVG^&_B!I7B76A<ZA=6
M$L^GV_FB>.WFME,BSLLGR$-'@\[U(!KSGXL?\$ZO%OP:^/?P3\6?LY^'_AC8
M:+\*],UZQGT;Q/K6H6@NI-3,!:83QV]U)+)NC=G>4[F+#).21]L440O#X--6
M_5N*@[^7*M.S;8ZDO:)*>J227RDY+YW?Z'Y[_!;_ ()P_%CX7?MJ^.?B]?\
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M&S^WJJZ>3"PC 0EV!5@23^E-%;2JR=55W\2_22EMMO%/:RLK&48I0=/H]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!_\ \HJ/^&4/'G_1S7QP_P#!5X/_ /E%7N%% 'A__#*'CS_HYKXX?^"KP?\
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M5X/_ /E%7N%% 'A__#*'CS_HYKXX?^"KP?\ _**C_AE#QY_T<U\</_!5X/\
M_E%7N%% 'A__  RAX\_Z.:^.'_@J\'__ "BH_P"&4/'G_1S7QP_\%7@__P"4
M5>X44 >'_P##*'CS_HYKXX?^"KP?_P#**C_AE#QY_P!'-?'#_P %7@__ .45
M>X44 >'_ /#*'CS_ *.:^.'_ (*O!_\ \HJ/^&4/'G_1S7QP_P#!5X/_ /E%
M7N%% 'A__#*'CS_HYKXX?^"KP?\ _**C_AE#QY_T<U\</_!5X/\ _E%7N%%
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M_P"G2ZK[RKX-_P"#:;_E#O\ #7_K\UG_ -.EU7WE0.6X4444""BBB@ KP_\
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M'_T'OCA_X>?QC_\ +.@#W"BO#_\ AWSX#_Z#WQP_\//XQ_\ EG1_P[Y\!_\
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M/_X=\^ _^@]\</\ P\_C'_Y9T?\ #OGP'_T'OCA_X>?QC_\ +.@#W"BO#_\
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MQC_\K*/^'@W@/_H _'#_ ,,QXQ_^5E 'N%%>'_\ #P;P'_T ?CA_X9CQC_\
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M * /QP_\,QXQ_P#E90![A17A_P#P\&\!_P#0!^.'_AF/&/\ \K*/^'@W@/\
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M >X45X?_ ,/!O ?_ $ ?CA_X9CQC_P#*RC_AX-X#_P"@#\</_#,>,?\ Y64
M>X45X?\ \/!O ?\ T ?CA_X9CQC_ /*RC_AX-X#_ .@#\</_  S'C'_Y64 >
MX45X?_P\&\!_] 'XX?\ AF/&/_RLH_X>#> _^@#\</\ PS'C'_Y64 >X45X?
M_P /!O ?_0!^.'_AF/&/_P K*/\ AX-X#_Z /QP_\,QXQ_\ E90![A17A_\
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M=HZ!A"^&9<KC->J44 >'_P#"??M)?]$G^!__ (=?5/\ YG:/^$^_:2_Z)/\
M _\ \.OJG_S.U[A10!X?_P )]^TE_P!$G^!__AU]4_\ F=H_X3[]I+_HD_P/
M_P##KZI_\SM>X44 >'_\)]^TE_T2?X'_ /AU]4_^9VC_ (3[]I+_ *)/\#__
M  Z^J?\ S.U[A10!X?\ \)]^TE_T2?X'_P#AU]4_^9VC_A/OVDO^B3_ _P#\
M.OJG_P SM>X44 >'_P#"??M)?]$G^!__ (=?5/\ YG:/^$^_:2_Z)/\  _\
M\.OJG_S.U[A10!X?_P )]^TE_P!$G^!__AU]4_\ F=H_X3[]I+_HD_P/_P##
MKZI_\SM>X5\__M)_M!>+?AKX_P!6M=!.FM'IND6306=XNV.[FNWO<RF0*S+Y
M0LD5< C,S[E;Y",ZE105W_7]/3_@79I"#E>W37^OZ_$T/^$^_:2_Z)/\#_\
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M=AGN;<$RM9!3(TD$8 4M$HN(S)-'S6E2FX;^?X.WK^NJ(B^:*GT_K?TZ_P#
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M^(M>N+-;CPSI]Y'XUU5H/##2:TL+1 BP/DW:K;'R507G$@,K.4 V@N@JU?\
M_!2>2PN)-/\ ^$'DFUV.X2/['!J4EPIB:Z@L%N 8K9Y&B-]+)$-L99HX&D"D
MGRA7*]+];?>TG;U2:O;UVU)C-2=EY_<FXW]+IG:?\)]^TE_T2?X'_P#AU]4_
M^9VC_A/OVDO^B3_ _P#\.OJG_P SM=%K_P ?M2T7]F&;Q\WA>:WU:*R$YT/4
MKB33]LQD$?EO+)#OC3<<AVA!VX.P9Q7CNO\ [?OB+PU\2;ZQ3P?=:Y>+9F :
M%IDDUXL5S:W.K1W,D4T%H\TOF"SA1%>-%#,-QCPQ*M[W+U-$KPYUMI^+LO\
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M=KW"B@#P_P#X3[]I+_HD_P #_P#PZ^J?_,[1_P )]^TE_P!$G^!__AU]4_\
MF=KW"B@#YSU#P1\;OC'\</A+JGB[P?\ "OPKX=^'OB6Z\17<^C^.K_6KVZWZ
M'JNFI#'!+H]JG^LU!'+&886-L*Q(KZ,HHH **** "BBB@#X+_P"#B?\ Y,A\
M)?\ 92O#O_I0]?>E?!?_  <3_P#)D/A+_LI7AW_TH>OO2@?0****!!7+_&__
M )(MXO\ ^P)>_P#HAZZBN7^-_P#R1;Q?_P!@2]_]$/0!\:_\&TW_ "AW^&O_
M %^:S_Z=+JOO*O@W_@VF_P"4._PU_P"OS6?_ $Z75?>5 Y;A1110(**** "B
MBB@ HHHH **** "BBB@ HHHH **** "LC7_ &A>*]0ANM4T;2]2N;>-HHI+J
MU29HT8@LH+ X!(!_"M>B@#E?$GP>TGQ3XO\ ".K7'G*O@F66YTNQC2);6*9[
M>2V$N-F\%(9944*RKB0Y4D*12NOV9_AO?:0NGS?#_P $36"7)O5MGT*U:%9R
M IE"%,>8551NQG"@9X%=O11=[_UO?\PZ6_K^O\V9FI^"M&UN\>XO-)TR\N)!
M"'EFM4D=Q#(TD()(R?+D9G7^ZS$C!)-8=K^S[X!L=*AL8/ _A"&QM_.\JW31
MK=8H_.C$4VU0F!YD8"-@?,HP<CBNOHH"[O<Y&Q^ '@/3-3TF]MO!/A&WO/#Y
M)TN>+1[=)=-)+L3"P3,>3+(3MQS(_P#>.9;/X&^"=/\ &,_B*W\'^%H/$%T_
MF3:G'I,"WDS;M^YI@F\G=\V2>O/6JOQY_:%\%_LQ?#R?Q5X\\06?AW0K>5(/
MM$ZO(TTKG"111QAI)9&/"QQJS-V!KS34O^"G_P $M%^&FG^*[WQ5JEGINK:F
M^CV-K<>%]6BU:^ND19'2+3FM1>2!4=6++"5 ().*7,F[KI^%[?G=>N@.+:LU
MO^-K_EKZ:GIG@;X$^'_ &K>(KNSMDD_X21(+>>W>W@2WM[6"(Q0VD<<<:CR4
M5GPK;C^\;)(P!<\4_!?P=XYTZ&SUOPGX9UBTMK<6<,%]I<%Q'% "K")5=2 F
M40[1QE%XX%>3ZC_P5&^ ND?##PUXRNOB)8V_ASQ9X@7PKI]T]A=JR:H=W^B7
M$7E>9:2#:2WVA8P@^\1D4?&S_@I_\$OV>-8\46/BSQ5JEG<>"KB*VUTVGA?5
MM1CTMY+=;E#+);6LB*IA=6WYVC."000'+367]62_22_\"7?4C[SM'?7\W?\
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MJX\4^7!\5-*N=;\+-_9MV?[4L[>T%[-+@19BVVY#[9=C'.T M\M<#I'_  6
M_9_UOX1ZMX\A\7>($\'Z-':2W&J7'@K7;>&1;J98(##YEFIN-\CJN(0Y&03@
M<TY1:DXRWZKK>[6OS37JFN@1TBI+9ZI]UY'MF@_ ?P3X2TN6ST?PAX7T>WF=
M96CLM)MX4\Q)6F1]JIM++,[R D'#LS=237)_"W]BOX>_"_1+BS_X1_2-<:XU
M0ZR9M1TBP'DW7DPP"2**""*&$B."(9CC4DKDY))J?]F_]M#X9_M:MK$?@/Q,
M-5OO#LB1ZIIUUI]UIFHZ<7&4,MI=1Q3HK $JS(%;'!-2ZC^V+\-=)_:CL?@K
M<>*K6/XG:EI1UNVT,V\V^6T!;+^;L\D-\CGRRX<JI;;CFBS3MUDOO5N;\E?T
M5]D'-HWVW_+7[[:]6;FD_L]^ =!\,:KHECX'\'V6BZZ0=2L(-&MH[74"  /.
MC5 LF  /F!Z5-#\"_!-M<V,T?@WPK'-I<+VUG(NDP!K2)]^^.,[,HK>9)E5P
M#YC9^\<^?7G_  43^#.GWWQ6M9O&UNEU\$8A/XU@_L^[,NC1E2P?;Y69UP#S
M )!GCKQ7-^,?^"MO[/OP^^).I>%-:\>3:9JFC36EOJ,T_A[5%T[3GNHDFMQ/
M??9OLL6])$(+R@?-@X.14Q]^UM;I->:>B:[IWLNX/W;WZ-W]5J_FM&SW&7X5
M^%YI$9_#>@NT<\=TA;3XB5FC6)4D'R\.JPP@-U BC ^Z,4]<^!?@GQ-;"'4O
M!WA74(00P2YTF"900TK X9".&GG/UFD/\;9Y[]I+]KWP!^R3\/[?Q5X[U;4M
M/\/W3$+>V&AW^KQHHC,AD<6<,QCC"*3YC@)[\BN A_X*N_ >;X6Z;XR_X2_5
M8]%UJ^_L[2TE\*:Q%J&KS>4LQ^RV36HNKA!&ZL9(HGC /+#!HYKW\K7\GI;T
MZ6^0TG9);-.WFEO\EU/:-4^#_A'7--DLKWPMX=O+.;F2"?389(W_ '_VCE2N
M#^__ 'O^_P#-][FJ<WP \!W/@D>&9/!/A&3PV)C<#2FT>W-B)3D%_)V;-QR>
M<9Y-5O@)^T?X)_:>^'W_  E'@77K?7M%6>2UED2*2":TGC.)(9H9566&5>\<
MB*PR,CD5Y#\./^"OG[/'Q8;4/[$\?32+I^EW^M,]WX<U6Q2ZM+$$WDENT]L@
MN3"%8LD!=A@\4I65XR[7?IO=^6E[_,<%*2O'NEIW>B7J]DM^A[!8_LV?#K3(
M[Y;;P#X*MUU2)(+Q8M#MD%W&FP(DF$^=5\J/ ;('EIC[HQ?G^"W@VYL9+63P
MGX9DM9=/BTEX6TN QO9Q,6CMBNW!A1F++']U220 37'?LP?ML_#G]L>PO+OX
M>ZEKFK6=E!!<M<7OAG5-(AFBF#&-XGO+>%9E8*3F,M@8)QD9Q+;_ (*1_!F_
M\8>,M#MO%EU=W7@"WOKG7KBWT'4IM/L5LDWW2"\6W-M)+$N=T4<C29!&TD$"
MJEXZ3TT;U[+=^B3U>RN33CS:0[I:=W:R]79676R.RUO]F'P5K'@?Q'X=CT6W
ML-)\5+#'J-M;JODR1PI'&D2Q.&C2+9&J^6J!#ESC<S$Z%Y^SUX!U#2(=/N/
M_@^>PME5(;:31K9H8@IE*A4*8 !FF(P.#+)_>;/FWCS_ (*:_!+X<:+X/OM1
M\8W%Q_PGFDQ:]H=GIF@ZEJFHWEA(@=+HVEK;R7$41##YI(U /!YXK5\)?\%
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M\!/ R1W"+X-\*QK=79OIPFE0+YUP0X,S87YI")906/)$CC.&.>LHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X+_P"#B?\ Y,A\)?\ 92O#
MO_I0]?>E?!?_  <3_P#)D/A+_LI7AW_TH>OO2@?0****!!7+_&__ )(MXO\
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M"44!<_/O_C9Q_P!6B_\ E8H_XV<?]6B_^5BOT$HH"Y^??_&SC_JT7_RL4?\
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M\^_^-G'_ %:+_P"5BC_C9Q_U:+_Y6*_02B@+GY]_\;./^K1?_*Q1_P ;./\
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L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
